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A New Approach to Kainoids :  
Total Syntheses of (-)-Kainic Acid and (+)-Allokainic Acid 
 
Young Chun Jung 
ABSTRACT 
 
 (-)-α-Kainic acid and its C-4 epimer, (+)-α-allokainic acid are parent members 
of a class of substituted pyrrolidines known as kainoids. They have been found to exhibit 
powerful biological properties, principally neuroexcitatory. Kainic acid has become  
especially important in the study of Alzheimer’s disease, epilepsy, and other neurological
 disorders. The total syntheses of (-)-α-kainic acid and (+)-α-allokainic acid were 
achieved using (L)-glutamic acid as the starting material and the sole source of 
stereochemical induction. The key steps for these successful syntheses involve formation
of the γ-lactam core via rhodium (II) catalyzed intramolecular C-H insertion of the 
α-diazo-α-(phenylsulfonyl)acetamide intermediate and the stereoselective 
dephenylsufonylation.                                                                         
Pd(II)-catalyzed and oxygen promoted carbon-carbon bond formation 
methodologies using organoboronic reagents were developed. The first one is a mild and  
efficient Pd(II) catalysis, leading to the formation of carbon-carbon bonds between 
a broad spectrum of organoboron compounds and alkenes. Molecular oxygen was 
employed to reoxidize the resultant Pd(0) species back to Pd(II) during catalytic cycles. 
This oxygen protocol promoted the desired Pd(II) catalysis, whereas it retarded  
xvii
 
competing Pd(0) catalytic pathways such as Heck or Suzuki couplings. The second one  
is the formation of symmetric biaryls and dienes via oxidative dimerization of aryl and  
alkenyl boronic acids. These conditions utilized Pd(II) catalysts under an oxygen  
atmosphere with water as the solvent. The use of phase transfer catalysts promoted  
efficient and mild syntheses of a wide range of materials.  
xviii
 
Chapter One 
Introduction of Kainoids 
 
1.1 Isolation and Structural Features 
The kainoids1 are an important class of natural non-proteinogenic amino acids 
which have a common characteristic structure consisting of a pyrrolidine nucleus with  
two carboxylic groups A1 (Figure 1-1). Common to all members of the kainoid family 
is the S-absolute stereochemistry at C-2 and a trans stereochemical relationship 
to the adjacent substituent at C-3. With the exception of allokainic acid A3, all of the  
kainoids isolated so far have possessed a cisrelative disposition of the C-3 and C-4  
substituents. Some of the members of this family like (-)-α-kainic acid A2, 
domoic acid A4 or acromelic acids A A5 and B A6 show interesting biological properties
 as explained in Section 1-2.                                                       
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Figure 1-1. Structure of kainoids  
1
 
The parent member, (-)-α-kainic acid A2 was first isolated in 1953 from the 
Japanese marine algae Digenea simplex2  along with its C-4 epimer (+)-allokainic acid 
A3. Since then (-)-α-kainic acid A2 has been found in the related algae Centrocerus 
clavulatum 3  and the Corsican moss, Alsidium helminthocorton. 4  The structure was  
originally assigned as 3-carboxymethyl-4-isopropenylpyrrolidine- 2-carboxylic acid 
in a series of classical chemical degradations and syntheses of degradative products by  
several Japanese groups5 in the mid 1950's. Among the early and important degradative  
reactions were a soda-lime distillation that led to the isolation of a pyrrole,  
and an ozonolysis which yielded formaldehyde.5 Morimoto6 was the first to deduce the  
relative stereochemistry of the pyrrolidine ring substituents by chemical studies, and this 
has been supported by X-ray evidence.7
Since then a rigorous assignment of the absolute stereochemistry has been  
provided by Oppolzer and Thirring8 in their concise synthesis of (-)-α-kainic acid A2. 
In a similar manner, the structure of the C-4 epimer, (+)-α-allokainic acid A3 has been 
established on the basis of chemical9 and X-ray7 evidence.                                           
(-)-Domoic acid A4 was originally isolated by Daigo et. al.10 from another  
Japanese marine algae, the warm water algae Chondria armata. Since then it has been  
found in the Canadian phytoplankton Nitzschia pungens11 and the algae Alsidium  
corallinum.3,4 Levels in excess of 1% dry weight of the plankton have been observed.  
There is also a high probability that other phytoplankton such as Amphora coffaeformis11 
are primary producers of domoic acid A4. Domoic acid A4 has an octadienoic side chain 
at C-4, this was originally determined by a combination of classical degradations 
2
 
and spectral techniques.12 This led to a proposed (trans-, trans-) diene geometry with 
undefined stereochemistry at C-5'.12 This was later redefined as (cis-, trans-) and the 
absolute s tereochemistry at  C-5 '  was establ ished (as R)  by Ohfune and 
Tomita 13  in their total synthesis of (-)-domoic acid A4.                       
A number of kainoids related to domoic acid A4 have also been isolated from the 
same algae. They include isodomoic acids A-F14  the C-5' domoic acid diastereomer15  
and domoilactones A and B.16 The acromelic acids A A5 and B A6, in which the  
C-4 substituent is a functionalized 2-pyridone, were first isolated in sub-
milligram quantities in 1983,17 and were found in quite a different organism to the  
previously described kainoids, namely the poisonous Japanese mushroom Clitocybe  
acromelalga. Due to the limited sample quantity only 1H NMR and U.V. spectral data  
were available for structural assignment. From these data, the structure of the acromelates
A A5 and B A6 was deduced by comparison with those of related compounds including  
kainic acid A2 and domoic acid A4. Since then both acromelate structures have been  
confirmed by total synthesis.18 Since the isolation of the acromelates, numerous other  
kainoid amino acids have been shown to be minor constituents of Clitocybe acromelalga,
 including the acromelic acids C, D and E.18        
                           
1.2  Biological Properties  
The kainoid amino acids have attracted considerable interest largely because of  
their pronounced insecticidal, anthelmintic and principally neuroexcitatory properties.  
The ability of the kainoids to act as insecticides has long been utilized by inhabitants of  
3
 
Yakushima Island, Japan. They used an extract of red algae, from which kainic acid A2  
and domoic acid A4 have since been isolated for its fly killing properties. Since then,  
domoic acid A4 and isodomoic acids A, C have shown to be potent insecticides when  
injected subcutaneously into the abdomens of the American cockroach (Periplaneta  
americana).14 The insecticidal activity 19 is found to be strongly dependent on the nature  
of the side chain at the C-4 position of the pyrrolidine ring. Domoic acid A4 is 23 times 
more active on the American cockroach than isodomoic acid C. In comparison, the  
activity of domoic acid A4 was also compared with that of the well known pesticide 1,1,1
-trichloro-2,2-bis(4-chlorophenyl)ethane (DDT), and it was found to be 14 times more 
active. 14 This illustrates the extremely strong insecticidal activity of domoic acid A4. The
algae Digenea simplex, from which kainic acid A2 was first isolated, has been used for its
anthelmintic (anti intestinal worm) properties for more than a thousand years in Japan.  
Since then the active component, kainic acid A2, has been found to have an intense  
anthelmintic effect, about 10 times that of santonin without side effects.7 The cis stereoch
emistry of the C-3 and C-4 substituents appears to be crucial to the anthelmintic 
function, as the C-4 epimer, allokainic acid A3, is said to have a very weak  
anthelmintic effect. Indeed, among the known stereoisomers of kainic acid A2, all show  
considerably reduced anthelmintic activity compared with that of kainic acid itself.20 The 
anthelmintic behavior of domoic acid A4 has also been demonstrated. Thus Daigo10  
found that oral administration of domoic acid A4 was extremely effective in expelling  
ascaris and pinworm without observable side effects in Japanese children.  
4
 
The pronounced neuroexcitatory properties of the kainoids have been well  
investigated.21 The kainoids have been shown to selectively block neuronal processes and
 as a consequence are valuable tools in the study of neurofunctioning. Their extremely  
potent activity, in both the vertebrate and invertebrate glutamergic system22, leads to  
specific neuronal death in the brain. The pharmacological effects and patterns of neuronal
degeneration observed after injection of kainoids have been shown to mimic the  
symptoms observed in patients suffering from neuronal diseases such as Epilepsy23 and  
Huntington's chorea. 24 In addition, there is a possibility that neuronal death caused by  
kainoids is a good experimental model for neuronal cell loss in senile dementia.21 The  
potent neuroexcitatory activity of the kainoids is attributed to their action as  
conformationally restricted analogues of the neurotransmitter glutamic acid and numerou
sstructure activity investigations25,26 of the kalnoids and analogue have been carried out.  
From these results it can be safely assumed that the C-4 stereoisomer, allokainic acid A3, 
is less of a neuroexcitant than A225b. The nature of the C-4 substituent, a double bond 
is essential for excitatory activity25c and its conformation,25d play a critical role in binding
 and functional activation at the recognition site. This is further supported by the  
observation that domoic acid A4 is even more neuroexcitatory than kainic acid A2.27  
Domoic acid A4 has been identified as the toxin in paralytic shellfish poisons (PSPs) and 
was believed to be responsible for an outbreak of mussel Kainoid amino acid chemistry  
4153 poisoning in Canada, which resulted in three deaths and 153 cases of intoxication.28
 The contamination of the mussel was thought to occur by ingestion of domoic acid A4  
through its main food source, Nitzschia pungens, which is a primary producer of the toxin. 
5
 
More recently, domoic acid A4 intoxication of brown pelicans and cormorants in 
California have been reported. 29
 The acromelic acids A A5 and B A6 were originally isolated from the mushroom  
Clitocybe acromelalga. Ingestion of the mushroom results in a sharp pain and a reddish  
oedemain the hands and feet after several days, which generally continue for up to a  
month. Since their isolation, the acromelates A5 and A6 have been tested for neuroexcita-
tory activity.22c,d  Both were found to be even more potent than domoic acid A4, the acid 
B being slightly less potent than acid A.  
The acromelates also showed a different mode of action to kainic acid A2. 22e   
More recently, the lethal toxicity of acromelic acid C to mice was reported at a dose of  
10mg/kg.18  Similar lethal doses of 7 and 8mg/kg were observed for acromelic acid A and 
B respectively. Acromelic acid D has also been investigated and shown to be as potent a  
neuroexcitant as kainicacid A2. 30 The powerful neuroexcitatory properties of acromelate 
analogues 31 have stimulated considerable synthetic interest in this area.  
 
1.3 Previous Syntheses of Kainic Acid 
1.3.1 Synthetic Challenge 
The kainoid amino acids represent a considerable synthetic challenge. Especially,  
the natural product (-)-α-kainic acid, which is the parent kainoid, has attracted the most 
synthetic attention amongst the kainoids to-date. A kainoid synthesis needs to address  
the formation of a pyrrolidine-2-carboxylic acid with defined stereochemistry at the three 
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contiguous stereocenters of the ring. The cis stereochemistry of the C-3 and C-4  
positions, except for allokainic acid A3, needs special consideration. In recent years,  
electrophysiologic studies about the mammalian CNS show that the specific activity of  
these receptors is principally due to an unsaturated isopropylidene chain on C-4 of  
the pyrrolidine system. Analogues with an unsaturated chain in this position with inverted
configuration at C-4 or without substituent at C-4 have very low agonist activity.
Recently, a worldwide shortage32 of kainic acid has stimulated the development of
 the total syntheses of kainic acid.33 The biological activity of kainic acid is linked to the 
trans C-2/C-3 and cis C-3/C-4 stereochemistries, and thus, any synthesis should result 
in efficient control of this relative stereochemistry. In addition an ideal synthesis would 
allow the ability to introduce various side chains at the C-4 position in a  
convergent manner to afford all the known kainoids and various kainoid analogues. I will
 now give an account of various total syntheses of the kainic acid and allokainic acid.       
                              
1.3.2 Oppolzer’s Synthesis 33(o)
The early syntheses of kainic acid A2 were relatively inefficient and non  
stereoselective. Since then, a number of stereoselective syntheses have been achieved,  
which in general have involved the construction of the C-3 / C-4 bond under the steric  
control of the C-2 substituent. The first enantioselective synthesis of kainic acid A2 
was developed by Oppolzer and Thirring. The key step was a stereocontrolled intra- 
molecular ene reaction (Scheme 1-1). The key diene A8 was prepared in good 
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yield from (L)-glutamic acid and subjected to thermolysis in hot toluene.  
The ene cyclization reaction proceeded to furnish thedesired trisubstituted pyrrolidine A9
 under the steric control of the chiral C-2 center. The relative stereochemistry 
of A9 was rigorously ascertained by conversion of this compound to kainic acid A2 in six
straightforward steps. A related approach to (±)-kainic acid A2 has since been reported. 
NHBoc
CO2H
EtO2C
H
NBoc
EtO2C
H OTBDMS
NBoc
CO2Et
H
OTBDMS
Toluene
Reflux70%
6 steps
NH
CO2H
CO2H
A7
A8
A9A2
Scheme 1-1. Oppolzer's Synthesis  
 
1.3.3 Knight’s Synthesis 33(n)
Knight and associates have developed an enantioselective synthesis of kainic acid 
A2 starting from the amino acid (L)-aspartic acid (Scheme 1-2). The key feature 
of their strategy is the use of a stereocontrolled enolate Claisen rearrangement to control  
the relative stereochemistry at the C-3, C-4 positions. The key 9-membered  
azalactone A10 was prepared from (L)-aspartic acid in modest overall yield. 
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 N
HO2C
CO2Me
N
O
O
CO2EtOTIPS
LDA, TBDMSCl
THF, -100oC
N
O
TBDMSO
OTIPS
CO2Et
H
1. -100oC to r.t.
2. K2CO3
OTIPS
Scheme 1-2. Knight's Synthesis
A10 A11
A12
 
Enolate formation in the presence of the silyl trapping agent, followed by  
rearrangement afforded (after silyl ester hydrolysis) the pyrrolidine A12, presumably via 
the boat-like transition state A11, in 55% yield. It is noted that the pseudo equatorial  
protected alcohol (CH2OTIPS) gives rise to the high diastereomeric purity obtained.  
Homologation of the acid A12 followed by oxidation furnished A2 in seven additional ste
ps and good overall yield.  
 
1.3.4 Baldwin’s Synthesis 34  
Baldwin and co-workers have applied a cobalt- mediated cyclization reaction 
to kainoid synthesis. Two approaches to (-)-kainic acid A2 have been reported, 
the first of which involved the cyclization of iodide A13 (Scheme 1-3). 
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 N
I
TBDMSO CO2Ph
BnO
Cobaloxime(I)
N
BnO
CO2PhTBDMSO
N
BnO
CO2PhTBDMSO
+
50% 30%
A13 A14 A15
Scheme 1-3. Baldwin's Synthesis  
On treatment of A13 with cobaloxime(I), cyclization afforded a 5:3 mixture of the
 separable syn- and anti-pyrrolidines A14 and A15 in 80% yield. Significantly,  
in addition to pyrrolidine ring formation, the cobalt reaction introduces a double bond at  
the C-4 side chain via a dehydrocobaltation process. Compound A14 was elaborated 
t o  k a i n i c  a c i d  A2  i n  s i x  f u r t h e r  s t e p s ,  w h i l e  t he  an t i -  i somer  A15  
was transformed in a similar manner to allokainic acid A3.                                                  
                               
1.3.5 Takano’s Synthesis 35
The synthesis of kainic acid A2 ,  and allokainic acid A3 ,  from (L)-
ser ine  has  beenrepor ted  by  Takano and co-workers .  In  th is  approach, 
the vinyl iodide A16 was treated with the radical generating agent tributyltin hydride, in  
the presence of AIBN, to promote a diastereo selective radical cyclisation leading to A17 
in an excellent 86% yield (Scheme 1-4). Pyrrolidine A17 was found to be a useful 
intermediate and was readily elaborated to A18 and A19. Two-step oxidation 
of  the primary alcohol  of  A18  fol lowed by react ion with 10 equiv.  of  
BF3.Et20 under dilute conditions in CH2C12 (1.7x10-3 M) promoted a C-2 directed  
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intramolecular protodesilylation and, after esterification, gave the kainic acid precursor  
A19 in 58% yield (together with 11% of the C-4 epimer). On treatment of A20 with  
3 equiv. of BF 3 .Et20 a C-3 directed intramolecular protodesilylation yielded  
the allokainic acid precursor A21 after reaction with diazomethane.                  
  
N
TBDPSO CO2Me
MeO2C
N
CO2PhTBDPSO
I
TMS TMS
MeO2C
N
CO2Me
TMS
PivO
HO N
CO2Me
MeO2C
PivO
N
CO2MeTBDPSO
TMS
HO2C
N
CO2MeOH
MeO2C
Bu3SnH, AIBN
Benzene, reflux
1. (COCl)2, DMSO, Et3N
2. NaClO2, NaHPO4
3. BF3OEt
4. CH2N2
1. BF3OEt2
2. CH2N2
A16 A17
A18 A19
A20 A21
Scheme 1-4. Takano's Synthesis  
 
1.3.6 Yoo’s Synthesis 33(l)
The Pauson-Khand reaction has also been utilized as the key step 
in the synthesis of (-)-kainic acid A2. On reaction of the glutamic acid derived  
ene-yne A22 with dicobalt octacarbonyl, followed by trimethylamine N-oxide  
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(or 4-methylmorpholine N-oxide), the enone diastereomers A23 and A24 (1.7:1 ratio)  
were isolated as an inseparable mixture in 95% yield (Scheme 1-5). Enone A23,  
which possesses  the  des i red  t rans C-2,  C-3 s tereochemistry ,  was then 
converted into kainic acid A2 in 41% yield.                                                                          
       
N
O
O
H
N
O
O
O
H1. Co2(CO)8
2. Me3NO
H
N
O
O
O
H
H
H2, Pd/C H
N
OTMS
OMOM
HH
Ts
N
H
CO2H
CO2H
A22 A23 A24
A25A2
Scheme 1-5. Yoo's Synthesis  
 
1.3.7  Monn Synthesis 33(m)
Monn and Valli reported a concise stereocontrolled thiazolium ylide approach to  
kainic acid A2. This centers on a tandem cycloaddition-cyclization of the ylide derived 
from A26 with 2-cyclopentenone to afford the tetracycle as a 6.8: 1 mixture of 
diastereomers A27, A28 (Scheme 1-6). The diastereomers A27, A28,  
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which could be prepared on a large scale (up to 1.5 mol), were isolated in 70-80% yield. 
Reductive cleavage of the thiazoline C-S bond with Bu3SnH followed by hydrolysis 
of the resulting hemiaminal and N-protection gave A29 in 64% yield. The bicyclic A29  
was then converted to racemic A2 in 16% yield, via a concise six-step sequence. 
This approach represents an extremely short and efficient method. 
N
S
NS
O
HO
EtO2C
Br
O
TEA, CH3CN
O
HH
CO2EtH
MeH
NS
O
O
HH
CO2EtH
MeH
6.8:1
N
O
HH
CO2Et
CO2Bn
1. Bu3SnH, AIBN
2. HCl, H2O
3. BnOCOCl, NaOH
N
HH
CO2Et
CO2Bn
A2
+
A26 A27 A28
A29 A30
Scheme 1-6. Monn's Synthesis  
 
1.3.8 Hanessian’s Synthesis 33(k) 
A trimethylstannyl radical carbocyclization of a diene was utilized as a key step in
 the synthesis of (-)-α-kainic acid A2 and its C4 epimer (+)-α-allokainic acid A3. A diene 
compound A32 prepared from L-serine occurred, was treated with trimethyltin hydride 
generated under Stork’s conditions,36 the resulting mixture of stannylated compounds  
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were obtain-ed in only 50% yield, favoring the cis stereochemistry at the C-3,  
C-4 centers in a ratio of 2.8:1. However, a slow addition of sodium cyanoborohydride  
over aperiod of 1 h to a refluxing solution containing the substrate A32 and trimethyltin  
chloride afforded the cyclized products A33 and its C-4 isomer as an inseparable 
mixture in 88% yield without compromising the cis/trans ratio. The destannylation of the
 trisubstituted pyrrolidine nucleus was achieved via an oxidative cleavage of the 
N
O
O
CO2tBu
Me3SnCl
slow NaCNBH3
tBuOH, AIBN
reflux
N
O
O
CO2tBuMe3Sn
N
H
CO2H
CO2H
L-Serine
N
O
O
CO2tBu
N
O
O
CO2tBu
Me3Sn
N
H
CO2H
CO2HMe3SnCl
slow NaCNBH3
tBuOH, AIBN
reflux
A31
A32 A33
A34 A35
A2
A3
Scheme 1-7. Hanessian's Synthesis  
C-Sn bond with ceric ammonium nitrate. This provided a dimethyl acetal that was further 
transformed into the intended α-kainic acid A2. When the same radical carbocyclization 
was attempted on a triene A34, the 2,3-trans/3,4-trans A35 and the 2,3-trans/3,4-
cis adducts were obtained in a 2.5:1 ratio, respectively. This approach was used to synthe
size (+)-α-allokainic acid A3.              
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1.3.9 Naito’s Synthesis 33(e)
Sulfanyl radical addition/cyclization/elimination of diallylamines in the presence  
of thiophenol and AIBN gave the 2, 3, 4-trisubstituted pyrrolidine in high yield.  
This reaction was extended to a radical cyclization using a catalytic amount of thiophenol
.A successful application was demonstrated by the asymmetric synthesis of (−)-kainic  
acid. Sulfanyl radical addition/cyclization/elimination of A36 in the presence of  
thiophenol andAIBN proceeded smoothly to give a 1:1.5 mixture of the cyclized products
A37 and A38 in combined 94% yield. 
N
R
PhS
OR
PhSH,AIBN
C6H6 N
R OR
SPh
N
R OR
SPh
1:1.5
N
H
CO2H
CO2H
+
A36 A37 A38
A2
Scheme 1-8. Naito's Synthesis  
Similarly, treatment of A36 with a catalytic amount of thiophenol gave A37 and A38 in 
an almost similar ratio. Next, A37 was converted to (-)-α-kainic acid in 8 steps.  
                                                                                        
1.3.10 Ganem’s Synthesis 37
Ganem and coworkers reported a metal-promoted enantioselective ene reaction  
that provides entry into the kainic acid ring system from very simple precursors.  
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Moreover, the zirconium-mediated Strecker reaction demonstrates remarkable  
chemoselectivity and stereoselectivity. Diene A39 was prepared from N-prenylamine  
in 4 steps. The thermal and metal-catalyzed intramolecular ene reactions of dienes A39 
formed cis-substituted and trans-substituted pyrrolidones A41 and A42 in 20/1 ratio 
(Scheme 1-8). Lactam A41 was transformed into (-)-α-kainic acid as depicted 
in Scheme 1-8. Reaction with Schwartz’s reagent (Cp2ZrHCl, 1.5 equiv. in THF) 
generated an imine. It was subjected, without purification to cyanotrimethylsilane  
(TMSCN) in CH2Cl2, to afford the all-cis nitrile A43 in 70% overall yield from A39. 
Although alkenes readily react with Schwartz’s reagent, no hydrozirconation of the isopr
openyl group in A39 was detected. Nitrile A43 was reacted with 4 N HCl-
methanol and then directly basified with KOH to afford A2 in 97% yield. 
This procedure presumably involves alcoholysis of the nitrile in A3 to a diester, which un
dergo epimerization and saponification to A2. 
N
R
O
EtO2C
N
R
O
EtO2C
N
R
O
EtO2C
N
R
NC
EtO2C
N
H
HO2C
HO2C
Mg(ClO4)2,
 
CH2Cl2, r.t.
20:1
1. Cp2ZrHCl, THF
2. TMSCN, CH2Cl2
N N
O O
Ph Ph
+
A39
A40
A41 A42
A43 A2
Scheme 1-9. Ganem's Synthesis  
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1.3.11 Clayden’s Synthesis 33(b)
Clayden and coworkers reported a dearomatizing cyclization method using chiral  
lithium amide bases, which are able to deprotonate N-benzyl-N-cumyl anisamides 
enatioselectively to yield enatiomerically enriched benzyl organo lithiums. Chiral lithium
 base A45 was used to promote the asymmetric cyclization of the precursor A44 to yield  
the partially saturated isoindolones A48. The hydrochloride salt A45⋅HCl was dissolved  
in THF, and then 2 equiv. of BuLi were added to form a solution of chiral lithium amide 
A45 plus lithium chloride. Once the amide A44 had been added the mixture was allowed 
to warm, promoting asymmetric deprotonation to A46 and cyclization to the enolate A47. 
NBoc
O
CO2MeCO2Me
N Ph
OMe
MeO
O
N Ph
OMe
MeO
ONLi
LiCl, THF Li
N
OLi
OMe
MeO Ph
H
N
O
OMe
O Ph
H
H
NH
CO2HCO2H
A44
A45
A46
A47A48
A2A49
Scheme 1-10. Clayden's Synthesis  
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An aqueous quench and acidic work-up returned the enone A48 in a good yield and  
enatiomeric excess. These isoindolone derivatives are converted in nine steps, among  
them a surprisingly resioselective Baeyer-Villiger reaction, to (-)-kainic acid A2.  
 
1.3.12 Anderson’s Synthesis 38
A flexible route to the kainoid skeleton is exemplified by the synthesis of  
(±)-kainic acid from 3-butyn-1-ol by Anderson. The route relies on the aza-[2,3]-Wittig  
sigmatropic rearrangement, to efficiently install the relative stereochemistry between  
C-2 and C-3. The C-4 stereocenter was derived from a diastereocontrolled  
iodolactonization.  
BocN
OtBu
SiPhMe2
CONMe2
HN CONMe2
SiPhMe2
OtBu
Boc
LDA
HN CONMe2
OtBu
Boc
I2
O
NHBoc
t-BuO
I
ON
H
HO
Ot-Bu
CO2HN
Cbz
TsO
OH
CO2H
N
Cbz
OH
CO2H
[CH2=C(CH3)]2CuCNLi2
N
H
CO2H
CO2H
TFA, KOH
A50 A51 A52
A53A54A55
A56 A2
Scheme 1-11. Anderson's Synthesis  
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The aza-[2,3]-Wittig rearrangement potentially allows structural diversity at C-3 and 
the displacement of the tosyloxy group with retention of stereochemistry allows structural
diversity at C-4. The trans C-2 carboxylic acid functional group was found to be  
the most important for retention of the stereochemistry at C-4 upon treatment  
with a higher order cyano cuprate. The aza-[2,3]-Wittig rearrangement was induced 
by using LDA (1.4 equiv.) at -78 °C with warming to 0 °C for 2 h to give the  
pivotal unnatural amino acid derivative A51 in  78% yield. Protodesilylation was  
achieved by an optimum 1.5 equiv. of water in the first step of a two step process that  
furnished silanol and alkene A52 as a 1:2 mixture in the crude material.  Direct treatment  
with excess TBAF gave A52 in 59% overall yield. Iodolactonization with I2 in DME/H2O
gave a 7:1 mixture of A53 in 74% yields. Deprotection of the amine substituent followed 
by base-induced ring opening of the lactone gave the proline skeleton A54 after 5-exo-
tet cyclization in 86% yield. They used a higher order diisopropenyl cyano cuprate,  
generated from CuCN and 2-lithiopropene. This reaction was very sensitive to reaction 
conditions and care had to be taken to rigorously dry the CuCN and perform the reaction 
under a positive pressure of argon. Optimum reaction conditions involved treatment of  
A55 with 5 equiv. of the higher order cuprate reagent at -78°C followed by  
warming to room temperature for 2 h to give a 56% yield of the desired product.  
Retention of stereochemistry was verified by one dimensional nOe experiments. 
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1.3.13 Trost’s Synthesis 39  
BnO
HN
OTBS
TsN
O
BnO
[CpRu(CH3CN)3]PF6
10%
2% water/acetone
96% ee, 80% yld
TsN
O
HO
SiMe2Ph
20%
[Ir(cod)Py(PCy3)]PF6
    2000psi, H2
TsN
O
HO
SiMe2Ph
HN
HO2C CO2H
Scheme 1-12. Trost's Synthesis
A57 A58 A59
A60A2
 
Trost group reported a novel route to kainic acid A2 using the key concept  
derived from a ruthenium-catalyzed cycloisomerization of a tethered alkyne propargyl  
alcohol A57 to form a cylic 2-vinyl-1-acyl compound A58. A single stereocenter  
introduced by an asymmetric reduction of a ketone sets the stage for all the other  
stereocenters. A novel 1,6-addition of silyl cuprate serves to install a hydroxyl group at  
the diene termines A60. The relative stereochemistry was then set by a directed  
hydrogenation of α,β-unsaturated alkene A59. Removal of the benzyl group 
to reveal the more powerfully directing free hydroxyl group was then carried out with  
Crabtree’s catalyst [Ir(cod)Py-(PCy 3 )]PF 6 with 1:1 formic acid/methanol 
to produce A60.                                                                 
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1.3.14 Lautens’s Synthesis 40  
NPh2
O
p-Tol
S
N
OMe
O
N
O
SO
NPh2
OMeMgI2
THF
78%
N
O
SO
NPh2
OMe
HO
9-BBN, THF
then
NaOH/H2O2
91%
N CO2Me
CO2Me
Ts
N
H
CO2H
CO2H
reflux
A61 A62 A63 A64
A65A2
Scheme 1-13. Lautens's Synthesis
 
Recently reported by Lautens was a concise and enantioselective synthesis of (-)-
(α)-kainic acid A2 in 13 steps with an overall yield of 15%. The pyrrolidine kainoid 
precursor of A63with the required C-2/C-3 trans stereochemistry was prepared 
with excellent diastereoselectivity (>20:1) via a MgI2-mediated ring expansion 
of a tertiary methylene cyclopropyl amide A61. A selective hydroboration was then  
employed to set the remaining stereochemistry at the C-4 position enroute to (-)-(α)-
kainic acid A2. 
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1.3.15 Fukuyama’s Synthesis 41
O OAcO
Me3Si NBn
OMe
TFA(10 mole %)
CH2Cl2
83%
N
H H
CO2R"
O OAcO
N
OMOM
H H
CO2R"
MeN
N
H sec-BuLi, THF
-73oC
CO2(g)
65%
N
OMOM
H H
CO2R"
CO2HN
OMOM
H H
CO2R"
HO2C
19 : 81
N
H
CO2H
CO2H
H H +
A66
A67
A68 A69
A70
A71 A72A2
Scheme 1-14. Fukuyama's Synthesis  
Very recently, Fukuyama reported a stereocontrolled total synthesis of (-)-kainic  
acid A2 using two key steps. cis-3,4-Disubstituted pyrrolidine ring A68 was constructed 
by [3 + 2]  cycloaddition of azomethine ylide A67 with chiral butenolide A66.  
The crucial introduction of carboxyl group at the C-2 position was executed by 
regio- and stereoselective lithiation of the pyrrolidine ring in the presence of  
a (+)-sparteine surrogate followed by trapping with carbon dioxide. The crucial  
1,3-dipolar cycloaddition of the chiral butenolide A66 with the azomethine ylide A67  
took place smoothly upon reatment of a mixture of A66 and A67 with 10 mol % of TFA. 
It afforded the desired ycloadduct A68 in 83% yield with high diastereoselectivity (20:1). 
O’Brien and co-workers reported that the diamine could serve as a surrogate for  
(+)-sparteine A70 for nantioselective lithiation of N-Boc-pyrrolidine A69. 
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O’Brien’s group examined the lithiation-carboxylation protocol in the presence of the  
(+)-sparteine surrogate A70. The reaction in the presence of 2.5 equiv. of A70 only gave  
a mixture of the desired isomer A72 and its regioisomer A71 (81:19). Thus, they have  
successfully controlled the diastereoselectivity, albeit with similar regioselectivity.           
                       
1.4  Previous Syntheses of Allokainic acid 
(+)-α-Allokainic acid A3 is the C-4 epimer of the (-)-α-kainic acid. As described  
in Section 1.2 the cis stereochemistry of the C-3 and C-4 positions needs special  
cons ide ra t ion  fo r  the  ka ino id  syn thes i s  excep t  (+) -α -a l loka in ic  ac id . 
So, the non-stereoselective synthetic procedures used for kainic acid A2  
have often also been utilized for allokainic acid A3. Other synthetic approaches to A3  
which have not yet been mentioned are discussed below.                                                     
  
1.4.1 Oppolzer’s Synthesis 42  
N
Men O2C
COCF3
EtO2C
EtO2C
Et2AlCl
-35oC, 18h
57%
N
EtO2C
EtO2C
Men O2C
COCF3
A73 A74
Scheme 1-15. Oppolzer's Synthesis
(-)Phen- (-)Phen-
 
A synthesis of (+)-allokainic acid A3 from (Z)-β-chloroacrylic acid was reported 
by Oppolzer and associates, there report stated the use of the high asymmetric induction 
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obtained in a Lewis acid-promoted intramolecular ene-type reaction.  
The chiral precursor, (Z)-8-phenylmenthyl ester A73, was treated with a mild  
Lewis acid (e.g. 3 mole equiv. of Me2AlCl or Et2AlCl in dry CH2Cl2 at -35 °C) 
to afford the 3S,4R-pyrrolidine A74 in 57% yield (Scheme 1-15). It is noted  
that the use of the corresponding (E)-phenylmenthyl ester led to an opposite sense of  
induction and A74 was only formed in 9% yield (while the 3R, 4S diastereomer was  
found in 72% yield). Subsequent saponification and decarboxylation of A74 afforded  
enantiomerically pure allokainic acid A3, in which the configuration at C-2  
was determined by the stereochemistry at the C-3 centre. 
 
1.4.2  Kraus’s Synthesis 43  
N S
BnO
O
HO
EtO2C
Br
N S
O
O
BnO
EtO2C
N
H
O
BnO
EtO2C
1. TEA
2. Silicagel
1. Bu3SnH
2. HCl, EtOH
+
A75
A76
A77 A78
Scheme 1-16. Krause's Synthesis  
Kraus and Nagy have made use of the 1,3-dipolar cycloaddition of an  
azomethine ylide to synthesis  of (±)-allokainic acid A3 (Scheme 1-16). They reacted 
the disubstituted olefin A75 with the ylide derived from A76 and the tricyclic compound 
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A77  was isolated in 59% yield. Reaction of A77 with Bu3SnH followed by treatment  
with acidic ethanol afforded pyrrolidine A78 in good yield, which was then elaborated  
to allokainic acid A3 in eight steps (including epimerization of the C-2 position).         
 
1.4.3 Deshong’s Synthesis 44
DeShong has synthesized racemic allokainic acid A3 using a [3+2] dipolar  
cycloaddition of an azomethine ylide to establish the requisite pyrrolidine  
stereochemistry as shown in scheme 1-16. Upon heating aziridine A80  
with enone A81 in a sealed tube at 175 °C, the trisubstituted pyrrolidine A82 was  
obtained in 70% yield. This was elaborated to (+)-allokainic acid A3 in six steps 
including Wittig olefination (to introduce the C-4 isopropenyl moiety) and C-2  
epimerization using aqueous sodium hydroxide. 
NMeO2C
OTBDMSO
NMeO2C
N
Bn
MeO2C
Bn
TBDMSO
O
175oC,  70%
Bn
A79
A80
A81
A82
Scheme 1-17. DeShong's Synthesis  
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1.4.4 Moiweer’s Synthesis 45
NH
AcO
MeO2C
CO2Me
O
N OMe
O CO2Me
TMS
N
HO
EtO2C
CO2Me
CH2Cl2 
then MeOH
52%
BF3OEt2
A83 A84 A85
Scheme 1-18. Mooiwer's Synthesis  
A racemic synthesis of A3 has been reported which centers on two allylsilane  
N-acyliminium ion reactions. An initial intermolecular N-acyliminium coupling reaction 
was employed in the synthesis of A83 which was subsequently elaborated to the key allyl
silane intermediate A84 in four steps (scheme 1-18).      
On treatment of A84 with BF3.Et2O (4 equiv.) in CH2C12 followed by methanol,  
the trisubstituted pyrrolidine A85 was isolated in 52% yield via an intramolecular  
N-acyliminium cyclisation reaction. Pyrrolidine A85 was subsequently elaborated to A3  
using standard methodology.                                                                            
 
1.4.5 Murakami’s Synthesis 46
N
O
TBDMSO
EtO2CNC
TBDMSO
MeO2C
OTMS
COCH2OPh
1. Zn(OAc)2
2. (PhOCH2CO)2O
52%
N
O
TBDMSO
EtO2C
COCH2OPh
H2, Pd-CaCO3
90%
A86 A87 A88
Scheme 1-19. Murakami's Synthesis  
One racemic synthesis of allokainic acid A3 was reported by Murakami, which  
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employs a zinc acetate catalyzed cyclisation of an 7-isocyano silyl enol ether. The  
reaction of silyl enol ether A86 with Zn(OAc)2⋅2H2O in DMSO containing ca. 2 equiv. of
methanol, cyclisation proceeded smoothly to produce, after N-protection, predominantly 
the trans-2-pyrroline A87 in 52% yield (scheme 1-19). The corresponding cis isomer 
was isolated in 22% yield. Stereoselective hydrogenation of A87 was achieved in the pres
ence of 5% Pd/CaCO3 to afford the allokainic acid precursor A88. 
 
1.4.6 Agami’s Synthesis 47
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Scheme 1-20. Agami's Synthesis  
An enantioselective synthesis of the (-)-enantiomer of allokainic acid A3 has  
been reported using a tandem aza-Cope/Mannich reaction. The (E)-alkene A89, formed 
from (R)-phenylglycinol, was reacted with glyoxal in a slightly acidic  
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(pH 4-5) aqueous medium to afford the desired bicyclic hemiacetal A92 (in 45% yield as 
70:30 mixture of epimers) via the iminiumions A90 and A91 (Scheme 1-20). The three 
contiguous stereocenters are thus introduced in a one-pot reaction, using  
(R)-phenylglycinol as a chiral template. The axial attack of the double bond on iminium 
ion A90 establishes the stereochemistry at the C-2 position, while the (E)-
stereochemistry of the double bond is responsible for the stereospecific formation of the 
C-3 center. The elaboration of A92 to (-)-A3 was accomplished in an additional ten steps. 
 
1.4.7 Montgomery’s Synthesis 48
A direct and highly stereoselective formal total synthesis of (+)-α-
allokainic acid A3 was reported by Montgomery. The strategy involves the nickel- 
catalyzed cyclization of a D-serine derived alkynyl enone with trimethyl aluminum 
followed by a palladium-catalyzed allylic carbonate reductive transposition  
(Scheme 1-21). Cyclization of A93 with commercial trimethylaluminum 
and [Ni(cod)2] (10 mol%) in THF afforded a 73% yield of A94 with a diastereomeric  
ratio (d.r.) of >97:3 in favor of the desired trans isomer, and commercial dimethylzinc  
under identical conditions afforded a 67% yield of A94, also with a >97:3 diastereomeric 
ratio. Treatment of A94 with [Pd2(dba)3]/PBu3 and HCO2H/Et3N cleanly produced A95  
in74% yield with a 95:5 diastereomeric ratio in favor of the all-trans stereochemical  
relationship of the three substituents at the pyrrolidine ring, as seen in allokainic acid.  
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A3Scheme 1-21. Montgomery's Synthesis  
 
1.4.8 Ma’s Synthesis 49
N
O
CO2Me
CO2tBu
COPh
MgBr
THF, -78 oC N
OH
CO2Me
CO2tBu
COPh
N
OCOMe
CO2Me
CO2tBu
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refluxN
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Scheme 1-22. Ma's Synthesis  
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Pd(PPh3)4/PPh3-catalyzed hydrogenolysis of A98 derived from trans-4-hydroxy-
L-proline A97 using ammonium formate as a hydride reagent, provides olefin A99 as a  
major product, which is hydrolyzed to give (+)-α-allokainic acid (Scheme 1-22). 
 
1.4.9 Cook’s Synthesis 50  
The Pd-catalyzed carbocyclization of ketoamides A100 was investigated and  
found to be highly dependent on the phosphine ligand as well as the presence of  
coordinating counterions. Nitrogen heterocycles were formed without erosion of the  
stereochemical integrity. The utility of the lactam products was demonstrated by the 
formal synthesis of (+)-α-allokainic acid (Scheme 1-23). 
ON
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O O O
Pd(0)
EtOLi, EtOH
- CO2
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O O
HN
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HN
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A100 A101 A102
A3Scheme 1-23. Cook's Synthesis  
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Chapter Two 
The Syntheses of (-)-α-Kainic Acid and (+)-α-Allokainic Acid 
2.1 Theoretical background 
2.1.1   Chiral γ-Lactams from α-Amino Acids via Rh-Catalyzed 
Intramolecular C-H Insertion  
 
Recently, Jung’s group developed an intramolecular C-H insertion of α-diazo-α- 
(phenylsulfonyl)acetamides to afford γ-lactams with high regio-and stereoselectivities.1  
The highly functionalized γ-lactams are key intermediates for the synthesis of natural 
products, 2  which are biologically active. α-Diazo-α-(phenylsulfonyl)acetamides B3 
was derived form from secondary amines B1 via the corresponding α-(phenylsulfonyl) 
acetamides B2. Acylated compounds from secondary amines B1 and α-haloacetyl halide 
in TEA and CH2Cl2 at 0 °C were treated with sodium benzenesulfinate in DMF at room  
temperature to afford α-(phenylsulfonyl)acetamides B2. A diazo transfer reaction of B2 
employing with p-acetamidobenzenesulfonyl azide (p-ABSA) and DBU yielded the  
corresponding α-diazo-α-(phenylsulfonyl)acetamides B3 (Scheme 2-1). 
N
R2
R1
N2
PhO2S
O
N
R2
R1PhO2S
O
HN
R2
R1
1. XCH2COX
    TEA, CH2Cl2
2. PhSO2Na
    DMF
80-85%
ABSA
DBU
CH3CN
85-90%
Scheme 2-1. The preparation of  α-diazo-α-(phenylsulfonyl)acetamides.
B1 B2 B3
 
Using α-amino acids B4 as an amine source, the preparation of various bicyclc  
γ-lactams were explored via intramolecular C-H insertion of α-diazo-α-(phenylsulfonyl) 
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acetamides B6, which possess various functional groups. The cyclizations were highly  
regio- and stereoselective and afforded chiral γ-lactam compounds B7 in high yields.1(b)
N
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R R
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Scheme 2-2. C-H insertion of α-diazo compounds.
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The high regioselectivity and stereoselectivity were rationalized using transition  
state of the reaction as shown in Figure 2-1. During the insertion reaction, the 
N
O
Ph
PhSO2
O
Rh
N
O
O
PhSO2
Ph H
N
PhSO2
O
Rh O
Ph
s-cis, B8
s-trans, B8
HN Ph
H
O
Rh
O
HN H
Ph
O
Rh
O
1,3-diaxial interaction
PhSO2PhSO2
B9 B10
B11
Figure 2-1. Transition state of cyclization  
conformationally restricted metallo carbenoid B8 adopts the s- cis conformer,  
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due to the severe nonbonded interaction between the gem-dimethyl group and the  
carbonyl substituents present in the s-trans conformer B8. Only the s-cis conformer 
B8 is suitable for cyclization. Now, two possible transition states, B9 and B10, where the 
phenyl group can be located in either the pseudo axial or the pseudo equatorial positions, 
can be involved in the next C-H insertion reaction respectively. 3  The former  
case experiences a severe 1,3-diaxial nonbonded interaction, whereas the latter 
adopts a stable chairlike transition state with large groups occupying equatorial positions,
 which lead to relative stereochemistries at C-3, C-4, and C-5 of compound B11. 
The newly generated stereochemical configuration at C-3 and C-4 were  
induced by the chirality of the starting α-amino acid during the  
insertion reaction. The stereochemical assignment for B11 was confirmed by X-ray  
crystallographic analysis. 1(b)   
 
2.1.2  Intramolecular Michael Addition of Cyclic β-Ketoester on Conjugated  
Acetylenic Ketone 4
 
Based on the known stereoelectronic principles,5 the first intermediate generated  
in the nucleophilic addition on a conjugated acetylenic ketone (ynone) should be an  
allenic enolate, which on protonation produces the corresponding α,β-unsaturated  
ketone (enone). Since allene cannot be accommodated without considerable strain in the  
rings smaller than cyclooctane,6 the intramolecular Michael addition on ynone to produce
 small ring is not expected to take place. Contrary to this conclusion, the Michael type  
small ring formations from the intramolecular neuclephilic addition on ynones were  
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reported by Deslongchamps.4  They proposed a new stereoelectronically controlled  
pathway. The cyclization was carried out with cesium carbonate at room temperature.  
The results showed that the formation of five and six-membered  
rings takes place with ease and in good yield. 
Scheme 2-3. Intramolecular Michael addition
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They also indicate that seven and eight-membered rings can be produced 
but in very low yield. The observation of an A/B cis junction was reported inall cases.   
Figure 2-2. Nucleophilic addition to ynone
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According to the explanation, it is normally expected that the addition of a  
neucleophile onto an enone should take place on the π bond of the triple bond which is  
conjugated with the carbonyl group. On that basis, the approach of neuclephile Nu- on  
an ynone such as B16 can take place from the rear or from the front to produce the two  
enantiomeric allenic enolates B17 and B18 respectively. In another word, the formation  
of bicyclic B15 from cyclic β-ketoester B12 should not take place because the  
intermediate bicyclic allenic enolate ion B17 would be too strained when n < 2. This led  
to the consideration of the possibility that the neucleophilic addition might occur on the  
“non-conjugated π bond” of the triple bond of the ynone. Such an addition can take place 
from the top or the bottom of the face of ynone B16; producing the enone-anions 
B17 and B18 respectively. The non-bonded electron pair in these two anions is not  
conjugated with the carbonyl group. It is therefore expected that they are less stable than 
the allenic enolates B17 and B18. The enone-anions should therefore not be observed  
when it is possible to form the allenic enolates, however, when the latter cannot be  
produced, it might be possible to generate the formers. The intramolecular  
version of the process B16 + B20; the pathway B12 to B14 + B15 could indeed lead to  
the formation of bicyclic enone when n < 2. The anions B19 and B20 may be less basic  
than one could first anticipate because they are vinylic anions next to a carbonyl group.  
Indeed, the induc-tive effect of this group should reduce the basicity of the vinylic  
anions, which could have a basicintermediate between vinylic and an acetylenic anion.  
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Theoretical calculation7 were carried out for the allenic enolate (B17 or B18, Nu=
H) and the two geometrically isomeric enone-anions (B19 and B20, Y=H). It showed  
that the allenic enolate is the most stable anion and the enone-anion B19 is  
17 kcal/mole less stable. It was concluded that these calculations indicate that the  
allene enolate should be the only anion formed normally but when the formation  of this  
anion is prohibited by other factors, the higher energy enone-anion B20 could well be  
generated and that would explain the results. Stereoelectronic principles predict that the  
anion must be produced in a conformation where the newly formed C-C bond  
must be parallel (i.e. pseudo-axial), to the π system of the ketone group of ring A.  
Accepting this requirement, examination of molecular models shows that anion B14 is  
easily constructed when n = 0 or 1. There are howeversome steric constraints when n = 2,
 which become much more severe when n = 3. On that basis, formation of five- and six-
membered rings would occur via the formation of intermediate B19 and the formation,  
although in a low yield, of  seven and eight membered rings would occur via intermediate
B18 and B17 respectively.8                                              
N
SO2Ph
O
OO
Cs2CO3
CH3CN
NPhO2S
O
O
O
C46 C45
Scheme 2-4. Intramolecular Michael addition of phenylsulphone compound
A B
C93%
 
Based on these results, we applied the concept to our system, which is α-phenyl 
sulphonyl-γ-lactam compound B46. We received the desired cyclized product in 95%  
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yield with a high regio- and setereoselctivity. We are confident that the stereochemistry 
would be A/B cis junction and B/C cis junction based on the result for the intramolecular  
Michael addition of cyclic β-ketoester on conjugated acetylenic ketone.4  
 
2.1.3  Baeyer-Villiger Oxidation of Cyclohexeneone   
The vinyl group of an α,β-unsaturated primary alkyl ketone shows preferential  
migration in the Baeyer-Villiger oxidation (Scheme 2-5).9 The most efficient method for  
oxidation of cyclohexenone B21 involved treatment of B21 with trifluoro peracetic acid  
generated from the reaction of trifluoroacetic anhydride and the urea hydrogen peroxide  
complex to give the desired enol lactone B22 in 92% yield. Hydrogenation of B22  
provided the caprolactoneB23, and the usual hydrolytic removal of the chiral auxiliary  
gave the butyrolactone carboxylic acid B24.  
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Scheme 2-5. Baeyer-Villger oxidation of α,β-unsaturated primary alkyl ketone
B21 B22
B23B24
 
Katzenellenbogen10 reported the synthesis of halo enol lactones from β-halo  
cycloenones, using Baeyer-Villiger oxidation, for the study of mechanism-based  
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inactivators of serine proteases. During the course of this investigation they needed enol  
lactone compounds such as B26, B28.  For these endocyclic lactones, Baeyer-
Villiger oxidation was utilized(Scheme 2-6). The success of this strategy depended  
upon the preferential migration of the vinyl group over the primary alkyl group. Several  
examples of such vinyl migration are known.11 However, the presence of the electron-
withdrawing halogen on the vinyl group was expected to decrease its migratory aptitude  
to some extent. Another anticipated difficulty with these substrates was the potential for  
competing epoxidation of the olefin; this reaction could be avoided under relatively acidi
coxidat ion condi t ions .  Treatment  of  β -bromocyclohexenone B27 with  
pertrifluoroacetic acid in a buffered system afforded the desired lactone in 68% yield afte
rchromatography on cyanopropyl functionalized silica gel.                                          
O
O
O
Br
Br
CF3CO3H
Na2HPO4
68%
O
O O
Ph
Br Br
Ph
CF3CO3H
CH2Cl2
82%
Scheme 2-6. Baeyer-Villger oxidation of β-halo cyclohexenone
B25 B26
B27 B28
 
1H NMR analysis of the reaction products offered no evidence of competing alkyl  
migration. This method was also employed in the synthesis of the lactone B26, obtained  
in 82% yield from 2-phenyl-1,3-indandione B25. In this case, the vinylic-benzylic  
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carbon migrated preferentially to the phenyl group, as anticipated. This method does  
provide an efficient route to these endocyclic lactones; however, the requirement for the 
vinylic migratory preference may limit potential substrate molecules to those with  
primary alkyl substituents at the α position.                                                    
 
2.2 Synthetic Strategy / The Core Intermediate 
Early on in the development of our rhodium catalyzed intramolecular C-H  
insertion methodology, we discovered just how promising and effective this transforma-
tion was. The applicability of our initial, acylic methodology was profoundly broadened  
by its adaptation to accommodate α-amino acids as starting materials.12  
Figure 2-3. Synthetic target
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Stereoselective Introduction of Isopropenyl group
Reduction of Carbnyl group of the γ-lactam
 
Using only the α-amino acid as the source of stereogenic bias, γ-lactams were  
synthesized regio- and stereoselectively yielding a single diastereomer. Two additional  
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stereocenters were formed simultaneously as dictated by the original stereocenter of the  
starting material. Based on these precedent results13 and theoretical background, we  
discussed in Section 2.1, we turned our full attention to the total synthesis of (-)-
kainic acid A2.    
Compared with (-)-α-kanic acid A2, the key intermediate C3 has several  
important structural similarities. The key intermediate C3 can be prepared utilizing fore 
mentioned Rh-catalyzed C-H insertion reaction with high stereoselectity (Figure 2-3).  
The stereochemistries of C-2 and C-3 on the product A2 are same with C-4 and  
C-5 of the intermediate B3, which means that the stereochemistries would be installed via 
the C-H insertion reaction. The next challenging step for the synthesis of (-)-α-kanic acid 
A2 would be a stereoselective introduction of the isopropenyl group onto the C-3 
position of the γ-lactam compound C3. The reduction of the amide carbonyl of the  
γ-lactam should be carried on in proper order and way to produce the pyrrolidine core  
of the (-)-α-kainic acid. With this basic strategy in mind, a retrosynthetic route was  
proposed as explained in Section 2.2.1. 
 
2.2.1 Retrosynthetic Analysis of (-)-Kainic Acid (First) 
We had observed the application of C-H insertion reaction to (L)-glutamic acid  
yielded a highly functionalized γ-lactam that could be converted to the pyrrolidine 
core of (-)-kainic acid A2.  Retrosynthetically we envisioned an expedient route to the  
target molecule featuring two key steps (Figure 2-4). 
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(-)-Kainic acid A2 is readily available via Jones oxidation of the diol compound  
C1, which could be derived from the bicyclic γ-lactam C2 via the reduction of  
the carbonyl group and deprotection. The γ-lactam C2 is the product of the second key  
step of the synthesis, namely an introduction of isopropenyl group on the C-3 position  
having a syn relationship with the adjacent bulky alkyl group on C-4. The bicyclic  
γ-lactam C3 is a product of our Rh-catalyzed intramolecular C-H insertion methodology  
of a α-diazo-α-(phenylsulfonyl)acetamides C4. This is the first key step in the  
synthetic route. The α-diazo insertion precursor C4 can be efficiently derived from  
(L)-glutamic acid C5 (Figure 2-4). 
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N
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Figure 2-4. Retrosynthetic analysis of the total synthesis of (-)-kainic acid (first)  
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2.2.2 Strategy for the Stereoselective Isopropenylation 
Figure 2-5. Synthetic Strategy
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The substitution of phenylsulfone group on the intermediate C3 to isopropenyl 
group would be an inavoidable process for the synthesis of (-)-α-kainic acid.  Two 
plausible routes were proposed; one is the Isopropenylation-Dephenylsulfonylation route, 
the other one is the Dephenylsulfonylation-Isopropenylation route (Figure 2-5).   
As discussed in Section 1-3, an efficient control of the cis stereochemistry 
between C-3 and C-4 positions is the key issue for the successful synthesis. It was proved 
from the successful precedent reports that were depicted in Section 1-3.  There are three 
main strategies, utilized for the control of the stereochemistry, in the successful  
precedent reports. One, the two bulky groups were introduced at the same time to  
derive the cis relationship via conserted reactions such as ene reaction, 14   
Claisen rearrangement. 15  Two, the two bulky substituents were installed via a  
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ring opening step, which usually were sterically rigid and formed at the early stage of  
the reaction.   The typical ring formations such as Pauson-Khand reaction, 16   
[3 + 2] cycloaddition17 were employed for this purpose. Three, the syn relationship  
was obtained from the hydrogenation method of a double bond, which was between  
C-3 and C-4 position.18 An exo vinyl group attached  on C-4 position was another  
choice for the location in the hydrogenation route. Then, the reactions such as 
intramolecular protodesilylation,19 hydroboration 20 were followed by for a stereocontrol.  
Which strategy can we choose for our synthesis? This was our main focus after 
getting the γ-lactam compound C3 in hand. The structural features and key factors in the 
key intermediate C3 were analyzed.  
 
2.2.3 Bicyclic γ-Lactam Intermediate 
N
O
O
PhSO2
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Figure 2-6. Controlling factors
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Upon introducing a bulky isopropenyl group onto the C-3 position of the  
intermediate C3, there are three factors to be considered; (1) convex-concave interaction  
of the bicyclic system, (2) 1,2-induction derived from the adjacent bulky group,  
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(3) an easy enolization character of the C-3 position due to adjacent carbonyl 
group and double bond. Unfortunately, the factors (1) and (2) were not surportive but co
mpetitive, and the factor (3) made worse the introduction of the isopropenyl group in syn  
fashion. Our long journey to the (-)-kainic acid got started with knowledge  
of these findings.  
 
2.2.4 Synthesis of the Bicyclic γ-Lactam Intermediate 
Our endeavor into the synthesis of (-)-kanic acid began with the development of 
an efficient route for the synthesis of γ-lactam compound C3. Esterification reaction of L-
glutamic acid C521 was conducted employing SOCl2 in MeOH as an acid source. The 
HCl salt of the product of the ester was treated with NaHCO3 to produce neutral L-
glutamic acid dimethyl ester C6. Both ester groups were then reduced to diol by reacting 
with LAH to give amino alcohol C74 after Fisher work-up.
NH2
CO2H
HO2C
 SOCl2, MeOH
TBDMSO
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OHNClCH2COCl
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Scheme 2-7. Synthesis of the acetylated compound C10
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The primary alcohol and the nitrogen of the amine were simultaneously protected as  
an acetonide by refluxing C7 in acetone in the presence of MgSO4. In this reaction,  
5-membered acetonide C8 was the main product, with a trace amount of side product 
including 7-membered acetonide. The remaining primary alcohol was protected with 
TBDMS group using NaH/TBDMSCl condition.22 The general TBDMSCl protection 
such as TBDMSCl/imid, TEA/DMAP in CH2Cl2 delivered poor yield of the desired 
product C9. N-Acylation using chloroacetyl chloride proceeded readily to give the 
chloride C10 in high yield. The choice of the chloroacetyl chloride instead of 
bromoacetyl bromide was a phenomenal decision in terms of the yield and the stability of 
the product.  
TBDMSO
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O
ON
TBDMSO
PhO2S
O
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p-ABSA
DBU, CH3CN
ON
TBDMSO
PhO2S
O
N2
cat. Rh2(OAc)4
CH2Cl2
N
O
O
PhSO2
H
TBDMSO
PhSO2Na
C10 C11
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Scheme 2-8. C-H insertion reaction for γ-lactam intermediate
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The resulting chloride C10 was treated with PhSO2Na to displace the chlorine  
with a phenylsulfone group resulting in the formation of phenylsulfone compound C11  
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 in excellent yield. Diazo transfer to the α-position of the acetamide C11 occurred  
readily using p-ABSA and DBU in acetonitrile providing the α-diazo- 
α-(phenylsulfonyl)acetamide C12, which is a precursor for the C-H insertion reaction. 
The product was purified using a flash column chromatography. The standard  
reaction condition for our C-H insertion protocol was applied to the diazo compound C12. 
It provided us the bicyclic γ-lactam intermediate C13, which is a key intermediate,  
in high yield. The reaction was highly regio- and stereoselective as expected  
providing only one diasereomer after a simple chromatography (Scheme 2-8). 
 
2.3 Total Synthesis of (+)-Allokainic Acid 
2.3.1 Introduction of Isopropenyl Group 
Upon obtaining the bicyclic γ-lactam C13 successfully, next challenging goal was 
the introduction of the isopropenyl group onto the α-position of the γ-lactam C13.  
The stereoselectivity of the isopropenylation was the most important factor for  
the synthesis of (-)-kanic acid A2, which should have a cis relationship between C-3 and 
C-4 substituents. As discussed Section 1-3 and 1-4, the most of successful syntheses 
utilized their own strategy, which was to achieve the cis relationship.23 The failure on  
the installation of the cis relationship between C-3 and C-4 substituents and obtaining  
a trans diastereomer usually resulted in the synthesis of (+)-allokainic acid A3,  
which is the C-4 epimer of (-)-kainic acid A2.  
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Our initial endeavor into the stereocontrol began with the stereoselective 
dephenylsulfonylation route from the isopropenylated intermediate C15. The preparation 
of the isopropenylated compound C15 was accomplished as described in Scheme 2-9.  
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Scheme 2-9. Introduction of isopropenyl group
α
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Acetylation onto the α-position was utilized for the preparation of a synthon for the 
isopropenyl compound C15. A noble acetylation condition for this center was developed 
utilizing Ac2O and NaH in THF solution producing a high yield of the product C13 as  
a white solid. The reaction was regio- and stereoselective giving only one diastereomer. 
We were confident with the stereochemistry of the compound C13 based on Meyer’s 
concept. It showed that alkylations of bicyclic systems typically occur on the β-face 
(convex face in this case) of the molecule. Next, attention was focused to the vinylation 
of the carbonyl group in the acetyl compound C13. The typical olefination protocols,  
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including Wittig, 24  Tebbe, 25  Lombardo, and Takai 26  , were not effective in  
this system due to the easy deacetylation or dephenylsulfonylation. To circumvent the 
side reaction, we chose a by-pass of triflate C14 by treating the compound C13 with 
KHMDS and Tf2O.27 The methylation reaction of the triflate C14 occurred readily using  
a Negishi type Pd(0) catalyzed alkylation protocol.28 Dimethyl zinc was the choice of the 
reagent as a coupling partner for the reaction producing the isopropenyl compound 
C15.29
 
2.3.2  Synthesis of (+)-Allokainic Acid (1) ;  Isopropenylation-
Dephenylsulfonylation Route 
 
With the isopropenylated compound C15 in hand, the stereoselective dephenyl- 
sulfonylation reaction30 became the focus of the next leg of the synthesis. Surprisingly  
the reduction of phenylsulfone group using 10% Na(Hg) in MeOH occurred readily 
resulting in only one diastereomer C16 (Scheme 2-10).   
Na/Hg N
O
O
H
TBDMSO
N
O
O
PhSO2
H
TBDMSO C15 C16
Scheme 2-10. Stereoselective dephenylsulfonylization
3 12
88%
MeOH
 
The stereochemistry of the C-3 position on the lactam compound C16 was not 
known at the time of the first synthesis. The coupling constant (J) of the proton on C-3 
position was 12.8 Hz implying a high possibility of trans-relationship with the proton on 
C-4 position. The result was surprising as we anticipated a degree of diastereoselection  
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based on the single electron mechanism through, which this reaction proceeded.11  
The reaction was reproducible giving only one diasteromer. The stereochemistry of  
C-3 position became an issue because the final compounds, (-)-kainic acid A2 or  
(+)-allokainic acid A3, would be destined by the stereochemistry of C-3 position.  
There was no choice but to touch the final compound and verify its stereochemistry  
by comparing with the known data. So, we embarked on the later part of the synthesis 
with a hope for the syntheis of (-)-kainic acid A2.   
The acetonide in compound C16 was unmasked via Dowex 50W-8X condition  
in boiling MeOH resulted in the simultaneous TBDMS deprotection to give the diol C17. 
Both hydroxyl groups were protected with TBDMS group employing the regular  
TBDMS protection method delivering the amide C18. Subsequent BOC protection of  
the amide group resulted in the synthesis of the amide C19 (Scheme 2-11). 
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Next, our attention turned to the reduction of the carbonyl group of the amide  
C19 to introduce a pyrrolidine core for kainoids synthesis. The Rubio method31 was  
used for for this purpose to protect the sensitive functional groups including the alkene. 
The BOC protected amide C19 was treated with Superhydride at -78 °C, resulting in  
high yield of the hemiaminal compound C20. Consecutive reaction with BF3OEt2 in  
the presence of Et3SiH provided the reduced pyrollidine compound C21, along  
with TBDMS deprotected compounds. 
Jones Ox
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Scheme 2-12. The synthesis of (+)-allokainic acid (1)
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The undesired TBDMS deprotection was not an issue because the next step was  
the deprotection of both TBDMS protected hydroxyl groups. With the diol C22 in hand, 
the next step was an employment of the Jones reagent to oxidize the alcohol to the 
carboxylic acid C23. The deprotection of the BOC group using TFA in CH2Cl2  
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provided the final product. Much to our dislike, the final compound was proven to be  
(+)-allokainic acid from the NMR studies (Scheme 2-12). 32  With this knowledge,  
an intensive exploration for the correct stereochemistry in favor of (-)-kainic acid A2 was 
begun. 
 
2.3.3   Synthesis of (+)-Allokainic Acid (2) ; Dephenylsulfonylation-
Isopropenylation route 
 
The search for the method to get a correct stereochemistry on the C-4  
position guided us to get another route of (+)-allokainic acid A3. It is the second strategy 
which was discussed in Section 2.2.2. The route was well described in Scheme 2-13. 
Reductive dephenylsulfonylation reaction of C3 occurred smoothly using Na(Hg)  
in MeOH. The reaction gave the bicyclic amide C24. With the bicyclic compound C24 
elicited, we took advantage of the structural feature of the bicyclic compound. There are 
two factors that can affect the face selection for the aldol reaction (Section 2.2.3) ;  
one is the concave/convex interaction of the bicyclic system and the other one is the 1,2-
induction induced from the bulky group on the C-4 position. Unfortunately the  
two factors contradicted each other, offering opposite stereoselectivities. The amide  
C24 was treated with LDA at -78°C, the resulting enolate was reacted with acetone  
to yield the aldol products as a mixture of the two diastereomers. The mixture  
was separable and had a ratio of 5:1 = C25:C26 in favor of the synthesis of (+)-allokainic 
acid A3 and, not (-)-kainic acid A2.  The 1,2-induction of the bulky group on the  
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C-4 position was a more important factor for the stereoselectivity than concave/convex 
nature of the bicyclic system. 
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The two diatereomers were separated using a column chromatography. At this 
point, our attention turned to the dehydration of the tert-alcohol in the compounds C25 
and C26 to introduce the isopropenyl group. PCl533 was the choice for the reagent for 
elimination due to the high yield and short reaction time. The NMR of C16 was exactly 
the same as the product we got from the dephenylsulfonylation method as shown  
Scheme 2-10. The desired isopropenylated compound C2 for the synthesis of  
(-)-kainic acid A2, also successfully prepared using the same dehydration method.  
It was not meaningful to follow the later part of the synthesis for (-)-kainic acid A2 using 
the minor diastereomer. 
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2.3.4 Model Study and Other Endaevors 
We embarked on the model study for the dephenylsulfonylation with a hope of get
ting the correct stereochemistry, in favor of (-)-kainic acid (Table 2-1). This reductive 
dephenylsulfonylation occurred readily, in high yield, to give the reduced products.   
Na/Hg
MeOH
N
O
O
PhSO2
H
TBDMSO
R
N
O
O
H
TBDMSO
R N
O
O
H
TBDMSO
R
+
trans / cisentry
1
2
3
R
O
MeO
OH
Br
4
5
4/1
1/1
N/A*
* Dehalogenation occured.
Table 2-1. Model study of dephenylsulfonylation
trans only(C15)
(C27)
(C28)
(C29)
(C30)
trans only
 
Acetyl compound C27  delivered the trans compound exclusively (entry 2), as for the  
isopropenylated compound C15 (entry 1). Each of them is bulky and an activating group 
making the proton on the α-position enolizable. The MOM group attached product,  
which is bulky but not activating, produced the mixture of the two diastereomers in a 4  
to 1 ratio (entry 3). The α-hydroxylated compound, which was prepared using  
the Davis oxazirididine,34 delivered 1/1 mixtures of the diastereomers (entry 4). The  
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bromide was not effective for this reaction due to the dehalogenation in the reaction  
condition (entry 5).  
N
O
O
H
TBDMSO C24
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O
O
H
TBDMSO
Br
C31
N
O
O
H
TBDMSO
Br
C32
+
1/1
Scheme 2-14. Bromination reaction
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NBS
60%
 
As an alternative route, the bromination reaction was studied to introduce a  
bromide group that could be substituted with the isopropenyl group via Sn2 type cuprate 
alkylation (Scheme 2-14). 35  The bromination reaction onto the α-position of the  
bicyclic compound B14 utilizing LDA/NBS condition provided a 1/1 mixture of the diast
ereomers.  
Our endeavor to circumvent the stereochemistry issue was continued as described 
in Scheme 2-15, 16, and 17. A hydrogenation route featuring the use of α-exo vinyl-γ-
lactam compound C35 as a key intermediate was tested. The concept is that hydrogen  
would approach from the α-face due to the 1,2-induction from the adjacent 
substituent providing the desired cis compound C36.  The aldol reaction of the  
dephenylsulfonylated compound C24 with α-benzyloxy acetone occurred readily  
to provide the compound C33. The manipulation of function groups and  
dehydration reaction utilizing SOCl2 condition derived the formation of the alkene  
compound C35.  
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Scheme 2-15. Hydrogenation route (1)  
The reaction yield and regioselectivity for the exo vinyl compound C35 were not  
improved to our expected level. Next, hydrogenation was effective accompanying the  
debenzylation step to give the alcohol C36 in 40%. However the stereoselectivity in  
hydrogenationstep was not verified. The elimination step, which introduces the  
isopropenyl group, was not effective and made us to stop this route (Scheme 2-15).  
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The preparation of the alkene compound C39 was tried to get an intermediate for 
hydrogenation route. The compound C24 was unmasked and the resulting amide was  
reduced using boranein DME reflux condition. However, the elimination of  the alcohol c
ompound C38 to the alkene C39 was not effective (Scheme 2-16). 
As depicted in Scheme 2-17, the α-diazo ester C41 was prepared from the  
ester C40 via LDA / PNBA  condition.36 The resulting complex was quenched with  
buffer solution (pH=7) to deliver yellowish diazo compound C41 successfully. 
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OTBDMS
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Scheme 2-17. α-Diazo ester route
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The nextchallenging step, C-H insertion reaction, using Rh(II) catalyst  
resulted in exclusive β-hydride elimination reaction yielding the compound C43.  
The pyrollidine compound C42 was not isolated from the reaction.  
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2.3.5 Conclusion 
The first generation of the retrosynthetic analysis (Figure 2-4) for the synthesis  
of (-)-kainic acid A2 did not work out. The two synthetic strategies depicted in  
Section 2.2.2 for the stereoselective isopropenylation were studied. Instead of (-)-kainic  
acid A2, (+)-allokainic acid A3 was synthesized from the two methods, which was  
developed during the study. The two route was efficient for the synthesis of (+)-
allokainic acid A3 by producing the compound in 11% overall yields after 15 steps  
starting from (L)-glutamic acid C5.  
From the results and model study, it was inferred that the direct use of the phenyl-
sulfone compound C3 for the stereoselective introduction of the isopropenyl group in a  
syn fashion neededanother concept to be considered.  
 
2.4  Total Synthesis of (-)-Kainic Acid 
2.4.1 Retrosynthetic Analysis of (-)-Kainic acid (Second) 
After a complete reevaluation of the proposed synthetic strategies, we inferred tha
tthe two substituents on C-3 and C-4 position should be handled together via ring  
formation until the late stage of the synthesis. Meanwhile, a new route was envisioned  
based on a precedented Michael type cyclization reaction, which is the formation of a  
bicyclic cyclohexenone from the cyclic β-ketoester containing conjugated  
acetylenic ketone B12 (Scheme 2-18).37
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The new and expedient route to the target molecule features three key steps;  
C-H insertion reaction, intramolecular Michael type cyclization, and stereoselective  
dephenylsulfonylation. Retrosynthetically, (-)-kainic acid A2 would be available from  
the cyclohexenone compound C44 via Baeyer-Villiger oxidation and ring opening.  
The bicyclic cyclohexenone compound C44 with an A/B cis junction could be derived 
utilizing stereoselective dephenylsulfonylation of the cyclized phenylsulfone compound  
C45.  
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An intramolecular Michael type cyclization reaction would provide the tricyclic  
compound C46. The precursor for the cyclization reaction C46 could be prepared from  
the compound C3 via deprotection, oxidation, Grignard reaction, and oxidation. It was  
allowed us to take advantage of the C-H insertion as a first key reaction to prepare  
the γ-lactam compound C3 (Figure 2-7). 
 
2.4.2 Michael - type Cyclization 
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Scheme 2-19. Preparation of ynone compound for Michael - type cyclization
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The goal of the next leg of the synthesis was to functionalize the C-4 substituent  
on the intermediate C3 and make a precursor C46 for the cyclization. The TBDMS group
 on the compound C3 was deprotected using TBAF. This was done to prepare the alcohol
 C47. The oxid-ation reaction of the alcohol to aldehyde C48 using Dess-
martin periodinane38 occurred readily in high yield. It was followed by a Grignard  
 
64
 
reaction using 1-propynylmagnesium bromide, which delivered the secondary  
alcohol C49.  The secondary alcohol was oxidized to the ynone compound C46, which is 
a precursor for the Michael type cyclization (Scheme 2-19). 
N
SO2Ph
O
OO
Cs2CO3
CH3CN
NPhO2S
O
O
O
C46 C45
Scheme 2-4. Intramolecular Michael addition of phenylsulphone compound
A B
C93%
 
 With the compound C46 in hand, we implemented the Michael type cyclization  
using  Cs2CO3 as a base.1 The reaction occurred readily to provide the desired tricyclic  
compound C45 successfully.  The low concentration (0.0025M) of the reaction solution  
was a key factor for the high yield. Prolonged reaction time and high concentration  
produced low yield of the product. The reaction is highly regio-
and stereoselective to yield only one diastereomer. The other diastereomers were not  
detected at all. It was believed that the stereochemistry would be an A/B cis junction  
based on the Deslongchamps’s results (Scheme 2-4).1
 
2.4.3 Synthesis of Bicyclic Cyclohexenone System 
At this point, it was expected that the dephenylsulfonylation would give the desire
d cis diastereomer exclusively, however, the two diastereomers C50, C51 was produced  
in a 1 to 1 ratio from the tricyclic compound C45 under the regular dephenylsulfonylation
condition (Scheme 2-20). 
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Scheme 2-20. Dephenylsulphonylation of tricyclic system  
Next, a bicyclic system was prepared by unmasking the acetonide C45 and 
functionalizing the resulting alcohol to the ester compound C55, which was necessary for 
the kainic acid A2 (Scheme 2-21).  
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Scheme 2-21. Preparation of the bicyclic system
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Treatment of the tricyclic compound C45 with Dowex 50W-8X in MeOH delivered the 
alcohol compound C52 quantitatively. It was followed by the Jones oxidation to make the 
acid C53, esterification using TMSCHN2 39 for the ester compound C54. The BOC 
protection of an amide group on C54 produced the bicyclic precursor C55 for the 
challenging next step.   
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2.4.4 Dephenylsulfonylation of Bicyclic Cyclohexenone System 
At this point, our focus was on the elucidation of the best intermediate for the 
clean and stereoselective dephenylsulfonylation. Some shortcomings on the amide C54 
and BOC-protected bicyclic compound C55 were found. The amide C54 was a good 
intermediate to get cis junction product C56 but the reaction condition for a BOC 
protection ruined the stereochemistry, due to the unexpected side reaction leading to the 
diBOC compound C57. On the other hand, the BOC-protected bicyclic compound C55 
was not stable under the Na(Hg) reduction condition and decomposed (Scheme 2-22).  
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Scheme 2-22. Dephenylsulphonylation of bicyclic system
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2.4.5 Dephenylsulfonylation of the Silyl Enol Ether  
The idea, the formation and utilization of the the silyl enolether system derived 
from the cyclohexenone,40 was tested. It was assumed that the diene system of the  
6-membered ring would make the ring flat during the dephenylsulfonylation  
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preventing epimerization. The silylation of the cyclohexenone C55 using TBSOTf in  
the presence of TEA occurred readily to give a mixture of two isomers C58 and C59.  
Both were subjected to the reduction condition using Na(Hg) at -20 °C providing  
only one diastereomer in 98% yield. The stereochemistry was not known at the moment, 
but it was proved that the product C44 has a desired stereochemistry for (-)-kainic acid. 
TBS deprotection step after dephenylsulfonylation occurred simultaneously to yield  
the cyclohexenone compound C44. The mixture of THF/MeOH (90/10) was the choice  
of the solvent for the dephenylsulfonylation step to get high yield of the product  
C44 (Scheme 2-23). 
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Scheme 2-23. Stereocontrol using dephenylsulphonylation of silyl dienol ether
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2.4.6  NOE study  
The stereochemical assignment of the compound C44 was made on the basis of 
NOE experiments and coupling constant analysis. We became confident with the 
stereochemistry after this point and verified the correct stereochemistry by making the 
final product, (-)-kainic acid A2.  
N
O
CO2Me
O
Boc
H
HHH H
1
2 345
1
23 4 5
7.2Hz
Figure 2-8. 1H NMR spectrum of C44  
Firstly, each proton peak was assigned base on the 1H-NMR, 13C-NMR, COSY-
NMR. The coupling constant of H1 with H2 was 7.2 Hz which was a typical coupling 
constant between syn hydrogens (Figure 2-8).  
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Figure 2-9. NOE - H1 spectrum
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Secondly, significant NOE between H1 and H2 was observed when H1 was 
irridiated; H1 and H2 are on the same face (Figure 2-9). 
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Figure 2-10. NOE - H2 spectrum  
Thirdly, significant NOEs between H2 and H4, H2 and H1 were observed when H2 
was irridiated; H2 and H4, H2 and H1 are on the same face (Figure 2-10). 
71
 
1 23 4 5
2
1
3
4
5N
O
CO2Me
O
Boc
H
HHH H
1
2 345
Figure 2-11. NOE - H4 spectrum  
Fourthly, significant NOEs between H4 and H2, H4 and H5 were observed when H4 
was irridiated (Figure 2-11). 
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Figure 2-12. NOE - H5 spectrum  
Fifthly, significant NOEs between H5 and H4, H5 and H3 were observed when H5 
was irridiated (Figure 2-12). 
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2.4.7   Rationale for the Stereochemistry 
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H1-H2, H2-H3, H4-H5
J 1, 2 = 7.2 Hz
Figure 2-13. NOE experiment, Overall  
The stereoselective dephenylsulfonylation from the silyl enol ether providing sole 
A/B cis junction could be explained from NOE study as summarized in Figure 2-13. The 
result could be rationalized using the model of the transition state in 
dephenylsulfonylation step. The sp2 character on ring A made the ring system flat holding, 
when the enolate picks up the proton from a protic solvent in the reaction condition 
(Figure 2-14).   
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Figure 2-14. Silyl enol ether
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2.4.8 Endgame for the Synthesis of (-)-Kainic Acid (1) 
With the bicyclic γ-lactam in hand, ring opening of the cyclohexenone  
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became the focus of the end game in the synthesis. Schultz reported a Baeyer 
Villiger oxidation of α,β-unsaturated primary alkyl ketone to get 7-membered 
enol lactone (Scheme 2-5). 41  The cyclohexenone compound C44 in our system  
underwent a regioselective Baeyer-Villiger oxidation with pertrifluoroacetic acid  
prepared in situ, according to the procedure reported by Schultz,5 whereby  
trifluoroacetic anhydride is reacted with urea-hydrogen peroxide in dichloromethane  
in the presence of sodium hydrogen phosphate. Under these reaction conditions the  
enol lactone C60 was stable but prolonged reaction time resulted in a low yield of  
the product. As an alternative peroxyacid, m-CPBA also gave an excellent 
regioselectivity and higher yield of the product C60 (Scheme 2-24).  
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Scheme 2-24. Baeyer-Villiger oxidation
60%
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The hydrogenation route was tested to introduce isopropenyl and ester group that 
were needed for the synthesis of (-)-kainic acid A2. Hydrogenation reaction42 of the enol 
lactone C60 occurred readily with an excellent stereoselectivity to give 7-member lactone 
compound C61. The rationale for the assignment of the stereochemistry of C61 is based 
on the convex-concave concept, which leads to a favored approach of the hydrogen and 
catalyst to the less hindered α-face of C60 (Scheme 2-25). 
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After receiving the lactone C61, it was believed to be promising intermediate to 
get to the final compound, (-)-kainic acid A2, because the C-4 epimer of C61 was utilized 
as an intermediate for the synthesis of (-)-kainic acid A2 (Scheme 2-26). 43  
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(-)-kainic acid
Scheme 2-26. Clayden's synthesis  
Unexpectedly, the same condition with Clayden’s synthesis for the lactone ring  
opening gave a totally different product in our system (Scheme 2-27). Lactone compound 
C61 was reacted with NaOMe and the resulting alkoxide anion on C62 attacked  
the carbonyl of the BOC-protected amide group on C62. It resulted in the formation of  
γ-lactone compound C63.  
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2.4.9 Endgame for the Synthesis of (-)-Kainic Acid (2) 
Now, it was encouraging to go through the issue of the undesired competing 
reaction, the formation of γ-lactone compound C63, by developing a new reaction route. 
The ring opening at the enol lactone C60 stage using NaOMe at -78 °C was tested. 
Fortunately, the aldehyde ester 44 compound C66, which is a noble compound, was 
obtained without epimerization on the α-position of the γ-lactam ring. Next, one pot 
reduction of both the aldehyde and the amide carbonyl utilizing DIBAL at -78 °C 
occurred readily to provide the hemiaminal alcohol compound C67 in high yield  
(Scheme 2-28).   
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The mixture of four diastereomers was carried forward for the selective 
mesylation of the primary alcohol on C67. To be our delight, the reaction yielded  
the mesylated hemiaminal intermediate C68 selectively. Further reduction of the 
hemiaminal compound using Et3SiH and boron BF3⋅OEt2 protocol was followed  
to generate the pyrrolidine core for the kainoid synthesis. The mesylated pyrrolidine 
intermediate C68 was subjected to the elimination reaction of the mesyl group. This  
was done to introduce the isopropenyl group utilizing NaI/DBU condition,45 in boiling 
DME, produced the isopropenyl pyrrolidine compound C70. The final deprotections  
took place on treatment with LiOH and trifluoroacetic acid.46 After purification with  
ion-exchange resin, the final product, (-)-kainic acid A2, was obtained successfully.  
The total synthesis of A2 was accomplished in 25 steps with a 5% overall yield.  
The synthetic (-)-kainic acid A2 was identical spectroscopically to reported data.  
The other physical properties including specific rotation and melting point were 
coinciding with standard data of the natural product and the other synthetic product 
reported by other research groups.47  
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Scheme 2-29. Endgame for the total Synthesis of (-)-Kainic acid
N
OH
CO2Me
Boc
MeO2C
HO
C67
75%
75%
85%
85%
 
 
2.4.10 Conclusion and Features 
One, (-)-α-kainic acid A2 and (+)-α-allokainic acid A3 were synthesized 
stereosectively utilizing three key reactions; C-H insertion reaction, intramolecular 
Michael type cyclization, and stereoselective dephenylsulfonylation of silyl enol ether. 
Two, the trans relationship between C-2 and C-3 was installed by the C-H insertion 
reaction and the cis relationship between C-3 and C-4 was installed using the 
stereoselective dephenylsulfonylation of the silylenol ether. Three, all stereochemistries 
were introduced from (L)-glutamic acid without using any chiral auxiliary. Four, the total 
synthesis of (-)-α-kainic acid A2 was accomplished in 25 steps with a 5% overall yield.  
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 Total Synthesis of (-)-α-Kainic Acid 
Number of steps 25 steps 
Overall yield  5% 
Key reactions - Rh(II) catalyzed intramolecular C-H insertion reaction 
- Michael-type cyclization 
- Stereoselective dephenylsulfonylatio 
Key points - Regio- and stereoselective 
- No chiral auxiliary or expansive material ewre used 
- All stereochemistries were introduced from (L)-glutamic acid 
Total Synthesis of (+)-α-Allokainic Acid 
Number of steps 19 steps 
Overall yield  9% 
Key reactions - Rh(II) catalyzed intramolecular C-H insertion reaction 
- Stereoselective dephenylsulfonylatio 
Key points - Regio- and stereoselective 
- No chiral auxiliary or expansive material ewre used 
- All stereochemistries were introduced from (L)-glutamic acid 
Table 2-2. Summary of the syntheses of (-)-kainic acid and (+)-allokainic acid 
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Chapter Three 
Experimental Data 
 
All experiments were carried out under nitrogen atmosphere using oven dried  
glassware (or flame dried when necessary). All chemicals were purchased from Aldrich  
Chemical Co. and/or Acros Organics and used without further purification unless  
otherwise noted. CH2Cl2 was distilled over calcium hydride. THF and diethylether were  
distilled over sodium metal. 1H nuclear magnetic resonance (400 MHz) and 13C (100  
MHz) spectra were recorded at room temperature in CDCl3 unless otherwise noted. All  
chemical shifts are reported as δ relative to CHCl3 (δH 7.26 ppm) and CDCl3 (δC 77.0  
ppm) as internal standards, respectively, using a INOVA 400 spectrometer. Infrared  
spectra were recorded using a Nicolet Magna FTIR 550 spectrometer and are reported in  
reciprocal centimeters (cm-1). Mass analysis was preformed using Hewlett-
Packard HRMS spectroscopy. Thin layer chromatography (TLC) was preformed on EMD
 precoated silica plates with silica gel 60 Å, 250 µm thickness. Visualization of TLC was  
accomplished using a UV lamp (254 nm), iodine or charring solutions (ninhydrin and  
PMA). Flash column chromatography was performed on Whatman Purasil 60 Å (230-
400mesh) silica gel. 
 
3.1 Preparation of (L)-Glutamic acid Dimethyl ester C6 
NH2
CO2H
HO2C
 SOCl2, MeOH
NH2
CO2Me
MeO2C
then NaHCO3
C5 C6  
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Thionyl chloride (100 mL, 1.28 mol) was added dropwise to a solution of (L)- 
glutamic acid (100 g, 0.64 mol) in methanol (700 mL) at 0 °C, and the mixture was warm
ed to r.t. with stirring and kept stirring for 10 h. The resulting solution was concentrated  
under vacuum and dissolved in fresh MeOH (300ml). The solution was neutralized to pH
=7.0 by adding solid NaHCO3 with stirring. After filtration of the precipitate, the solvent 
was evaporated to give (L)-glutamic acid dimethylester as colorless oil. To the  
resulting oil 300 ml of CH2Cl2 was added to precipitate the salts such as NaCl, NaHCO3. 
The solution was filtered to afford the desired neutral (L)-glutamic acid dimethylester  
C6 as colorless oil (222 g, 99%). The crude product was used for the next step without  
further purification. For compound C6: 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1 H), 4.22 
(t, 1 H, J = 5.6 Hz), 3.75 (s, 3 H), 3.61 (s, 3 H), 2.68-2.50(m, 2 H), 
2.40-2.22(m, 2 H) ; 13C NMR (100MHz, CDCl3) δ 173.0, 170.4, 53.4, 52.8, 52.0, 30.0, 
25.9; IR (thin film, cm-1) 2954, 1736, 1439, 1225; HRMS (ESI+)  for MH+ C7H14NO4 :  
calcd 176.0913, found 176.0927 ;[α]D25 = + 92.8  (c = 1.93, MeOH)  
 
3.2 Preparation of 2-amino-1, 5-pentanediol C7 
HO
OH
NH2NH2
CO2Me
MeO2C
LAH
C6 C7  
A solution of C6 (50g, 0.28 mol) in dried THF (100 ml) was added to the mixture 
of  lithium aluminum hydride (27g, 0.70 mol) in dried THF (450 mL) at 0 °C. The result-
ing reaction mixture was stirred for 10 hours at room temperature and quenched by  
successive addition of water (27 mL) - 20% NaOH (27 mL) - water (54 mL).  
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The precipitate was filtered and washed with THF. The filtrate was dried over Na2SO4  
and concentrated to give amino alcohol C7 as an oil (23 g, 70%), which was used for the 
next step without further purification. For compound C7: 1H NMR (400 MHz, CD3OD) δ
3.60-3.42 (m, 3 H), 3.4-3.23 (m, 1 H), 2.80-2.70 (m, 1 H), 1.70-1.40 (m, 3 H), 1.39-
1.25 (m, 1 H); 13C NMR (100 MHz, CD3OD) δ 66.06, 61.76, 52.68, 29.63, 29.08; IR  
(thin film, cm-1) 3322, 2943, 1025 ; HRMS (ESI+) for MH+  C5H14NO2 : calcd 120.1019,  
found 120.1017; [α]D25 = + 2.9 (c = 0.65, MeOH) 
 
3.3 Preparation of acetonide C8 
Acetone
MgSO4
HO
OH
NH2
HO
OHN
C7 C8  
The mixture of the amino alcohol C7 (20 g, 0.17 mol) in acetone (400 mL) and  
CH2Cl2 (400 mL) was warmed to 40 °C with stirring. To the resulting solution anhydrous
 MgSO4 (21 g, 0.17 mol) was added slowly. After refluxing  the solution with stirring for 
2h, the reaction mixture was filtered and concentrated to give the acetonide intermediate  
C8 (24 g, 91%). For compound C8: 1H NMR (400 MHz, CDCl3) δ 3.91 (t, 1 H, J= 7.2), 3
.62-3.43 (m, 2 H), 3.38-3.25 (m, 1 H), 3.17 (t, 1 H, J=8.0 Hz), 1.67-1.52 (m, 3 H), 1.52-
1.41 (1, 1 H), 1.36 (s, 3 H), 1.24 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 95.0, 70.9, 62.1,
 58.3, 30.8, 30.5, 27.6, 26.6; IR (thin film, cm-1)  3388, 2936, 1364 ;  
HRMS (ESI+) for MH+ C8H18NO2: calcd 160.1332, found 160.1333 ; [α]D25 = + 11.6 (c = 
0.79, MeOH) 
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3.4 Preparation of TBDMS protected acetonide C9 
TBDMSO
NaH
TBDMSCl
OHN
HO
OHN
C8 C9  
Sodium hydride (3.1 g, 76 mmol) was suspended in THF (250 ml) after being  
washed with hexane. The solution of the alcohol C8 (10 g, 63 mmol) in THF (50 ml) was
 added to this mixture at 0°C and the solution was warmed up to r.t and stirred for 45 min
 at which time a largeamount of an opaque white precipitate had formed. The solution of  
TBDMSCl (9.5 g, 63 mmol) and TEA (2ml) in dried THF (50 ml) was then added at 0°C,
and vigorous stirring was continuedfor 45 min at r.t. The mixture was poured into EtOAc 
(500 mL), washed with brine (100 mL), dried over Na2SO4, and concentrated in vacuo to 
give the protected acetonide C9 (14 g, 85%).The resulting oil was used for the next step 
without further purification. For compound C9: 1H NMR (400 MHz, CDCl3) 3.92  
(t, 1 H, J = 7.2 Hz), 3.59 (t, 2 H, J = 5.6 Hz), 3.40-3.32 (m, 1H),  
3.20 (t, 1 H, J = 8.0 Hz), 1.60-1.42 (m, 4 H), 1.39 (s, 3 H), 1.26 (s, 3 H), 
0.85 (s, 9 H), 0.00 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 95.0, 71.0, 62.7, 58.2, 30.2,  
30.0, 27.7, 27.7, 26.4, 25.9, 25.8, 25.7, 18.2, -5.3, -5.5 ; IR (thin film, cm-1) 
3388, 2936, 1364; HRMS (ESI+) for MH+ C14H32NO2Si: calcd 274.2197, found  
274.2207; [α]D25 = +16.2 (c = 3.1, MeOH). 
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3.5  Preparation of α-chloro acetonide B10 
TBDMSO
Cl
O
TBDMSO
OHN
ONClCH2COCl
C9 C10  
Chloroacetyl chloride (6.5 g, 4.6 mL, 58 mmol) was added to a mixture of 
acetonide compound C9 (14 g, 48 mmol) and TEA (9.7 g, 13 mL, 96 mmol) in CH2Cl2 
(240 mL) at 0 °C. After stirring for 3 hours at 0 °C, the reaction mixture was washed with 
brine, and the aqueous layer was extracted with CH2Cl2 (100 mL). The combined organic 
layers were washed with brine, dried over Na2SO4 and concentrated. The residue was 
purified by column chromatography (Hex/ EtOAc = 5/1) to give α-chloroacetyl amide 
compound C10 (14 g, 88%) as colorless oil. For compound C10: 1H NMR  
(400 MHz, CDCl3) δ 4.06 (ABq, 1 H, JAB = 12.4 Hz), 3.94 (ABq, 1 H, JAB = 12.4 Hz), 
3.93-3.87 (m, 2 H), 3.82-3.80 (m, 1 H), 3.66-3.55 (m, 2 H), 1.82-1.70 (m, 1 H), 1.60  
(s, 3 H), 1.58-1.40 (m, 3 H), 1.46 (s, 3 H), 1.83 (s, 9 H), 0.00 (s, 6 H) ; 13C NMR  
(100 MHz, CDCl3) δ 168.3, 101.0, 72.4, 67.4, 62.8, 48.5, 36.5, 34.7, 31.9, 31.4, 31.3, 
27.9, 23.7, 0.1, 0.00 ; IR (thin film, cm-1) 2976, 1736, 1655, 1410, 1247 ; HRMS (ESI+) 
for MH+ C16H33ClNO3Si : calcd 350.1913, found 350.1912 ; [α]D25 = + 16.6  
(c = 3.43, CHCl3). 
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3.6 Preparation of Phenylsulfone C11 
TBDMSO
Cl
O
ON
TBDMSO
PhO2S
O
ONPhSO2Na
C10 C11  
PhSO2Na (9.9 g, 60 mmol) was added to a solution of chloroacetyl amide 
compound C10 (14 g, 40 mmol) in DMF (200 mL) at r.t. After stirring for 6 hours, the 
reaction mixture was diluted with EtOAc, washed with water twice, dried over Na2SO4 
and concentrated. The residue was purified by column chromatography (Hex/EtOAc=2/1) 
to give α-phenylsulfonyl acetamide C11 (16 g, 91%). For the compound C11:  
mp 118-119°C ;  1H NMR (400 MHz, CDCl3) δ 7.91-7.52 (m, 5 H), 4.31 (ABq, 1 H,  
JAB = 13.6 Hz), 4.20-4.16 (m, 1 H), 3.98 (ABX, 1 H, JAB = 9.2 Hz, JAX = 5.2 Hz),   
3.97 (ABq, 1 H, JAB = 13.6 Hz), 3.83 (ABX, 1 H, JAB = 9.2 Hz, JAX = 0 Hz), 3.71-3.60 
(m, 2 H), 1.82-1.70 (m, 1 H), 1.70-1.50 (m, 3 H), 1.56(s, 3 H), 1.47 (s, 3 H), 0.87 (s, 9 H), 
0.05 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 157.7, 138.7, 134.1, 129.0, 128.5,  
95.4, 66.7, 62.1, 61.7, 58.0, 30.6, 29.2, 26.2, 25.8, 22.3, 18.2, -5.3, -5.5; IR (thin film,  
cm-1) 2950, 1646, 1428 ; HRMS (ESI+) for MH+ C22H38NO5SSi : calcd 456.2234,  
found 456.2233 ; [α]D25 = + 43.5 (c = 1.36, CHCl3). 
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3.7 Preparation of α-Diazo-α-(phenylsulfonyl)acetamide C12 
TBDMSO
PhO2S
O
ON
p-ABSA
DBU, CH3CN
ON
TBDMSO
PhO2S
O
N2
C11 C12  
To a solution of α-phenylsulfonyl acetamide (9.5 g, 20 mmol) in acetonitrile (100 
mL) was added p-N-acetylbenzosulfonylazide (p-ABSA, 5.8 g, 24 mmol) followed by 
DBU (7.5 mL. 50 mmol). The reaction mixture was stirred for 3 h at 0 °C. After 
evaporation of acetonitrile the residue was diluted with EtOAc. The organic layers were 
washed with brine twice, dried over Na2SO4 and then evaporated. The residue was 
purified by column chromatography to give α-diazo-α-(phenylsulfonyl)acetamide C12 as 
yellow oil (8.5 g, 89%). For compound C12: 1H NMR (400 MHz, CDCl3) δ 7.98  
(d, 2 H, J = 8.0 Hz), 7.62 (m, 1 H), 7.53 (m, 2 H), 3.99 (ABX, 1 H, JAB = 8.8 Hz,  
JAX = 5.6 Hz), 3.94-3.87 (m, 1 H), 3.81 (ABX, 1 H, JAB = 8.8 Hz, JAX = 2.8 Hz),  
3.64-3.57 (m, 2 H), 1.75-1.66 (m, 1 H), 1.59 (s, 1 H), 1.50-1.42 (m, 1 H), 1.39 (s, 3 H), 
1.23 (s, 9 H), 0.04 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 207.9, 154.1, 142.3,  
134.0, 129.3, 128.0, 96.8, 67.9, 62.6, 57.7, 44.7, 31.1, 29.4, 26.5, 26.2, 26.1, 23.9, 18.5,  
-5.0; IR (thin film, cm-1) 2956, 2089, 1744, 1646, 1375, 1239 ; HRMS (ESI+)  
for [M+Na]+ C22H35N3O5SSiNa : calcd 504.1959, found 504.1955 ; [α]D25 = + 94.8  
(c = 1.86, CHCl3). 
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3.8 Preparation of γ-lactam C3 
ON
TBDMSO
PhO2S
O
N2
cat. Rh2(OAc)4
CH2Cl2
N
O
O
PhSO2
H
TBDMSO
C12 C3  
To a solution of the α-diazo-α-(phenylsulfonyl)acetamide C12 (7.5 g, 15 mmol) 
in dry CH2Cl2 (300 mL, C = 0.05 M) was added catalytic amount of Rh2(OAc)4 (66 mg, 
0.15 mmol). The mixture was refluxed with stirring for 12 hours under N2, cooled to room 
temperature, and was then concentrated. The residue was purified by column 
chromatography (Hex/EtOAc = 2/1) to give α-(phenylsulfonyl)-γ-lactam C3 as a single 
isomer (6.2 g, 92%). For compound C3: mp 64-65°C ; 1H NMR (400 MHz, CDCl3)  
δ 7.99 (d, 2 H, J = 7.2 Hz), 7.65 (m, 1 H), 7.54 (m, 2 H), 4.12 (d, 1 H, J = 10.0 Hz), 4.08 
(ABX, 1 H, JAB = 8.6 Hz, JAX = 5.4 Hz),  3.92-3.80 (m, 1 H), 3.78-3.50 (m, 2 H), 3.44 
(ABX, JAB = 8.6 Hz, JBX = 9.0 Hz), 2.90-2.81 (m, 1 H), 2.38-2.29 (m, 1 H), 1.80-1.68  
(m, 1 H), 1.46 (s, 3 H), 1.37 (s, 3 H), 0.89 (s, 9 H), 0.07 (s, 3 H), 0.05 (s, 3 H);  
13C NMR (100 MHz, CDCl3) δ 161.7, 137.8, 134.3, 130.2, 129.0, 92.3, 75.1, 70.1, 63.8, 
61.1, 37.4, 35.8, 26.6, 26.2, 26.1, 23.7, 18.5, -5.2; IR (thin film, cm-1) 2977, 2931, 1702, 
1447, 1308, 833 ; HRMS (ESI+) for MH+ C22H36NO5SSi : calcd 454.2078,  
found 454.2090 ; [α]D25 = + 39.7 (c = 3.53, CHCl3). 
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3.9 Preparation of acetylated γ-lactam C13 
N
O
O
PhSO2
H
TBDMSO
N
O
O
PhSO2
H
TBDMSO
O
Ac2O, NaH
THF
C3 C13  
To a solution of phenylsulfone C3 (1 g, 2.4 mmol) in dry THF (24 mL, 0.1M) was 
added NaH (190 mg, 4.8 mmol) in one portion at -10°C. The resulting reaction mixture 
was stirred for 30 min at -10°C and Ac2O (485 mg, 0.45 ml, 4.8 mmol) was added and 
stirred for 1 h. The reaction mixture was quenched by addition of saturated aqueous 
NH4Cl solution and extracted with 100 ml of EtOAc two times. The combined organic 
layer was washed with brine, dried over Na2SO4, concentrated in vacuo. The product was 
separated using flash column chromatography (Hex/EtOAc = 2/1) to afford the acetylated 
compound C13 (1.1 g, 90%) as a white solid. For compound C13: 1H NMR  
(400 MHz, CDCl3) δ 8.02 (d, 2 H, J = 8.0 Hz), 7.60 (m, 1 H), 7.48 (m, 2 H), 4.00  
(m, 1 H), 3.81 (m, 1 H), 3.65 (m, 1 H), 3.47 (m, 1 H), 3.24 (m, 1 H), 3.03 (m, 1 H),  
2.42 (s, 3 H), 2.21 (m, 1 H), 1.37 (s, 3 H), 1.23 (s, 3 H), 0.86 (s, 9 H), 0.03 (s, 3 H),  
0.00 (s, 3 H) ; 13C NMR (100 MHz, CDCl3) δ 208.6, 198.0, 161.6, 136.1, 134.2, 131.8, 
128.4, 91.9, 90.7, 70.0, 63.2, 60.7, 42.5, 31.5, 31.2, 26.3, 26.0, 18.2, -5.5. 
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3.10 Preparation of Vinyl triflate C14 
N
O
O
PhSO2
H
TBDMSO
O
N
O
O
PhSO2
H
TBDMSO
OTf
KHMDS
 Tf2O
C13 C14  
To a solution of ketone C13 (0.3 g, 0.61 mmol) in THF (6 mL, 0.1M) was added  
KHMDS (0.5M in toluene) (1.5 ml, 0.73 mmol) dropwise via syringe at -78°C.  
The mixture was allowed to stir for 10 min upon which a solution of Tf2O (0.2 g, 0.123  
ml, 0.73 mmol) in THF (1 ml) was added dropwise. The resulting reaction mixture was  
stirred for 1 h, quenched by addition of saturated NaHCO3, allowed to warm to r.t.  The  
reaction mixture was extracted with EtOAc (30ml × 2) and the combined organic layers  
were dried over Na2SO4 and then evaporated. The residue was purified by column  
chromatography (Hex/EtOAc = 5/1) to give the triflate C14 as colorless oil (272 mg,  
71%). For compound C14: 1H NMR (250 MHz, CDCl3) δ 8.08 (d, 2 H, J = 11.9 Hz),  
7.67 (m, 1 H), 7.54 (m, 2 H), 5.83 (d, J = 8.3 Hz, 1 H), 5.67 (d, J = 8.3 Hz, 1 H), 4.12  
(m, 1 H), 3.88-3.77 (m, 2 H), 3.57 (m, 1 H), 3.45-3.31 (m, 2 H), 2.43-2.25 (m, 1 H),  
1.72-1.60 (m, 1 H), 1.42 (s, 3 H), 1.37 (s, 3 H), 0.93 (s, 9 H), 0.11 (s, 3 H), 0.09 (s, 3 H)  
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3.11 Preparation of α-isopropenyl-α-phenylsulfonyl-γ-lactam C15 
N
O
O
PhSO2
H
TBDMSO
N
O
O
PhSO2
H
TBDMSO
OTf
 ZnMe2
Pd(PPh3)4
C14 C15  
To a solution of triflate C14 (270 mg, 0.43 mmol) in THF (4.3 ml) was added 
Pd(PPh3)4 (24 mg, 5 mole%) at 0°C. The mixture was allowed to stir for 15 min upon  
which a solution of ZnMe2 (5.4 ml, 0.16M solution in THF, 0.86 mmol) was added  
dropwise. The resulting reaction mixture was allowed to warm to r.t and stirred for 24 h, 
quenched by addition of saturated NH4Cland extracted with EtOAc (30 ml × 2). The  
combined organic layers were dried over Na2SO4 andthen evaporated. The residue was  
purified by column chromatography (Hex/EtOAc = 5/1) to givethe triflate C15 as  
colorless oil (150 mg, 72%). For compound C15: 1H NMR (250 MHz, CDCl3) δ 8.09  
(d, 2 H, J = 13Hz), 7.67-7.36 (m, 3 H), 5.46 (s, 1 H), 5.41 (s, 1 H), 4.11 (m, 1 H),  
3.78-3.69 (m, 2 H), 3.52 (m, 1 H), 3.40 (m, 1 H), 3.20 (m, 1 H), 2.40-2.25 (m, 1 H), 
1.94 (s, 3 H), 1.65-1.55 (m, 1 H), 1.42 (s, 3 H), 1.30 (s, 3 H), 0.94 (s, 9 H), 0.11 (s, 3 H), 
0.08 (s, 3 H) . 
 
3.12 Preparation of α-isopropenyl-γ-lactam C16 
Na/Hg
MeOH
N
O
O
H
TBDMSO
N
O
O
PhSO2
H
TBDMSO C15 C16  
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10% Sodium amalgam (0.72 g, 3 mmol) was added to a solution of the α-
isopropenyl-α-phenylsulfone-γ-lactam C15 (150 mg, 0.3 mmol) and anhydrous disodium 
hydrogen phosphate (0.17 g, 1.2 mmol) in dry methanol (6 mL) at -78 °C. The mixture 
was allowed to be warmed to 0°C and stirred for 3 h, quenched with NH4Cl, and filtered. 
The reaction solution was concentrated in vacuo, diluted with EtOAc (50ml). After phase 
separation, the water layer was extracted with EtOAc and the combined organic layers 
were washed with brine, dried over Na2SO4, filtered and concentrated. The product was 
separated using flash chromatography (Hex/EtOAc = 2/1) to give C16 as colorless oil  
(93 mg, 88%). For compound C16: 1H NMR (250 MHz, CDCl3) δ 5.00 (s, 1 H), 4.85  
(s, 1 H), 4.15 (m, 1 H), 3.85 (m, 1 H), 3.65-3.55 (m, 3 H), 3.20 (d, J = 12.8, 1 H), 2.25  
(m, 1 H), 1.76 (s, 3 H), 1.65 (s, 3 H), 1.70-1.50 (m, 2 H), 1.46 (s, 3 H), 0.89 (s, 9 H),  
0.04 (s, 6 H).  
 
3.13 Preparation of  C18 
N
O
O
H
TBDMSO
1. Dowex 50W-8X
C16
NH
OTBDMS
O
TBDMSO
2. TBDMSCl
C18  
To a solution of bicyclic acetonide C16 (0.75 g, 2.1 mmol) in MeOH  
(11ml, 0.2M) was added 2.5 g of Dowex-50W-8X in one pot. The resulting solution was 
heated under reflux condition for 3 h. The mixture was filtered and concentrated  
to provide the diol compound as pale yellowish oil. The product was used for the next 
step without further purification. The crude diol compound was dissolved in CH2Cl2  
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(11 ml, 0.2 M). To the resulting solution were added TEA (1.1 g, 1.5 mL, 10.5  
mmol), DMAP (259 mg, 2.1 mmol), and TBDMSCl (0.8 g, 5.3 mmol) consecutively. 
After stirring the mixture for 12 h, the mixture was washed with brine, dried over Na2SO4, 
filtered, and distillated to give the crude product. The product was separated using  
flash column chromatography (Hex/EtOAc = 1/1) to provide the amide C18 (0.63g, 70%). 
For compound C18: 1H NMR (250 MHz, CDCl3) δ 5.92 (s, 1 H), 5.00 (s, 1 H), 4.92  
(s, 1 H), 3.80 (m, 1 H), 3.64 (t, J =  10.0 Hz, 2 H), 3.52-3.33 (m, 2 H), 2.92 (d, J = 9.7 Hz, 
1 H), 2.25-2.05 (m, 1 H), 1.75 (s, 3 H), 1.77-1.65 (m, 2 H), 0.89 (s, 9 H), 0.88 (s, 9 H), 
0.06 (s, 6 H), 0.04 (s, 6 H).  
 
3.14 Preparation of BOC-protected γ-lactam C19 
NH
OTBDMS
O
TBDMSO
NBoc
OTBDMS
O
TBDMSO
Boc2O
C18 C19  
TEA (164 mg, 0.23 ml, 1.62 mmol), Boc-anhydride (0.64 g, 2.94 mmol) and  
DMAP (0.18 g, 1.47 mmol) were added to a solution of γ-lactam C18  
(0.63 g, 1.47 mmol) in CH2Cl2 (15 mL, 0.1M). The mixture was stirred for 2 h and  
concentrated under reduced pressure. The residue was purified by flash chromatography  
(Hex/EtOAc = 2:1) to afford the title compound C19 as a colorless oil (0.56g, 80%).  
For compound C19: 1H NMR (250 MHz, CDCl3) δ 4.94 (s, 1 H), 4.87 (s, 1 H), 4.05  
(m, 1 H), 3.75-3.55 (m, 5 H), 2.92 (d, J = 8.7 Hz, 1 H), 1.74 (s, 3 H),  
1.77-1.65 (m, 2 H), 1.50 (s, 9 H), 0.85 (s, 9 H), 0.84 (s, 9 H), 0.00 (s, 12 H). 
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3.15 Preparation of C20 
NBoc
OTBDMS
O
TBDMSO
NBoc
OTBDMS
OH
TBDMSO
LiEt3BH
C19 C20  
A 1.0M solution of LiEt3BH in THF (1.44 ml) was added to a solution of γ-lactam 
C19 (0.56 g,  1.2 mmol)  in THF (12 ml) at -78 °C under N2 atmosphere. After 30 min 
the reaction mixture was quenched with saturated aqueous NaHCO3 (2.5ml) and warmed 
to 0 °C. 30% H2O2 (5 drops) was added and the mixture was stirred at 0°C. After 20 min, 
the organic solvent was removed in vacuo, and the aqueous layer was extracted with 
CH2Cl2 (3 × 10ml). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The crude product was used without purification (0.5 g, 90%).  
For compound C20: 1H NMR (250 MHz, CDCl3) δ 6.55 and 6.34 (s, 1 H), 4.80-4.78  
(m, 2 H), 3.95-3.85 (m, 1 H), 3.70-3.55 (m, 4 H), 3.50-3.40 (m, 1 H), 3.10-2.90 (m, 1 H), 
2.00-1.80 (m, 1 H), 1.83 (s, 3 H), 1.60-1.50 (m, 10 H), 0.86 and 0.84 (s, 18 H),   0.02  
and 0.00 (s, 12 H). 
 
3.16 Preparation of isopropenyl pyrrolidine C21 
BF3OEt2
Et3SiH
NBoc
OTBDMS
OH
TBDMSO
NBoc
OTBDMS
TBDMSO
C20 C21  
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A solution of hemiaminal compound C20 (0.5 g, 0.94 mmol) and Et3SiH (0.11 g, 
0.15 ml, 0.94 mmol) in CH2Cl2 (9 ml, 0.1M) was cooled at -78 °C and BF3⋅OEt2 (0.15 g, 
0.13 ml, 1.0 mmol) was then added dropwise under N2 atmosphere. After 30 min Et3SiH 
(0.11 g, 0.15 ml, 0.94 mmol) and BF3⋅OEt2 (0.15 g, 0.13 ml, 1.0 mmol) were added. The 
resulting mixture was stirred 2 h at -78°C. The reaction mixture was quenched saturated 
aqueous NaHCO3, extracted with CH2Cl2 and dried over Na2SO4. Evaporation of the 
solvent and purification by flash column chromatography (Hex/EtOAc = 2/1) gave the 
product C21 as a colorless oil (300 mg, 75%). For compound C21: 1H NMR (250 MHz, 
CDCl3) δ 4.84 (s, 2 H), 3.80-3.61 (m, 6 H), 3.04 (m, 1 H), 2.45-2.30 (m, 1 H), 2.00-1.80 
(m, 1 H), 1.70-1.60 (m, 1 H), 1.68 (s, 3 H), 1.44 (s, 9 H), 0.86 (s, 9 H),   0.01 (s, 6 H). 
 
3.17 Preparation of diol C22 
NBoc
OTBDMS
TBDMSO
TBAF
NBoc
OH
HO
C21 C22  
To a solution of pyrrolidine C21 (200 mg, 0.39 mmol) in THF (3.9 ml) was 
added TBAF (1M in THF, 0.9 ml, 0.9 mmol) slowly. After stirring of the reaction 
mixture for 1 h at r.t, concentrated in vacuo and diluted with 10ml of EtOAc. The 
organic layer was washed with brine solution, dried over Na2SO4 and concentrated in 
vacuo. The products were separated using flash column chromatography (EtOAc) to 
afford the diol B23 (88 mg, 80%) as a colorless oil. For compound C22: 1H NMR  
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(250 MHz, CDCl3) δ 4.86 (s, 2 H), 3.75-3.55 (m, 6 H), 3.10 (m, 1 H), 2.40 (m, 1 H),  
1.90-1.60 (m, 3 H), 1.70 (s, 3 H), 1.44 (s, 9 H).  
 
3.18 Preparation of pyrrolidine-2-carboxylic acid C23 
Jones OxNBoc
OH
HO
NBoc
CO2H
CO2H
C22 C23  
Jones reagent (1.0 M, 1.4 mL, 1.4 mmol) was added to a solution of C22 (20 mg, 
0.07 mmol) in acetone (1.4 ml) at r.t and the resulting mixture was stirred for 2 h at that 
temperature. The reaction was quenched with i-PrOH, concentrated in vacuo. The 
reaction solution was dissolved in 10 ml of CH2Cl2 and 1ml of brine solution was added. 
After phase separation, the aqueous layer was extracted three times with CH2Cl2 and the 
organic layers were combined, dried over Na2SO4 and concentrated to give carboxylic 
acid compound C23 (15 mg, 70%) as a white solid, which was used for the next step 
without further purification. For compound C23: 1H NMR (250 MHz, CDCl3) δ 8.36 
(broad s, 2 H), 4.92 and 4.87 (s, 2 H), 4.05 and 3.90 (d, J = 14.4 Hz, 1 H), 3.78-3.59  
(m, 1 H), 3.40-3.20 (m, 1 H), 2.80-2.10 (m, 4 H), 1.70 (s, 3 H), 1.51 and 1.44 (s, 9 H). 
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3.19 Preparation of (+)-allokainic acid A3 
A3 (+)-allokainic acid
NBoc
CO2H
CO2H
NH
CO2H
CO2H
CF3CO2H
C23  
To a solution of diacid C23 (15 mg, 0.047 mmol) in CH2Cl2 (1 ml) was added CF3
CO2H (64 mg, 0.042 ml, 0.56 mmol) at r.t. After stirring the reaction mixture for 12 h, th
e solution was concentrated in vacuo to give the crude product. The crude product was ad
ded to a column containing Dowex-50 H+ (WX8-200, 8% cross-linking, 100-
 200 wet mesh). Elution with NH4OH (1 N), evaporation afforded (+)-
allokainic acid A3 (6 mg, 60%): [α]D25 = + 7.2° ( c= 0.2, H2O) . [lit : [α]D25 = + 7.4° (c = 0.
7, H2O)]; 1H NMR (D2O) δ 4.85 (s, 2 H), 4.08 (d, J = 8.7 Hz), 3.50-3.30 (m, 1 H), 3.29-
3.05 (m, 1 H), 2.85-2.70 (m, 1 H), 2.70-2.40 (m, 3 H), 1.56 (s, 3 H);  
13C NMR (62.5 MHz, D2O) δ 177.1, 175.3, 139.1, 115.9, 65.3, 51.1,47.6, 40.9, 34.3, 17.0. 
 
3.20 Preparation of  γ-lactam B25 
N
O
O
PhSO2
H
TBDMSO
Na/Hg
MeOH
N
O
O
H
TBDMSOC3 C24  
10% Na(Hg) (5.4 g, 22.5 mmol) was added to a solution of the α-phenylsulfone-γ-
lactam  C3 (2.0 g, 4.5 mmol) and anhydrous disodium hydrogen phosphate (2.0 g, 13.5 
mmol) in dry methanol (90mL) at 0°C. The reaction mixture was warmed to r.t slowly  
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for 3 h, quenched with aqueous NH4Cl. After filtration, the reaction solution was 
concentrated in vacuo, diluted with 100 ml of EtOAc, wished with brine. The organic 
layer was dried over Na2SO4, filtered and concentrated to give C24 as colorless oil  
(1.4 g, 96%). For compound C24: 1H NMR (400 MHz, CDCl3) δ 4.04 (m, 1 H), 3.86  
(m, 1 H), 3.54 (m 1 H), 3.45 (m, 1 H), 2.57 (ABX, 1 H, JAB = 16.1 Hz, JAX = 5.6 Hz), 
2.46 (ABX, 1 H, JAB = 16.1 Hz, JAX = 12.0 Hz), 2.3-2.2 (m, 1 H), 1.75-1.62 (m, 1 H), 
1.59 (s, 3 H), 1.39 (s, 3 H) 0.83 (s, 9 H), -0.01 (s, 6 H) ; 13C NMR (100 MHz, CDCl3)  
δ 176.3, 96.6, 75.0, 72.4, 66.7, 49.4, 43.0, 41.4, 32.1, 31.4, 31.3, 29.2, 23.7, 0.16, 0.00.  
 
3.21 Preparation of alcohol C25 
LDA
acetone
N
O
O
H
TBDMSO
C24
N
O
O
H
TBDMSO
HO
C25
N
O
O
H
TBDMSO
HO
C26
+
 
To a solution of LDA (17.22 ml, 8.61 mmol, 0.5M solution in THF) was added  
the solution of γ-lactam C24 (1.8 g, 5.74 mmol) in dry THF (15 mL) at -78 °C, and the  
mixture was stirred at -78 °C for 1 h. Dry acetone (0.5g, 8.61 mmol, 1.5 equiv)  
was then added, and the mixture was stirred at -78 °C for an additional 1 h.  
The reaction mixture was quenched with saturated NH4Cl solution and allowed to warm  
to r.t. The organic phase was separated, and the aqueous phase was extracted with ethyl  
acetate (3 × 30 ml). The organic extracts were combined, dried over anhydrous Na2SO4,  
and then filtered. The solvent was removed, and the residual pale yellow oil consisted of  
a 5:1 mixture of C25 and C26. The products were separated using flash chromatography 
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(Hex/EtOAc = 1/1) to give the alcohols (1.96 g, 92%) : For compound C25: 1H NMR 
(400 MHz, CDCl3) δ 5.19 (s, 1 H), 4.06 (dd, J = 8.0 Hz, 5.6 Hz, 1 H), 3.80 (m, 1 H), 3.63 
(m, 1 H), 3.49 (m, 1 H), 3.41 (m, 1 H), 2.63 (d, J = 10 Hz, 1 H), 2.10-0.91 (m, 2 H), 1.61 
(s, 3 H), 1.42 (s, 3 H), 1.21 (s, 3 H), 1.17 (s, 3 H), 0.84 (s, 9 H), 0.00 (s, 6 H):  
For compound C26: 1H NMR (400 MHz, CDCl3) δ 4.05 (dd, J = 8.0 Hz, 5.2 Hz, 1 H), 
3.92 (m, 1 H), 3.88 (s, 1 H), 3.63 (m, 1 H), 3.46 (m, 1 H), 3.40 (m, 1 H), 2.74  
(d, J = 9.2 Hz, 1 H), 2.46 (m, 1 H), 2.01 (m, 1 H), 1.61 (s, 3 H), 1.41 (s, 3 H), 1.33  
(s, 3 H), 1.30 (s, 3 H), 0.88 (s, 9 H), 0.00 (s, 6 H). 
 
3.22 Preparation of α-isopropenyl-γ-lactam B17 
N
O
O
H
TBDMSO
N
O
O
H
TBDMSO
HO
PCl5
C16C25  
To a solution of C25 (100 mg, 0.27 mmol) in dry CH2Cl2 (3 mL) at -78 °C 
was added PCl5 (56mg, 1.0 equiv, 0.27 mmol), and the reaction mixture was stirred for  
30 min. The reaction mixture was quenched with saturated NaHCO3 solution and then  
extracted with CH2Cl2 (3×10 mL). The combined organic extracts were dried over  
Na2SO4, and the solvent was removed to give a yellow oil.  Purification by column  
chromatography  (Hex/ EtOAc = 2/1) gave C16 as a colorless oil (83 mg, 90%): For  
compound C16: 1H NMR (250 MHz, CDCl3) δ 5.00 (s, 1 H), 4.85 (s, 1 H), 4.15  
(m, 1 H), 3.85 (m, 1 H), 3.65-3.55 (m, 3 H), 3.20 (d, J = 12.8, 1 H), 2.25 (m, 1 H), 
1.76 (s, 3 H), 1.65 (s, 3 H), 1.70-1.50 (m, 2 H), 1.46 (s, 3 H), 0.89 (s, 9 H), 0.04 (s, 6 H). 
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3.23 Preparation of the alcohol C47 
NPhO2S
O
O
TBDMSO
 TBAF N
PhO2S
O
O
HOC3 C47  
To a solution of γ-lactam C3 (5 g, 11.4 mmol) in THF (57 mL) was added TBAF 
(17mL, 1M in THF) slowly. After stirring of the reaction mixture for 2 h at r.t, 
concentrated in vacuo and diluted with 100ml of EtOAc. The organic layer was 
washed with brine solution, dried over Na2SO4 and concentrated in vacuo. The 
products were separated using flash column chromatography (EtOAc) to afford the 
alcohol C47 (3.7g, 96%) as a colorless oil. For compound C47: 1H NMR (400 MHz, 
CDCl3) δ 7.96 (d, 2 H, J = 7.2 Hz), 7.62 (m, 1 H), 7.53 (m, 2 H), 4.16 (d, J = 9.2 Hz, 1 H), 
4.10 (ABX, 1 H, JAB = 8.6 Hz, JAX = 5.6 Hz), 3.88-3.82 (m, 1 H), 3.77-3.65 (m, 2 H), 
3.46 (ABX, 1 H, JAB = 8.6 Hz, JAX = 8.8 Hz), 2.92-2.83 (m, 1 H), 2.22 (broad s, 1 H),  
2.23-2.15 (m, 1 H), 1.89-1.79 (m, 1 H), 1.46 (s, 3 H), 1.35 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 161.8, 137.7, 134.5, 130.1, 129.1, 92.5, 75.2, 69.7, 64.4, 60.5, 36.4, 36.2, 26.7, 
23.6; IR (thin film, cm-1) 3507, 2987, 1701, 1263, 1147, 774 ; HRMS (ESI+) for  
MH+ C16H22NO5S : calcd 340.1213, found 340.1216; [α]D25 = + 46.8 (c = 3.53, CHCl3). 
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3.24 Preparation of aldehyde C48 
NPhO2S
CHO
O
O
NPhO2S
O
O
HO
DMP
C47 C48  
To a stirred solution of 4g (11.8 mmol) of alcohol C47 in CH2Cl2 (118 ml) at r.t 
was added NaHCO3 (3 g, 3equiv.) and Dess-Martin periodinane solution (35ml, 1.4 
equiv., 15 wt% in CH2Cl2). The reaction mixture was stirred for 20 min and quenched by 
addition of the 1:1 mixture of NaHCO3 and Na2S2O3 aqueous solution (118 ml). The 
resulting solution was stirred for 1 h and the layers were separated and the aqueous layer 
was extracted with EtOAc (50ml × 3). The combined organic layers were dried over 
Na2SO4, filtered, and evaporated. The product was separated using flash column 
chromatography (Hex/EtOAc = 1/2) to afford the aldehyde C48 (3.8 g, 95%) as colorless 
oil. For compound C48: 1H NMR (400 MHz, CDCl3) δ 9.75 (s, 1 H), 7.97 (d, 2 H, J = 7.2 
Hz), 7.66 (m, 1 H), 7.54 (m, 2 H), 4.17 (ABX, 1 H, JAB = 8.9 Hz, JAX = 5.5 Hz),  
3.71-3.64 (m, 1 H), 3.58 (ABX, 1 H, JAB = 8.9 Hz, JAX = 9.3 Hz), 3.43 (ABX, 1 H,  
JAB = 19.3 Hz, JAX = 2.7 Hz), 3.10-3.00 (m, 1 H), 2.85 (ABX, 1 H, JAB = 19.3 Hz,  
JAX = 10.5 Hz) 1.42 (s, 3 H), 1.38 (s, 3 H) ; 13C NMR (100 MHz, CDCl3) δ 199.6, 161.1, 
137.3, 134.6, 130.2, 129.1, 92.4, 73.9, 70.3, 64.2, 47.3, 33.7, 26.6, 23.6 ; IR (thin film, 
cm-1) 2985, 1735, 1706, 1240, 1044 ; HRMS (ESI+) for MH+ C16H20NO5S :  
calcd 338.1057, found 338.1058 ; [α]D25 = - 0.4 (c = 0.54, CHCl3). 
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3.25 Preparation of alcohol B45 
NPhO2S
CHO
O
O
NPhO2S
O
O
OH
MgBr
C48 C49  
To a solution of aldehyde C48 (3.5 g, 10.3 mmol) of in dry THF (50 mL)  under 
N2 atmosphere at -78 °C was added 1-propynylmagnesium bromide (45.4 mL, 22.7 mmol, 
0.5M solution in THF) dropwise and the mixture was warmed to 0°C. After stirring the 
mixture for 1 h, 25 ml of saturated aqueous NH4Cl solution was added at 0°C. The 
mixture was warmed to r.t and stirred for 15 min. The aqueous layer was extracted with 
EtOAc (3×50ml). The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuo. The product was separated using flash column 
chromatography (Hex/EtOAc = 1/2) to produce the propagyl alcohol C49 (3.6 g, 92%) as 
a colorless oil. For compound C49 (1:1 mixture of two diastereomers): 1H NMR  
(400 MHz, CDCl3) δ 8.01 (m, 2 H), 7.65 (m, 1 H), 7.55 (m, 2 H), 4.55-4.40 (m, 1 H), 
4.20-4.05 (m, 2 H), 3.97-3.83 (m, 1 H), 3.47 (m, 1 H), 3.10-2.82 (m, 1 H), 2.50-2.40  
(m, 1 H), 2.09-1.90 (m, 1 H), 1.89-1.80 (m, 3 H), 1.50-1.39 (m, 6 H); 13C NMR  
(100 MHz, CDCl3) δ 161.5, 137.7, 137.6, 134.5, 134.4, 130.3, 130.1, 129.0, 128.9, 92.5, 
92.4, 82.9, 82.4, 75.2, 74.9, 70.1, 70.0, 64.7, 64.3, 61.2, 61.0, 41.8, 40.4, 36.3, 35.9,  
26.7, 23.7, 3.8 ; IR (thin film, cm-1) 3448, 2983, 1734, 1703, 1146 ; HRMS (ESI+)  
for MH+ C19H24NO5S : calcd 378.1370, found 378.1367 ; [α]D25 = + 15.4 (c = 1.4, CHCl3). 
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3.26 Preparation of alkynyl ketone C46 
NPhO2S
O
O
OH
 DMP N
PhO2S
O
O
O
C49 C46  
To a stirred solution of alcohol C49 (3.5 g, 9.3 mmol)  in CH2Cl2 (93 ml) at r.t  
was added NaHCO3 (2.3 g, 2.9 equiv.) and  of Dess-Martin periodinane solution  
(28 ml,  1.4 equiv., 15wt% in CH2Cl2). The reaction mixture was stirred for 1 h and  
quenched by addition of 1:1 mixture of NaHCO3 and Na2S2O3 aqueous solution (93 ml). 
The resulting solution was stirred for1 h and the layer was separated and the aqueous  
layer was extracted with EtOAc (40ml × 3). The combined organic layers were dried 
overNa2SO4, filtered, and evaporated. The product was separated using flash column  
chromatography (Hex/EtOAc = 1/2) to afford the ketone C46 (3.3 g, 93%) as a colorless 
oil. For compound C46: 1H NMR (400 MHz, CDCl3) δ 7.98 (d, 2 H, J = 7.2 Hz), 7.66  
(m, 1 H), 7.55 (m, 2 H), 4.16 (ABX, 1 H, JAB = 8.9 Hz, JAX = 5.5 Hz), 4. 10 (d, 1 H,  
J = 10.4 Hz), 3.72-3.65 (m, 1 H), 3.55 (ABX, 1 H, JAB = 8.9 Hz, JAX = 9.3 Hz),  
3.50 (ABX, 1 H, JAB = 19.3 Hz, JAX = 2.7 Hz), 3.10-3.00 (m, 1 H), 2.88  
(ABX, 1 H, JAB = 19.3 Hz, JAX = 10.5 Hz), 2.03 (s, 3 H), 1.42 (s, 3 H), 1.34 (s, 3 H) ;  
13C NMR (100 MHz, CDCl3) δ 185.0, 161.0, 137.3, 134.6, 130.2, 129.1, 92.5, 92.3, 79.9, 
73.7, 70.4, 64.2, 48.6, 34.7, 26.6, 23.6, 4.4 ; IR (thin film,  
cm-1) 2985, 2222, 1734, 1706, 1671, 1242, 1147 ; HRMS (ESI+) for MH+ C19H22NO5S : 
calcd 376.1213, found 376.1219 ; [α]D25 = - 19.4 (c = 1.2, CHCl3). 
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3.27 Preparation of tricyclic enone compound B47 
N
SO2Ph
O
OO
Cs2CO3
CH3CN
NPhO2S
O
O
O
C46 C45  
To a solution of ketone C46 (3.2 g, 8.5 mmol) in CH3CN (1700 ml, 0.005M) at r.t 
was added Cs2CO3 (3.3g, 10.2 mmol). After stirring the mixture for 2 h, 50ml of saturated 
aqueous NH4Cl solution was added and stirred for 15 min. The reaction solution was 
concentrated and diluted with 200ml of EtOAc. The organic layer was washed with brine, 
dried over Na2SO4 and concentrated in vacuo. The product was separated using flash 
column chromatography (Hex/EtOAc = 1/1) to produce the tricyclic enone C45  
(3.0 g, 93%) as colorless oil. For compound C45: 1H NMR (400 MHz, CDCl3) δ 8.03  
(d, 2 H, J = 8.8 Hz), 7.69 (m, 1 H), 7.56 (m, 2 H),  6.27 (s, 1 H), 4.11 (ABX, 1 H,  
JAB = 8.6 Hz, JAX = 5.8 Hz), 3.74-3.66 (m, 1 H), 3.40 (ABX, 1 H, JAB = 8.6 Hz,  
JAX = 8.6 Hz), 3.19-3.15 (m, 1 H), 2.91 (ABX, 1 H, JAB = 18.2 Hz, JAX = 6.4 Hz),  
2.26 (ABX, 1 H, JAB = 18.2 Hz, JAX = 0.0 Hz), 1.96 (s, 3 H), 1.44 (s, 3 H), 1.37 (s, 3 H) ; 
13C NMR (100 MHz, CDCl3) δ 193.9, 162.4, 146.5, 136.2, 135.2, 133.6, 131.4, 129.2, 
93.4, 80.0, 68.7, 61.3, 41.7, 35.0, 26.2, 23.5, 21.7; IR (thin film, cm-1) 2985, 2928, 1705, 
1673, 1146 ; HRMS (ESI+) for MH+ C19H22NO5S : calcd 376.1213, found 376.1211  
; [α]D25 = + 7.7 (c = 0.73, CHCl3). 
 
 
109
3.28 Preparation of alcohol C52 
N
SO2Ph
O
OO
Dowex
 
50W-8X NH
SO2Ph
O
OHO
C45 C52  
To a solution of tricyclic acetonide C45 (3 g, 8 mmol) in MeOH (40 mL, 0.2M) 
was added Dowex-50W-8X (9 g) in one portion. The resulting solution was heated under 
reflux condition for 10 h. The mixture was filtered and concentrated to provide the 
alcohol C52 (2.6g, 95%) as pale yellowish oil.  The product was used for the next step 
without further purification. For compound C52: 1H NMR (400 MHz, CD3OD) δ 7.98  
(d, 2 H, J = 8.0 Hz), 7.76 (m, 1 H), 7.62 (m, 2 H),  6.28 (s, 1 H), 3.80-3.20 (m, 4 H),  
2.35 (d, J = 2.8, 2 H), 2.16 (s, 3 H) ; 13C NMR (100 MHz, CD3OD) δ 195.3, 167.7, 147.9, 
136.1, 135.0, 133.3, 130.7, 129.3, 74.9, 60.4, 57.2, 38.6, 33.0, 21.1; IR (thin film, cm-1) 
3340, 2945, 2834, 2071, 1716, 1671, 1448 ; HRMS (ESI+) for MH+ C16H18NO5S :  
calcd 336.0900, found 336.0900 ; [α]D25 = + 4.3 (c = 1.59, MeOH). 
 
3.29 Preparation of carboxylic acid B49 
Jones
OxNH
SO2Ph
O
OHO
NH
SO2Ph
O
CO2H
O
C52 C53  
Jones reagent (1.0 M, 103 mL, 103 mmol) was added to a solution of C52  
(2.5 g, 7.5 mmol) in acetone (75 mL, 0.1M) at room temperature and the resulting 
mixture was stirred for 2 h at that temperature. The reaction was quenched with i-PrOH, 
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concentrated in vacuo. The reaction solution was dissolved in 50 ml of CH2Cl2 and 2ml 
of brine solution was added. After phase separation, the aqueous layer was extracted 
three times with CH2Cl2 and the organic layers were combined, dried over Na2SO4 and 
concentrated to give carboxylic acid compound C53 (2.6 g, 99%) as a white solid, which 
was used for the next step without further purification. For compound C53:  
mp 216-218 °C ; 1H NMR (400 MHz, CD3OD) δ 8.00 (d, 2 H, J = 7.6 Hz), 7.78 (m, 1 H), 
7.64 (m, 2 H),  6.32 (s, 1 H), 3.83 (d, J = 9.6 Hz), 3.31 (m, 1 H), 2.68 (ABX, 1 H,  
JAB = 18.6 Hz, JAX = 0.1 Hz), 2.46 (ABX, 1 H, JAB = 18.6 Hz, JAX = 7.3 Hz), 2.12  
(s, 3 H) ; 13C NMR (100 MHz, CD3OD) δ 194.67, 170.89, 167.2, 147.2, 135.9, 135.2, 
133.6, 130.7, 129.3, 74.3, 56.5, 41.2, 33.5, 20.9 ; IR (thin film, cm-1) 3352, 2985, 2071, 
1718, 1673, 1025 ;  HRMS (ESI-) for M-H- C16H14NO6S : calcd 348.0543,  
found 348.0543 ; [α]D25 = - 3.4 (c = 0.29, MeOH). 
 
3.30 Preparation of ester B50 
NH
SO2Ph
O
CO2H
O
NH
SO2Ph
O
CO2Me
O
TMSCHN2
C53 C54  
The acid C53 (2.6 g, 7.4 mmol) was dissolved in a mixture of methanol (74 mL) a
nd toluene (185 mL) and to it was added TMSCHN2 (5.5 mL, 11.1 mmol, 2 M solution in
 ether) dropwise. After 5 min the reaction was quenched with acetic acid (2 drop) and the 
solvent removed under reduced pressure. The resulting solution was diluted with EtOAc (
100 mL) and washed with brine, dried over Na2SO4, concentrated in vacuo 
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to give the crude product. Purification by flash chromatography (EtOAc) afforded the 
product C54 as colorless oil (2.3 g, 91%). For compound C54: 1H NMR (400 MHz, 
CDCl3) δ 7.94 (d, 2 H, J = 8.0 Hz), 7.68 (m, 1 H), 7.54 (m, 2 H),  6.25 (s, 1 H), 3.80  
(d, J = 9.6 Hz), 3.73 (s, 3 H), 3.42 (m, 1 H), 2.69 (ABX, 1 H, JAB = 18.4 Hz,  
JAX = 0.4 Hz), 2.60 (ABX, 1 H, JAB = 18.4 Hz, JAX = 6.8 Hz), 1.98 (s, 3 H);  
13C NMR (100 MHz, CDCl3) δ 193.6, 169.5, 167.1, 146.3, 136.0, 135.4, 134.1, 131.0, 
129.5, 74.4, 56.5, 53.4, 41.1, 34.2, 21.8 ; IR (thin film, cm-1) 2985, 1724, 1675, 1149; 
HRMS (ESI+) for MH+ C17H18NO6S : calcd 364.0849, found 364.0844 ; [α]D25 = + 27.1 
(c = 1.33, CHCl3). 
 
3.31 Preparation of Boc protected amide C55 
N
SO2Ph
O
CO2Me
O
BocNH
SO2Ph
O
CO2Me
O
Boc2O
C54 C55  
Et3N (0.77g, 1.1 ml, 7.6 mmol), Boc-anhydride (2.7g, 12.6 mmol) and 
 DMAP (0.77g, 6.3 mmol) were added to a solution of γ-lactam C54 (2.3g, 6.3 mmol) 
in CH2Cl2 (63 mL). The mixture was stirred for 2 h and concentrated under reduced  
pressure. The residue was purified by flash chromatography (1:1 Hex/EtOAc) to afford 
the tile compound C55 as colorless oil (2.8 g, 95%). For compound C55: 1H NMR  
(400 MHz, CDCl3) δ 8.02 (d, 2 H, J = 8.0 Hz), 7.73 (m, 1 H), 7.60 (m, 2 H),  6.31  
(s, 1 H), 4.00 (d, J = 10.0 Hz), 3.76 (s, 3 H), 3.38 (m, 1 H), 2.90 (ABX, 1 H,  
JAB = 18.2 Hz, JAX = 6.8 Hz), 2.55 (ABX, 1 H, JAB = 18.2 Hz, JAX = 0.0 Hz),  
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1.87 (s, 3 H), 1.43 (s, 9 H) ; 13C NMR (100 MHz, CDCl3) δ 192.8, 169.2, 163.8, 147.9,  
145.3, 135.8, 135.5, 134.5, 131.4, 129.5, 85.8, 75.0, 60.5, 53.2, 37.5, 33.5, 27.9, 21.7;  
IR (thin film, cm-1) 2985, 1795, 1754, 1678, 1144 ; HRMS (ESI+) for [M+Na]+  
C22H25NO8SNa : calcd 486.1193, found 486.1188 ; [α]D25 = - 28.8 (c = 0.32, CHCl3). 
 
3.32 Preparation of silylenol ether C58 + C59 
N
SO2Ph
O
CO2Me
O
Boc
TBSOTf
TEA
N
O
CO2Me
TBSO
Boc
H
SO2Ph
N
O
CO2Me
TBSO
Boc
H
SO2Ph
+
C55
C58
C59  
To a stirred solution of ester C55 (2.8 g, 6.0 mmol) in CH2Cl2 (240 mL, 0.025M) 
at 0 °C was added freshly distilled (KOH) Et3N (3.0 g, 4.2 ml, 30 mmol) and TBSOTf 
(4.8 g, 4.1 ml, 18 mmol) in CH2Cl2 (5 mL). After 1 h at 20°C (TLC checked) the mixture 
was poured into aqueous saturated NaHCO3 and extracted with CH2Cl2. The combined 
organic phases were dried over Na2SO4 and evaporated to give a residue (3.5 g, 100%)  
that was chromatographed through a silica gel column with elution by Hex/EtOAc:Et3N 
(5:1:1%) to give mixture of C58, C59 (3.5 g, 100%). For compound C58, C59: 1H NMR 
(400 MHz, CDCl3) δ 7.94-7.40 (m, 5 H), 5.54 (s, 1 H), 4.87 (s, 1 H), 4.53 (s, 1 H), 4.03 
(d, J = 10.4 Hz, 1 H), 3.77 and 3.70 (s, 3 H), 3.50-3.40 (m, 1 H), 2.80 (ABX, 1 H,  
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JAB = 18.0 Hz, JAX = 5.8 Hz), 2.23 (ABX, 1 H, JAB = 18.0 Hz, JAX = 0.2 Hz), 1.42 and 
1.39 (s, 9 H), 0.90 and 0.84 (s, 9H), 0.25 and 0.18 and 0.00 (s, 6 H) ; 13C NMR  
(100 MHz, CD3OD) δ 172.2, 171.4, 171.2, 167.8, 166.7, 152.6, 149.7, 149.6, 137.6, 
136.1, 136.0, 135.9, 135.2, 133.0, 132.3, 132.2, 131.7, 130.0, 129.9, 129.5, 127.8, 118.4, 
109.2, 107.5, 97.3, 86.3, 86.2, 84.8, 75.9, 73.3, 68.1, 64.9, 63.9, 63.3, 61.8, 58.9, 56.3, 
53.6, 53.4, 53.2, 41.2, 37.7, 37.5, 31.9, 30.2, 28.5, 28.1, 28.0, 27.9, 26.7, 26.4, 26.2,  
26.0, 25.9, 22.7, 20.0, 18.9, 18.7, -4.1, -4.2, -4.7 ; IR (thin film, cm-1) 2960, 2214,  
2070, 1742, 1242, 1122 ; HRMS (ESI+) for MH+ C28H40NO8SSi : calcd 578.2238,  
found 578.2233 ; [α]D25 = + 24.1 (c = 0.78, CHCl3). 
 
3.33 Preparation of bicyclic enone C44 
N
O
CO2Me
O
Boc
H
H
Na/Hg
N
O
CO2Me
TBSO
Boc
H
SO2Ph
N
O
CO2Me
TBSO
Boc
H
SO2Ph
+
THF/MeOH
C58
C59
C44
 
10% Sodium amalgam (6.9 g, 30 mmol) was added to a solution of the silyl enol 
ether compound C58 + C59 (3.5 g, 6.0 mmol) and anhydrous disodium hydrogen 
phosphate (2.6 g, 18 mmol) in dry methanol (12 mL) and THF (108 mL) at -78 °C. The 
reaction mixture was warmed to -20 °C and stirred for 3 h. The reaction solution was 
quenched with aqueous NH4Cl and warmed to r.t. After filtration,  
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the reaction solution was concentrated in vacuo and diluted with EtOAc (100 mL). The 
organic solution was wished with brine, dried over Na2SO4, filtered and concentrated. 
The crude product was chromatographed through a silica gel column with elution  
by Hex/EtOAc (1/1) to give mixture the product C44 (1.85 g, 95%) as a colorless oil.  
For compound C44: 1H NMR (400 MHz, CDCl3) δ 5.94 (s, 1H), 4.25 (s, I H), 3.77  
(s, 3 H), 3.39 (d, J = 7.2 Hz, 1 H), 2.99-2.92 (m, 1 H), 2.61 (ABX, 1 H, JAB = 16.1 Hz, 
JAX = 5.6 Hz), 2.38 (ABX, 1 H, JAB = 16.1 Hz, JAX = 12.0 Hz), 2.18 (s, 3 H), 1.46  
(s, 9 H): 13C NMR (100 MHz, CDCl3) δ 195.1, 170.5, 168.9, 154.5, 149.5, 128.0, 84.7, 
62.4, 53.1, 47.1, 38.5, 35.5, 28.1, 23.7; IR (thin film, cm-1) 2980, 1790, 1750, 1670, 1304, 
1148 ; HRMS (ESI+) for [M+Na]+ C16H21NO6Na : calcd 346.1261, found 346.1257;  
[α]D25 = - 41.6 (c = 1.53, CHCl3).  
 
3.34 Preparation of enol lactone C60 
N
O
CO2Me
O
Boc
H
H
N
O
CO2MeO
Boc
H
H
O
mCPBA
C44 C60
CH2Cl2
 
To a solution of the enone compound C44 (1.8g, 5.5 mmol) in CH2Cl2  
(55 mL, 0.1M) was added m-CPBA (1.9g, 11 mmol) in one portion at r.t. After stirring  
at room temperature for 48 h, the reaction was quenched with saturated sodium sulfite. 
The organic layer was separated, and the aqueous layer was extracted with CH2Cl2.  
The combined organic layers were dried and evaporated. A flash chromatography 
(Hex/EtOAc = 1/2) gave C60 as colorless oil (1.1 g, 60%). For compound C60:  
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1H NMR (400 MHz, CDCl3) δ 6.37 (d, J = 1.2, 1 H), 4.58 (s, 1 H), 3.76 (s, 3 H), 3.25  
(d, J = 8.8 Hz, 1 H), 3.08-3.02 (m, 2 H), 2.60-2.53 (m, 1 H), 1.85 (d, J = 1.6 Hz, 3 H), 
1.45 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 170.6, 170.3, 168.4, 148.9, 137.3, 122.4, 
84.6, 62.5, 53.1, 47.6, 39.4, 36.8, 28.0, 20.1 ; IR (thin film, cm-1) 2980, 2200, 1793, 1756, 
1265, 907 ; HRMS (ESI+) for [M+Na]+ C16H21NO7Na : calcd 362.1210, found 362.1208 ;  
[α]D25 = + 15.7 (c = 1.11, CHCl3).  
 
3.35 Preparation of aldehyde C66 
N
O
CO2Me
OHC Boc
MeO2C
N
O
CO2MeO
Boc
H
H
O
NaOMe
MeOH
C60 C66  
Sodium methoxide (4.77 mmol, 1 M in MeOH) was added dropwise over 0.5 h to 
a solution of   the enol lactone C60 (1.1 g, 3.2 mmol) in methanol (64 ml, 0.05M) at  
-78 oC. The reaction mixture was stirred for 20 min and quenched with saturated NH4Cl  
solution and warmed to r.t. The reaction mixture was concentrated in vacuo and diluted  
with 50 ml of EtOAc. The organic layer was washed with brine, dried over Na2SO4 and  
evaporated under reduced pressure to afford the crude product. Purification by flash  
chromatography (Hex/EtOAc = 1:1) gave the ester aldehyde compound C66 (1.0 g, 87%, 
two diastereomeric mixture) as a colorless oil. For compound C66: 1H NMR (400 MHz,  
CDCl3) δ 9.79 and 9.58 (s, 1 H), 4.45 and 4.39 (s, 1 H), 3.79 and 3.71 and 3.67 (s, 6 H),  
3.2-2.2 (m, 6 H), 1.46 (s, 9 H), 1.37 and 1.10 (d, J = 7.2, 3 H); 13C NMR  
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(100 MHz, CDCl3) δ 201.9, 201.7, 172.2, 171.4, 171.3, 170.8, 170.6, 149.6, 84.5, 84.3,  
62.5, 61.9, 60.6, 53.1, 53.0, 52.5, 52.4, 47.2, 45.5, 44.0, 43.0, 34.9, 34.6, 34.0, 33.3, 28.1, 
12.2 ; IR (thin film, cm-1) 2980, 1790, 1735, 1309, 1150 ;  HRMS (ESI+) for  [M+Na]+  
C17H25NO8Na : calcd 394.1472, found 394.1469 ; [α]D25 = - 1.4 (c = 0.59, CHCl3). 
 
3.36 Preparation of diol C67 
N
OH
CO2Me
Boc
MeO2C
HODIBALN
O
CO2Me
OHC Boc
MeO2C C66 C67  
A solution of DIBAL (21.6 mL, 8 equiv., 1.0M in THF) was added dropwise to a 
stirred solution of the aldehyde C66 (1.0g, 2.7 mmol) in THF (27 ml) at -78 oC under 
nitrogen. After 1 h, the reaction was quenched by adding methanol and the mixture was 
warmed to r.t. To the resulting solution were added saturated potassium tartrate solution 
and EtOAc. The mixture was stirred for 15 min. The layers were separated and aqueous 
layer was extracted with ethyl acetate. The combined organic layer were washed with 
brine, dried over Na2SO4, and evaporated under reduced pressure to afford the diol 
compound C67 (1.0g, 97%). The crude product was used for the next step without further 
purification. For compound C67: 1H NMR (400 MHz, CDCl3) δ 5.52-5.35 (m, 1 H), 4.24 
and 4.17 (s, 1 H), 3.87 (d, J = 2.8 Hz, 1 H), 3.69 (s, 3 H), 3.67 (s, 3 H), 3.60-3.50  
(m, 1 H), 3.42-3.35 (m, 2 H), 2.73-2.60 (m, 2 H), 2.12-1.82 (m, 2 H), 1.36 (s, 9 H),  
1.04 (d, J = 6.4, 3 H) ; 13C NMR (100 MHz, CDCl3) δ 173.6, 172.7, 154.6, 82.2, 81.4, 
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66.4, 64.6, 52.5, 52.0, 46.8, 40.7, 34.7, 31.4, 28.4, 15.9 ; IR (thin film, cm-1) 3440, 2977, 
1739, 1685, 1368 ; HRMS (ESI+) for [M+Na]+ C17H29NO8Na : calcd 398.1785,  
found 398.1785 ; [α]D25 = - 22.6 (c = 1.11, CHCl3).  
 
3.37 Preparation of alcohol C68 
N
OH
CO2Me
Boc
MeO2C
HO N
OH
CO2Me
Boc
MeO2C
MsOMsCl, TEA
CH2Cl2
0oC
C67 C68  
p-Methanesulfonyl chloride (189.0 mg, 1.7 mmol) was added at 0°C to a stirred  
solution of alcohol C67 (400 mg 1.1 mmol)  and TEA (278 mg, 0.38 ml, 2.75 mmol) in  
CH2Cl2 (11 mL). After having been stirred for 15 min at 0 °C, the reaction mixture was  
quenched by addition of aqueous NaHCO3 solution, diluted with EtOAc (30 ml), and was
hed with brine solution. The organic layer was dried over Na2SO4, filtered, and concentra
ted to afford the crude product. Purification by flash chromatography (Hex/EtOAc = 1:1)  
gave the mesylated compound C68 (300mg, 65%) as a colorless oil. For compound C68 :
1H NMR (400 MHz, CDCl3) δ 5.50-5.38 (m, 1 H), 4.25 and 4.18 (s, 1 H), 4.10-
3.92 (m, 2 H), 3.81 (d, J = 2.8 Hz, 1 H), 3.69 (s, 3 H), 3.68 (s, 3 H), 2.96 (s, 3 H), 2.78-
2.57 (m, 3 H), 2.20-2.02 (m, 2 H), 1.35 (s, 9 H),  1.10 (d, J = 6.0, 3 H) ;  
13C NMR (100 MHz, CDCl3) δ 173.1, 172.4, 154.4, 81.9, 81.5, 72.5, 64.6,52.6, 52.1, 46.4
, 40.5, 37.6, 34.5, 29.4, 28.4, 15.8 ; IR (thin film, cm-1) 3436, 2977, 1736, 1697,  
1355, 1173 ;  HRMS (ESI+) for [M+Na]+  C18H31NO10SNa : calcd 476.1561, found 476.1
555 ; [α]D25 = - 18.2 (c = 1.01, CHCl3). 
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3.38 Preparation of pyrrolidine diester C69 
Et3SiH
BF3OEt
CH2Cl2
-78oC
N
CO2Me
Boc
MeO2C
MsO
N
OH
CO2Me
Boc
MeO2C
MsO
C68 C69  
A solution of hemiaminal compound C68 (200mg, 0.44 mmol) and Et3SiH (52 mg, 
0.072 ml, 0.44 mmol) in CH2Cl2 (4.4 ml) was cooled at -78°C and BF3⋅OEt2 (67 mg, 
0.061 ml, 0.48 mmol) was then added dropwise under N2 atmosphere. After 30 min 
Et3SiH (52 mg, 0.072 ml, 0.44 mmol) and BF3⋅OEt2 (67 mg, 0.061 ml, 0.48 mmol) were 
added. The resulting mixture was stirred for 2 h at -78 °C. The reaction mixture was 
quenched saturated aqueous NaHCO3, extracted with CH2Cl2 and dried over Na2SO4. 
Evaporation of the solvent and purification by flash column chromatography (Hex/EtOAc 
= 1/1) gave the product C69 (138 mg, 72%) as a colorless oil. For compound C69 : 1H 
NMR (400 MHz, CDCl3) δ 4.21-3.90 (m, 2 H), 3.80-3.60 (m, 6 H), 3.40 (m, 1 H),  
3.10-2.90 (m, 4 H), 2.80-2.60 (m, 2 H), 2.30-2.10 (m, 2 H), 1.90 (m, 1 H), 1.50-1.35  
(m, 9 H), 1.10-0.93(m, 3 H) ; 13C NMR (100 MHz, CDCl3) δ 172.6, 172.4, 172.3, 154.1, 
82.0, 80.6, 72.4, 64.9, 64.6, 52.7, 52.3, 52.2, 48.5, 48.3, 46.4, 42.5, 41.7, 41.3, 40.5, 40.3, 
37.7, 32.8, 32.4, 29.4, 28.6, 28.4, 15.9; IR (thin film, cm-1) 2989, 2974, 1738, 1697,  
1355, 1172 ; HRMS (ESI+) for [M+Na]+ C18H31NO9SNa : calcd 460.1612,  
found 460.1608 ; [α]D25 = - 10.0 (c = 0.28, CHCl3). 
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3.39 Preparation of isopropenyl pyrrolidine C70 
N
CO2Me
Boc
MeO2C
MsO N
CO2Me
Boc
CO2Me
NaI, DBU
DME
C69 C70  
To a solution of the mesylate C69 (100 mg, 0.22 mmol) in DME (2.2 ml) was 
added NaI (66 mg, 0.44 mmol) in one portion. After stirring the reaction mixture for 5 h 
at 60°C, DBU (100 mg, 0.66 mmol) was added and the reaction mixture was heated at 
reflux with stirring for 3 h. After the reaction mixture had cooled to r.t, EtOAc (30 mL) 
and H2O (20 mL) were added and the layers were separated. The combined organic 
layers were washed with saturated NaHCO3 solution and brine, dried over Na2SO4. 
Evaporation of the solvent and purification by flash column chromatography (Hex/EtOAc 
= 2/1) gave the product C70 (60 mg, 79%) as a colorless oil. For compound C70 (two 
rotamers) : 1H NMR (400 MHz, CDCl3) δ 4.89 (s, 1 H), 4.67 (s, 1 H), 4.13 and 4.04 (d, J 
= 3.2 Hz, 4.0 Hz, 1 H), 3.74 and 3.73 (s, 3 H), 3.68 and 3.66 (s, 3 H), 3.70-3.58 (m, 1 H), 
3.48-3.36 (m, 1 H), 3.02-2.95 (m, 1 H), 2.85-2.78 (m, 1 H), 2.36-2.20 (m, 2 H), 1.67 (s, 3 
H), 1.44 and 1.38 (s, 9 H) ; 13C NMR (100 MHz, CDCl3) δ 172.6, 172.4, 172.3, 172.2, 
154.3, 153.7, 141.4, 141.2, 113.4, 113.1, 80.2, 80.1, 64.0, 63.6, 52.3, 52.2, 51.8, 47.8, 
47.6, 46.0, 45.2, 41.9, 40.9, 32.9, 28.4, 28.2, 22.3, 22.2 ; IR (thin film, cm-1) 2989, 2975, 
1740, 1701, 1397, 1170 ; HRMS (ESI+) for [M+Na]+ C17H27NO6Na : calcd 364.1731, 
found 364.1729 ; [α]D25 = - 18.9 (c = 1.03, CHCl3), [lit: [α]D25 = - 19.1 (c = 0.62, CHCl3)]. 
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3.40 Preparation of α-(-)-kainic acid A2 
N
CO2Me
Boc
CO2Me
1. LiOH
2. CF3CO2H
A2 (-)-kainic acid
N
H
CO2H
CO2H
C70
3. Resin
 
The diester compound C70 (30 mg, 0.088 mmol) was dissolved in a mixture of  
THF (1 mL) and a 2.5% solution of KOH (1mL). The reaction mixture was stirred for  
12 h at r.t, and a solution of HCl (2M) was added until pH 3. The mixture was extracted 
with EtOAc and the organic layers were combined and dried over Na2SO4 and  
concentrated under reduced pressure. To the resulting residue, CH2Cl2 (2 mL) and TFA  
(12 equiv.) were added, and the reaction mixture was refluxed for 2 h. After removal of  
the solvent, the crude product was added to a column containing Dowex-50 H+ (WX8-
200, 8% cross-linking, 100- 200 wet mesh). Elution with NH4OH (1 N),  
evaporation afforded (-)- kainic acid 2A (15 mg, 80%): mp 242-244 °C  
[lit : mp 243-244]; HRMS (ESI-) for [M-H]- C10H14NO4 : calcd 212.0928,  
found 212.0932 ; [α]D25 = -13.9° ( c= 0.33, H2O). [lit : [α]D25 = - 14.2°  
(c = 0.18, H2O)];  1H NMR (D2O) δ 5.03 (s, 1 H), 4.74 (s, 1 H), 4.06 (d, 1 H, J = 3.1 Hz) 
3.62 (dd, 1H, J = 11.6, 7.3 Hz), 3.44 (dd, 1H, J = 11.7, 10.7 Hz),  
3.08-2.95 (m, 2 H), 2.29 (dd, 1 H, J = 15.7, 6.4 Hz), 2.16 (dd, 1H, J = 15.7, 8.1 Hz),  
1.78 (s, 3H); 13C NMR (100 MHz, D2O) δ 178.6, 174.3, 140.9, 114.1, 66.6, 47.2, 46.6,  
42.1, 35.4, 23.0. 
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Chapter Four 
Oxygen-Promoted Pd(II) Catalyzed Carbon-Carbon Bond Formation 
4.1 Introduction 
Palladium catalysis has achieved the status of an indispensable tool for organic  
synthesis. Among basic types of palladium catalyzed transformations, the Heck reaction  
and related chemistry is one of the most widely used standard tools for carbon-
carbon bond-forming reactions in organic synthesis.1 In addition to the conventional  
Heck reaction of unsaturated compounds with organic halides and triflates as an  
electrophile, the use of nucleophilic organo-metallic reagents such as organosilanes,2  
organoantimony,3 and organotins4 have attracted much attention. However, these organo
metallic reagents and their byproducts are highly toxic 5  and difficult to remove. 6   
Comparatively, organoboron reagents are less toxic,7 stable in air, and easilyaccessible, it
 is worthwhile to explore their synthetic utility for the various organic  
reactions. Two oxygen-promoted Pd(II) catalyzed carbon-carbon bond formation  
reactions are developed and described.  One is a mild and efficient Pd(II) catalysis,  
leading to the formation of carbon-carbon bonds between a broad spectrum of  
organoboron compounds and alkenes. Molecular oxygen was employed to reoxidize the 
  Na2CO3, DMF
CO2tBu PhB(OH)2+
50oC
CO2tBuPh
Pd(OAc)2, O2 (1)
 
resultant Pd(0) species back to Pd(II) during catalytic cycles. This oxygen protocol prom
oted the desired Pd(II) catalysis, whereas it retarded competing Pd(0) catalytic pathways 
such as Heck or Suzuki couplings (eq. 1).  
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Another reaction, which uses similar reaction condition and concept, is a method  
for the formation of symmetric biaryls and dienes via oxidative dimerization of aryl and  
alkenyl boronic acids. These conditions also utilized Pd(II) catalysts under an oxygen  
atmosphere with water as the solvent. The use of phase transfer catalysts promoted  
efficient and mild syntheses of a wide range of materials (eq. 2).  
Ar B(OH)2 Ar Ar
Pd(OAc)2,O2, NaOAc
 PTC, H2O, 23 oC
(2)
 
 
4.2 Oxygen-promoted Pd(II) Catalysis for the coupling of organoborons with olefins   
Our group has reported an improved method for the aryl-alkenyl coupling by 
utilizing arylstannanes via Pd(II) catalysis in the presence of oxygen or Cu(II) oxidants.8 
Due to the shortcomings of organometallic reagents including toxicity and difficulty of 
removing, it was strongly encouraged to develop alternative methods, which are more 
efficient and environmentally friendly. By utilizing a similar protocol with aryl-aryl 
coupling reaction of organoboron compounds (Section 4-3), 9  we embarked on the 
development of a mild and versatile condition of the Heck-type coupling reaction using 
organo boron reagents.  
 
4.2.1 Heck reaction in water 
Upon receiving successful results using water for the homo coupling reaction, 
water was firstly tested for the solvent in the Heck type reaction in the presence of phase 
transfer catalyst (Scheme 4-1). The reaction condition, which use water as a solvent and 
air as an oxidant, should be a green and environmentally friendly. Excitement grew from  
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the promising preliminary results; the desired products D3, D6 were isolated in moderate 
yields. The formation of homo coupling product D4, D7, which was a main side reaction, 
was blamed for the low yield. A long reaction time was needed for the starting materials 
to be consumed completely under the reaction condition. To circumvent the problem, the 
reaction condition was optimized as described in Section 4.2.4 resulting in the high yield 
of the product and short reaction time. 
Pd(OAc)2, O2
Water, NaOAc
50 oC
MeO B(OH)2 Ph+
Ph
MeO
OMe
OMe
+
50%
30%
24 h
Pd(OAc)2, O2
Water, NaOAc
50 oC
B(OH)2 Ph+
Ph
+
30%
50%
24 h
PTC
Ac Ac
Ac
Ac
Scheme 4-1. Heck reaction in water
D1 D2 D3
D4
D5 D6
D7
D2
 
 
4.2.2 Precedent report   
Uemura reported a Pd(0)-catalyzed cross coupling of boronic acids and alkenes  
via oxidative addition of Pd(0) to a carbon-boron bond.10 In this case, the reactions 
required long reaction times (20-38 h) and acetic acid as a solvent. 
Mori reported a Pd(II)-catalyzed pathway for the reaction between organoboron reagents 
and alkenes in the presence of Cu(OAc)2 as an oxidant, which involved transmetalation  
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As the initial step in the catalytic cycle. 11 However, the reaction conditions remained  
harsh (100 °C, DMF) and excess Cu(II) reagent was utilized as an oxidant, generating a  
poisonous waste. 12 The use of molecular oxygen as a sole reoxidant has been reported in  
palladium-catalyzed methodologies, encompassing oxidation of alcohols to carbonyl  
compounds, 13  cyclization of olefinic compounds, 14  and synthesis of hydrogen  
peroxide. 15 Recently, arylzinc compounds, 16 triarylbismuths,17 and arylboronic acids18  
were reported to be dimerized in the presence of oxygen.  
 
4.2.3 Oxygen effect  
As mentioned earlier, the use of oxygen for the oxidative homocouplings of aryl   
and akenylboronic acids has been reported.9 The mechanistic aspect of aerobic oxida-
tion of palladium catalysts via peroxopalladium(II) species has been well rationalized by 
Stahl. 19  
  Na2CO3, DMF
CO2tBu PhB(OH)2+
50oC, 3 h
CO2tBuPh
Pd catalystb
O2
O2
Pd(OAc)2
Pd(OAc)2
Pd(OAc)2
85%
oxidant
87%
entry
1
2
3
yield
0%
a N2 condition. b10 mole%.
"cat. Pd"
Pd2(dba)3
44%
12%Nonea
Air
Pd2(dba)3
4
5 Nonea
D8 D10D9
Table 4-1. Effect of Oxygen  
Described herein is the use of molecular oxygen as the catalyst oxidant in Pd(II)-
catalyzed couplings of organoboron compounds and olefins. The presence of oxygen  
was critical for catalyst reoxidation as reported earlier.8, 9 As shown in Table 4-1, 
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a low yield of the product was obtained when the reaction was  
run under a nitrogen condition (entry 1). Under air and oxygen, the product was obtained  
in 44 and 87% yields, respectively (entries 2 and 3). Interestingly, Pd(0) catalyst was 
also effective in delivering the desired product in 85% yield in the presence of oxygen  
(entry 4), whereas no product was observed under nitrogen conditions (entry 5). From  
these results, it was inferred that molecular oxygen played a pivotal role in  
Pd(II)-catalyzed reaction through the reoxidation of Pd(0) species to Pd(II). 
 
4.2.4 Optimization of the Reaction Condition 
In a further study, it was found that Pd(OAc)2 was the choice of the catalyst and  
Na2CO3 proved to be the best. Several bases such as NaOAc, Cs2CO3, and K2CO3 were  
effective as well under these aerobic conditions. DMF was the choice of the solvent,  
whereas protic solvents, including water and EtOH, delivered biaryls via homocoupling 
reaction exclusively.18 Regarding temperature, optimal results were obtained at 50 °C,  
while longer reaction times (12-24 h) were required to complete the reactions at 23 °C;  
increased amounts of homocoupling products were produced at higher temperatures such 
as 100 °C.  
 
4.2.5 Optimization of the Catalyst Amount 
To verify the efficiency of this this protocol, a study for the optimum catalyst  
dosage wasconducted (Table 4-2). Comparable results were obtained when 5 mol%  
Pd(OAc)2 was used and the decreased yield was observed when 1 mole% Pd(OAc)2  
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was used. 
CO2tBu CO2
tBu
PhPhB(OH)2+
Pd(OAc)2
81% 79% 42%yield
time
10 mole% 5 mole% 2.5 mole% 1 mole%
66%
3 h 5 h 24 h 24 h
1 mmole 1 mmole
Table 4-2. Dosage of catalyst
*Reaction conditions: O2, Pd(OAc)2, Na2CO3, DMF, 50  oC, 3 h
D8 D9 D10
 
 
4.2.6 Effect of Electron Density on Olefins 
To examine substrate versatility, we first probed the effect of electron density on  
olefins as shown in Table 4-3. tert-Butyl acrylate, which is an electron-poor alkene, 
was converted smoothly to tert-butyl trans-cinnamate D10 in 87% yield. An electron-
rich alkene, n-butyl vinyl ether delivered 73% of β-butoxystyrene D11 with an isomeric  
ratio of 2/1 at 23 °C after 10 h. Styrene, an aromatic nonallylic alkene, reacted with  
phenylboronic acid to give 90% of trans-stilbene D12. Allylbenzene  
was converted to (E)-1,3-diphenylpropene D13 smoothly in 86% yield. This newly 
developed protocol was effective regardless of the electron density on olefins and was 
regioselective to provide an (E)-isomer exclusively except with an electron-rich alkene. 
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 10 mole% Pd(OAc)2, O2
 Na2CO3, DMF, 50 oC, 3 h
R
PhR
73% a87%
Table 4-3. Effect of Electron Density on Olefines
90% 86%
E/Z =2/1
(D10) (D11)
       a 2.0 eq of n-butylvinylether, 23oC, 10 h. Yields were 
calculated based on boronic acid.
Ph B(OH)2
CO2tBuPh
Ph
Ph
CH2PhPh
OBu
Ph
(D12) (D13)
 
 
4.2.7 The Versatility of the Arylboronic Acid 
After screening olefins, we investigated the scope and limitation of organoboron  
compounds as summarized in Table 4-4. 4-Methoxyphenylboronic acid D1, which  
has an electron-donating group, and 3-acetylphenylboronic acid D2, which has  
an electron-withdrawing group, showed similar reactivities, furnishing the desired  
arylated products in 79 and 78% yields, respectively. Indole derivatization on the  
C-3 position was also possible by coupling 1-(phenylsulfonyl)- 3-indoleboronic acid 
D14 with alkene D8 in good yield. 2,2-Dimethyl-1,3-propanediol benzeneboronate 
D15 was prepared from the corresponding arylboronic acids20 and subjected to the  
Pd(II) catalysis, giving rise to the exclusive synthesis of tert-butyl trans-cinnamate. 
Likewise, 3,5-dimethyl-4-methoxybenzene catechol boronate D16 furnished the  
corresponding arylated product in 79% yield. No biphenyl product was observed at all.  
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Fused aromatic and heterocyclic boronic acids were also effective inthis protocol. The  
arylboronates of 1-naphthaleneboronic acid D17 and 4-dibenzofuranboronic acid D18 
afforded 85 and 77% yields of the desired arylated products, respectively. 
O
B
O
O
N
B(OH)2
SO2Ph
MeO B(OH)2 B(OH)2
Ac
CO2tBu
ArB(OR)2, 10 mole% Pd(OAc)2, O2
  Na2CO3, DMF, 50oC, 3 h
CO2tBuAr
B
O
O
BMeO
O
O B
O
O
B
O
O
S
ArB(OR)2 ArB(OR)2
 Table 4-4. Various Aryl Boronic acids Coupled with tert-Butyl acrylate
D5D1
D14
D15
D17D16
D18
D19
D8
yield
79%
75%
79%
77%
78%
92%
85%
52%
yield
 
Next, the coupling with 2,2-dimethyl-1,3-propanediol boronate of thianaphthene-
2-boronic acid D19 was smooth with moderate yield.  
 
4.2.8 The Coupling with Allylbenzene 
Table 4-5 shows the reactions of allylbenzene D20 with various boron  
compounds. Various arylboron compounds were coupled with allylbenzene smoothly to 
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deliver the mixture ofthe double-bond-migrated isomers. Electron density in arylboronic  
acids did not have a significant influence on the results, still giving the desired products  
in high yields (entries 1, 2). 
ArB(OR)2
ArB(OR)2, 10 mole% Pd(OAc)2, O2
  Na2CO3, DMF, 50oC, 3 h
PhArPh
 Table 4-5. Various Aryl Boron Reagents Coupled with Allylbenzene
yieldentry
3
4
1
5
2 D5
D1 80% (1/1.0)a
86% (1/1.6)a
83% (1/1.3)
85% (1/5.4)
82% (1/3.0)a
D17
D16
D18
a Reaction solvent = CH3CN.
D20
 
Arylboronates containing bulky fused aromatic or heterocyclic groups were equally  
effective in this protocol to provide the regioisomeric mixtures (entries 3-5).  
 
4.2.9 The Coupling with Highly Substituted Olefins 
Having obtained satisfactory results with monosubstituted alkenes, the research  
was expanded to the arylation of a highly substituted system as depicted in Table 4-
6. Ethyl trans-crotonate reacted with phenylboronic acid to give 70% yield of ethyl β-
methylcinnamate D21 with exclusive (E)-configuration. trans-β-Methylstyrene reacted  
smoothly with both phenylboronic acid and 3-acetylphenylboronic acid to  
furnish the corresponding trans-α-methylstilbenes D22, D23 in high yields.  
Conversely, α-methylstyrene delivered an inseparable mixture of trans-α-methylstilbene  
and α-benzylstyrene D24 in 69% yield in a ratio of 1/1.5. Cyclohexene, 
a cyclic disubstituted olefin, was also effective in our protocol  
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to furnish a 1/2 mixture of 3-phenylcyclohexene and 4-phenyl- cyclohexene D25 
in 48% yield. These data implied that this oxygen protocol could be applicable to most  
highly substituted olefin systems, resulting in outstanding (E)-selectivity.  
10 mole% Pd(OAc)2, O2
  Na2CO3, DMF, 50 oC, 3 h
Ph
CO2Et
Ph
Ph
Ph
Ph +
Ph
Ph
Ph
PhAc
70% 82%
69%
(1/1.5)
48%
(1/2)
Product
86%a
 a  3-Acetylphenylboronic acid was used as a coupling partner.
Olefin
(D21) (D22)
(D23) (D24)
(D25)
D9,
 Table 4-6. Coupling with Highly Substituted Olefins  
 
4.2.10 Phenol Formation 
During the research, it was found that phenols were sometimes observed as  
minor side products along with the aforementioned biaryls.18c  When arylboronic acids  
were utilized as couplingpartners the phenols were isolated in 5% yield, whereas  
arylboronates functioned as benign coupling partners for this methodology, decreasing th
eformation of side products such as biaryls and phenols (Table 4-7). From these data,  
some mechanistic insight was inferred and a catalytic passway were suggested for the  
homo coupling reactions after conducting further experiment later on.   
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CO2tBu CO2
tBu
PhPhB(OR)2+ Ph Ph Ph OH+ +
D8 D10 D33 D60
PhB(OR)2 (1.0 eq) D10 D33 D60
D9
D15
81% 7% 5%
90% 4% trace
Table 4-7. Phenol formation
*Reaction conditions: O2, Pd(OAc)2, Na2CO3, DMF, 50  oC, 3 h
 
 
4.2.11 Competition Reaction and Reaction Cycle 
To elucidate the catalytic pathway of this oxygen protocol, we conducted the  
competition reactions using tert-butyl acrylate (D8, 3 mmol), 21  2,2-dimethyl-1,3-
propanediol boronate of 3-acetylphenylboronic acid (D26, 1 mmol), and 2-
iodoanisole (D27, 1 mmol). As shown in Scheme 4-1, 71% of Pd(II) catalysis  
product D28 and 26% of Heck coupling product D29 were isolated using oxygen  
conditions, while only 18% of D30 was isolated together with Heck product as the major 
product using oxygen free conditions (argon atmosphere). The Suzuki coupling product22
 D30 was detected in low yield under both conditions. The side products,17,21 D31 and D3
2, were detected with oxygen conditions in 5 and 6% yields, respectively. From these  
results, it was inferred that molecular oxygen promoted the desired Pd(II) catalysis and  
suppressed the competing Pd(0) catalytic pathways (Scheme 4-2). 
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 CO2tBu Ar1 B
O
O
+ Ar2 I
Ar1
CO2tBuAr2
CO2tBu Ar1 Ar2
O2d
Ar
Ar1 Ar1 Ar1 OH
+
 Scheme 4-2. Competition Reaction
71% 26% 0.5%
18% 74% 1%
a Ar1 = 3-acetylphenyl. b Ar2 = 2-methoxyphenyl.
(D8, 3 mmole)(D26, 1 mmole)a(D27, 1 mmole)b
Heck  Suzuki
c
5%
0%
D31
6%
0%
D32
 d Oxygen was delivered by bubbling into the reaction solution slowly.
Pd(II) catalysis
D28 D29 D30
 c 20 mole% Pd(OAc)2, Na2CO3, DMF, 50 ?C, 6 h.
 
Although the details are not yet known, a mechanistic catalytic cycle was  
proposed as shown in Figure 4-1. Presumably, the Pd(II) works as the active species  
throughout the reaction as suggested by Mori.11 As delineated in cycle I, transmetalation  
of arylboronic acid gives Ar-Pd-L, and migratory insertion of the olefin is followed by β-
hydride elimination to produce the desired product and Pd(0) species. Molecular oxygen 
then oxidizes the Pd(0) to Pd(II) species, possibly via a peroxopalladium(II) complex.19 
The high efficiency of the Pd(0) complex, Pd2(dba)3, can be explained by this  
scheme involving the oxidation step of Pd(0) species by oxygen. The preference of our  
oxygen-promoted Pd(II) catalysis to the conventional Heck or Suzuki catalysis under  
an oxygen atmosphere can also be explained by this reaction scheme involving rapid oxid
ation of Pd(0) species. Therefore, Pd(0)-catalyzed oxidative addition of 2-iodoanisole can 
be suppressed to follow Heck or Suzuki pathways (cycle II). 
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  Figure 4-1. Reaction Cycle
Pd(0)
Pd(II)
R
R
Ar
Ar'-X
Cycle ICycle II
O2
Heck Catalysis
Suzuki Coupling
Oxygen promoted
Pd(II) Catalysis
Ar'-Pd-X
Ar-B(OR)2
Ar-Pd-L
"Oxidative addition"
"Fast"
R
Ar'Ar-Ar' or
"Slow"
"Transmetalation"
R
Ar
Pd-L
 
 
4.2.12 Conclusion 
In conclusion, a mild and efficient Pd(II)  catalysis, an organometallic variation of
 Heck reaction was elaborated. The newly developed protocol uses an environmentally fri
endly and inexpensive oxidant, molecular oxygen, and provides various aryl-
alkenyl coupling products from a broad spectrum of olefins and arylboron compounds in 
good to excellent yields. This oxygen protocol demonstrates a new mechanistic concept  
that oxygen would promote the Pd(II) catalytic pathway and in turn suppress the  
competing Pd(0) catalysis encompassing Heck or Suzuki couplings.  
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4.3 Oxidative Dimerization: Pd(II) Catalysis in the Presence of Oxygen using 
Aqueous Media 
The synthesis of biaryls has been widely studied beginning with the classic  
Ullmann coupling.23 Many reactions including Stille and Suzuki couplings allow for the  
syntheses of both symmetric and unsymmetrical biaryls in high yields. 24 Recent interest  
in oxidative dimerizations for the synthesis of symmetric biaryls has resulted in a number
 of studies, mostly employing organostannanes. 25 Our group has reported improved  
conditions for the rapid synthesis of biaryls from stannanes using Cu(II) salts as Pd(II)  
catalyst reoxidants.26 However, organotin compounds and their by-products are difficult 
to remove and highly toxic.27 To alleviate the problems associated with organostannanes, 
alternatives employing less-toxic analogs  such as boronic acids are desirable.  
Additionally, aryl and vinyl boronic acids are becoming more readily available from com
mercial sources.28  
 
4.3.1 Precedent Results of Homo Coupling with Organo Boron Reagent 
There have been several reports utilizing boronic acids in oxidative  
dimerizations29 and others using oxygen conditions.30 Jackson et al. reported Pd(II)  
catalyzed couplingsof arylboronic acids using oxygen conditions. 31  However, the  
reaction conditions gave side products resulting in low yields of desired products and  
provided limited examples. To minimize side reactions, useof phase transfer catalysts  
(PTC) was reported for the couplings of arylboronic acids with olefins in aqueous  
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media. 32 Report herein is the palladium-catalyzed carbon-carbon bond formation via 
the oxidative dimerization of boronic acids. By using oxygen as the catalyst reoxidant,  
rapid formation of dimerized products can be obtained in aqueous media under PTC  
conditions. 33  As a distinguishing feature, the procedure allows for the synthesis of  
dienes in good yields with limited side products.  
 
4.3.2 Effect of Oxidant 
The role of the catalyst reoxidant in the dimerization of phenylboronic acid D9  
was critical. The reaction was run under nitrogen, air, and oxygen as oxidants, which  
were delivered either by bubbling or via balloon (Table 1). Very low yields (<10%) of  
biphenyl D33 were obtained when the reaction was run under nitrogen conditions,  
indicating the need for an oxygen source (entry 1). 
oxidant
O2
time yield
3 h 95%
air 24 h 21%
48 h >10%N2
entry
1
2
3
Ph Ph
Pd(OAc)2, oxidant
 NaOAc, H2O, 23 oCD9 D33
Table 4-8. Effect of oxidant choice on oxidative dimerization of phenylboronic acid
PhB(OH)2
 
With the use of air, only 21% yield of the desired product was obtained (entry 2). 
With oxygen, a 95% yield of D33 was achieved in a shorter reaction time (entry 3).  
Surprisingly, no other side products were detected in the reaction mixture. From these  
results, it was inferred that oxygen was the source of reoxidation and best applied in the  
pure oxygen form. Then the optimum reaction conditions were established using NaOAc  
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as the base in aqueous media. In most cases, water was a highly effective solvent either  
with or without PTC.  
 
4.3.3 Effect of PTC 
The PTC employed depended on the substrates being screened, but it was found  
that PTCs with long chain alkyl groups were generally effective for this protocol with fe
wexceptions (Tables 4-9, 10, and 11). The exact mechanism of PTC in this reaction 
was not investigated. However, it was found that it increased the compatibility of  
arylboronic acids with water and palladium catalysts dramatically and minimized the side
 reactions using catalytic amounts.  
 
4.3.4 Example of the Functionalized Phenylboronic Acid 
A screening test of a variety of substituted phenylboronic acids was conducted as  
shown in Table 4-9. Electron rich 4-methoxyphenylboronic acid gave 4,4-dimethoxy  
biphenyl D34 in 95% yield after 3 h without the use of a PTC. Likewise, similar substrate
 4,4-diphenoxybiphenyl D35 was prepared in 95% yield after 10 h. As stated previously, 
the need for PTC to facilitate dimerization is dependent on the boronic acid employed. As
such, the dimerization of 3,4-(methylenedioxy)phenyl boronic acid required 
cetyltrimethylammonium hydrogensulfate (10 mol%, 0.1 M solution) as a PTC. The  
reaction was completed after 10 h to give the product D36 in 84% yield.  
No deacetalization products were detected in the reaction mixture. The dimerization of  
4-(dimethylamino)phenyl boronic acid was smooth to provide the biphenyl D37 in 93%  
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yield after 10 h. No side products resulting from direct oxidation of the nitrogen were  
detected. Electron withdrawing groups did not appear to have an effect on the course of  
the reaction as has been seen in other cases.34 3-Cyanophenylboronic acid gave 3,3-
dicyanobiphenyl D38 in 98% yield after 10 h in the presence of PTC.  
Pd(OAc)2, O2, NaOAc
PTC, H2O, 23 oC
95%95%
MeO
84% 93%
98% 99%
61%
Phase transfer catalyst (PTC) employed, 10 mol%, 0.1 M H2O solution: 
A = CH3(CH2)15N(CH3)3HSO4; B = CH3(CH2)13N(CH3)3Br; 
C = CH3(CH2)11OSO3Na
Ar B(OH)2 Ar Ar
F
NC
O
O
PhO
N
58%
B
A
B
C
94%
Ac
Table 4-9. Formation of biphenyls from boronic acids
OMe OPh
N
CN
F
Ac
O
O
D34 D35
D36 D37
D38 D39
D40 D41
D42
 
4,4-Difluorobiphenyl D39 was prepared in nearly quantitative yield after only 3 h  
without the need for PTC. The 4-bromo and 4-iodo congeners were also screened, 
but produced low yields of desired products (<30%) despite our best efforts.  
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3-Acetylphenylboronic acid gave the biphenyl product D40 in 94% yield in 3 hours. 
Next focus was determining the steric effects in the reaction. o-Tolylboronic acid 
was screened and gave only 61% yield of the biphenyl product D41. Likewise, 2,6-
dimethylphenylboronic acid gave a 58% yield of the corresponding  biphenyl D42 in 10 h
 using sodium dodecyl sulfate. Interestingly, this reaction was not effected using cetyltri-
methylammonium hydrogensulfate. From these results, we inferred that steric effects  
hindered product formation of these two substrates as compared with the result of phenyl
boronic acid. Additionally, it was attributed that the lower yields of these substrates to the
low solubility of the boronic acids in water, even under PTC conditions. If steric effects  
were a main factor, the addition of the extra methyl in D42 would have decreasedthe yiel
dproportionally.As gleaned from the experimental results, the yields for the products D41
, D42 arevirtually the same, implying that steric effect is not a sole governor on the  
reaction.  
 
4.3.5 Example of the Multi- and Heterocyclic Arylboronic Acid 
Having obtained satisfactoryresults in the dimerization of phenylboronic acids, th
etest ofversitility of aryl boronic acids was expanded to the multi- and  
heterocyclic arylboronic acids as shown in Table 4-10. Thus, 2-naphthaleneboronic 
acid was dimerized in 10 h and in 95% yield to provide D43. Likewise,  
1-naphthaleneboronic acid reacted to give an 87% yield of corresponding biaryl  
compound D44, albeit without the need of PTC. 
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 Pd(OAc)2, O2, NaOAc
PTC, H2O, 23 oC
R B(OH)2 R R
87%
95%
98% 79%
62%
Phase transfer catalyst (PTC) employed, 10 mol%, 0.1 M H2O solution: 
A = CH3(CH2)15N(CH3)3HSO4; B = CH3(CH2)13N(CH3)3Br
B
O
S
SOHC
A
B A
Table 4-10. Formation of biaryls from boronic acids
O
S
S CHO
D43
D44
D45 D46
D47
 
Next, 4-dibenzofuranboronic acid reacted under PTC conditions in very high  
yield of the product D45. Without the use of PTC conditions, we found numerous side p
roducts occurred. Phenol formation was the major side product, resulting from the additi
on of water to the palladium complex. Additionally, proton exchange also occurred with
 the boron moiety to generate the unfunctionalized aromatic.35 Next, the dimerization of 
heterocyclic boronic acids was studied. The dimerization of thianaphthene- 2-boronic  
acid was efficient, but gave only 79% yield of the product D46 after 10 h. Furthermore, 
5-formyl- 2-thiopheneboronic acid reacted to give the biaryl D47 in only 62% yield.  
In both cases, the starting material was completely consumed and only phenol and  
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unfunctionalized aromatic products were isolated. The dimerizations of other furan and  
thiophene- based boronic acids were attempted, but withlimited success.  
 
4.3.6 Synthesis of Diene 
The synthesis of dienes through the oxidative dimerization of vinylboronic acids 
was efficient as shown in Table 4-11. trans-2-Phenylvinylboronic acid gave good yield 
of the (E,E)-diene product D48 under PTC conditions. Only one isomer was isolated  
with no side products detected, and the remainder of the reaction mixture was unreacted  
starting material. The 4-fluoro congener reacted to give the (E,E)-
diene D49 exclusively in 73% yield after 10 h. 
Pd(OAc)2, O2, NaOAc
PTC, H2O, 23 oC
85%73%75%
79% 65%
R
B(OH)2 R
R
Phase transfer catalyst (PTC) employed, 10 mol%, 0.1 M H2O solution: 
A = CH3(CH2)13N(CH3)3Br; B = CH3(CH2)15N(CH3)3HSO4; C = Bu4NOH
A B B
C C
Table 4-11. Formation of dienes from boronic acids
F Cl
F Cl
D48 D49 D50
D51 D52
 
 Additionally, the 4-chloro compound gave 85% yield of the desired diene D50  
under similar conditions. The synthesis of long chain dienes was also effective using our 
protocol. For example, the dimerization of trans-1-hexen-1-ylboronic acid gave (5E,7E)- 
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5,7- dodecadiene D51 exclusively in 79% yield after 10 h. Additionally, trans-1-octen-1-
ylboronic acid gave (7E,9E)-7,9-hexadecadiene D52 in 65% yield. The remainder  
of the reaction mixture in D51 and D52 was unreacted starting material. With the long  
chain alkenyl boronic acids, we screened the standard PTCs that had been used with  
previous examples in Tables 4-9, 10, and 11. However, these catalysts were  
ineffective and  gave mostly unidentified side productsinstead of the desired dimerized  
materials. Fortunately, the use of tetrabutylammon-ium hydroxide facilitated the  
dimerization of long chain alkenyl boronic acids.  
 
4.3.7 Conclusion 
In conclusion, we have developed a method for the formation of symmetric biaryl
sand dienes via the oxidative dimerization of boronic acids. These conditions utilize Pd(II
)catalysts under an oxygen environment with water as the solvent. The use of PTCs allow
sfor the efficient and mild synthesis of a wide range of products in a rapid fashion.  
Our reaction allows for a more environmentally benign and cost-effective 
alternative to standard oxidative dimerization conditions with organostannanes. 
Additionally, our protocol enhances previous examples of  boronic acid dimerization by 
increasing utility of the reaction. We have achieved this by broadening the range of  
substrates employed to include substituted phenyls, biaryls, heterocycles, and dienes.  
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Chapter Five 
Experimental Data 
 
All experiments were carried out under nitrogen atmosphere using oven dried  
glassware (or flame dried when necessary). All chemicals were purchased from Aldrich  
Chemical Co. and/orAcros Organics and used without further purification unless  
otherwise noted. CH2Cl2 was distilled over calcium hydride. THF and diethyl ether were 
distilled over sodium metal. Proton nuclear magnetic resonance (250 MHz) and 13C  
(62.5 MHz) spectra were recorded at r.t in CDCl3 unless otherwise noted. All chemical  
shifts are reported as δ relative to CHCl3 (δH 7.26 ppm) and CDCl3 (δC 77.0 ppm) as  
internal standards, respectively, using a Buruker DPX 250 spectrometer. Infrared spectra 
were recorded using a Nicolet Magna FTIR 550 spectrometer and are reported in  
reciprocal centimeters (cm-1). Mass analysis was preformed using Hewlett-
Packered HRMS spectroscopy. Thin layer chromatography (TLC) was preformed 
on EMD precoated silica plates with silica gel 60 Å, 250 µm thickness. Visualization of  
TLC was accomplished using a UV lamp (254 nm), iodine or charring solutions  
(ninhydrin and PMA). Flashcolumn chromatography was performed on Whatman Purasil 
60 Å (230-400mesh) silica gel. 
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5.1 Oxygen-promoted Pd(II) Catalysis for the coupling of organoborons with olefins   
5.1.1 Representative Experimental Procedure : Preparation of  
(E)- tert-butyl cinnamate,D10 
 
CO2tBuPh
D10  
tert-Butyl acrylate (64 mg, 0.5 mmol, 1 equiv.) was dissolved in DMF (2.5 mL,  
0.2 M solution), and stirred at room temperature. To the clear solution, was added phenyl
boronic acid (74 mg, 0.6 mmol, 1.2 equiv.) followed by a single addition of Na2CO3 (106 
mg, 1.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.1 equiv.). The reaction flask
 was fitted with an oxygen balloon, heated to 50 °C, and stirred for 3 h. The mixture was  
then diluted with EtOAc (20 mL), and washed with aqueous brine solution (3 × 10 mL). 
The organic layer was dried over anhydrous Na2SO4 and filtered. The filtrate was 
concentrated in vacuo, and subjected to flash chromatography (30 g of SiO2). Elution wit
hHex (100 mL), then 10:1 Hex/EtOAc afforded tert-butyl trans-cinnamate (89 mg, 87%) 
as a colorless oil. Rf=0.6 (9:1 hexanes/EtOAc); 1H NMR (250 MHz, CDCl3)   
δ 7.59(d, J=16.0 Hz, 1 H), 7.50(m, 2 H), 7.38(m, 3 H), 6.37(d, 1 H, J=16.0Hz), 1.54 
(s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 166.3, 143.5, 134.6, 129.9, 128.8, 127.9, 120.1, 
80.5, 28.2.  
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5.1.2 Preparation of  (E)-stilbene, D12 
Ph
Ph
D12  
Rf=0.4 (Hex); 1H NMR (250 MHz, CDCl3) δ 7.55 (m, 4 H), 7.40 (m, 4 H), 7.30  
(m, 2 H), 7.15 (s, 2 H); 13C NMR (62.5 MHz, CDCl3) δ 137.3, 128.7, 128.6, 127.6, 126.5.
  
5.1.3 Preparation of  (E)-(2-butoxyvinyl)benzene, D11 
OBu
Ph
D11  
Rf=0.5 (Hex); 1H NMR (250 MHz, CDCl3) δ 7.60-7.11 (m, 5 H), 7.07 (d, 1 H,  
J = 23.5 Hz), 5.83 (d, 1 H, J = 23.5 Hz), 3.84 (t, 2 H, J = 6.5 Hz), 1.76-
1.44 (m, 4 H), 1.00 (t, 3 H, J = 7.3 Hz). 
 
5.1.4 Preparation of (E)-prop-1-ene-1,3-diyldibenzene, D13 
Ph
D13
Ph
 
Rf=0.8 (10:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.43-
7.20 (m, 10 H), 6.55-6.34 (m, 2 H), 3.59 (d, 2 H, J = 6.1 Hz); 13C NMR  
(62.5 MHz, CDCl3) δ 140.2, 137.5, 131.1, 129.2,128.7, 128.5, 127.1, 126.1, 39.4.  
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5.1.5 Preparation of (E)-ethyl 3-(4-methoxyphenyl)acrylate 
CO2tBu
MeO  
Rf=0.4 (1:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.54 (d, 1 H,  
J = 15.9 Hz), 7.45 (d, 2 H, J = 8.7 Hz), 6.89 (d, 2 H, J = 8.7 Hz), 6.23 (d, 1 H,  
J= 15.9 Hz), 3.83 (s, 3 H), 1.53 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ166.7, 161.1,  
143.2, 129.5, 127.3, 117.6, 114.2,  114.1, 80.2, 55.3, 28.2. 
 
5.1.6 Preparation of (E)-ethyl 3-(3-acetylphenyl)acrylate 
CO2tBu
Ac  
Rf=0.4 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.07 (s, 1 H), 7.92  
(m, 1 H), 7.67 (m, 1 H), 7.60 (d, 1 H, J = 16 Hz), 7.47 (m, 1 H), 6.43 (d, 1 H, J = 16 Hz), 
2.62 (s, 3 H), 1.53 (s, 9 H) ; 13C NMR (62.5 MHz, CDCl3) δ 197.5, 165.9, 142.3, 137.6,  
135.1,132.1, 129.5, 129.1, 127.5, 121.6, 80.8, 28.1, 26.6. 
 
5.1.7 Preparation of (E)-ethyl 3-(1-(phenylsulfonyl)-1H-indol-3-yl)acrylate 
 
CO2tBu
N
SO2Ph  
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Rf=0.7 (2:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.01 (d, J = 7.8 Hz),  
7.90 (m, 2 H), 7.79 (m, 2 H), 7.68 (d, 1 H, J = 16.1 Hz), 7.56-7.31 (m, 5 H), 6.45   
(d, 1 H, J = 16.1 Hz), 1.54 (s, 9 H) ; 13C NMR (62.5 MHz, CDCl3) δ 166.3, 137.7,  
135.6, 134.3, 129.4, 129.2, 128.2, 127.8, 126.8, 125.5, 124.1, 120.7, 118.5, 113.6, 80.6,  
57.6, 28.2.  
 
5.1.8 Preparation of (E)-ethyl 3-(4-methoxy-3,5-dimethylphenyl)acrylate 
CO2tBu
MeO
 
Rf=0.5 (10:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.48 (d, 1 H,  
J=15.9 Hz), 7.17 (s, 2H), 6.25 (d, 1 H, J =15.9 Hz), 3.73 (s, 3 H), 2.28 (s, 6 H), 1.52  
(s, 9 H) ; 13C NMR (62.5 MHz, CDCl3) δ 166.5, 158.6, 143.3, 131.3, 130.1, 128.6,  
118.8, 80.2, 59.7, 28.2, 16.1. 
 
5.1.9 Preparation of (E)-ethyl 3-(naphthalen-1-yl)acrylate 
CO2tBu
 
Rf=0.7 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3)  δ 8.43 (m, 1 H), 8.20  
(m, 1 H), 7.88(m, 2 H), 7.74 (m, 1 H), 7.58-7.44 (m, 3 H), 6.47 (d, 1 H, J = 15.7 Hz), 
1.59 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 166.2, 140.5, 133.6, 132.0, 131.4, 130.2,  
128.6, 126.7, 126.1, 125.4, 124.9, 123.4, 122.8, 80.6, 28.2. 
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5.1.10 Preparation of (E)-(4-benzofuranyl) tert-butyl acrylate 
CO2tBu
O
 
Rf=0.6 (2:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.95 (m, 2 H), 7.89  
(d, 1 H, J=16.1 Hz), 7.68-7.31 (m, 5 H), 7.00 (d, 1 H, J=16.1 Hz), 1.60 (s, 9 H);  
13C NMR (62.5 MHz, CDCl3) δ 166.6, 156.1, 154.3, 138.2, 128.1, 127.5, 124.9, 123.6,  
123.4, 123.1, 122.9, 121.9, 120.7, 119.9, 111.9, 80.6, 28.2. 
 
5.1.11 Preparation of (E)-ethyl 3-(benzo[b]thiophen-2-yl)acrylate 
CO2tBu
S
 
Rf=0.7 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.77 (d, 1 H, J = 15.6  
Hz), 7.76 (m, 2 H), 7.43 (s, 1 H), 7.37 (m, 2 H), 6.23 (d, 1 H, J = 15.6 Hz), 1.54 (s, 9 H);  
13C NMR (250 MHz, CDCl3) δ 165.8, 140.0, 139.7, 139.6, 136.6, 128.2, 126.0, 124.8,  
124.3, 122.4, 121.5, 80.8, 28.1. 
 
5.1.12 Preparation of D20 + D1 
MeO
Ph
 
Rf=0.8 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.38-7.15 (m, 7 H), 6.86  
(m, 2 H), 6.45-6.18 (m, 2 H), 3.81 (s, 3 H), 3.56-3.49 (d, 2 H). 
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5.1.13 Preparation of D20 + D5 
Ac
Ph
 
Rf=0.5 (2:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.93-7.77 (m, 2 H),  
7.54-7.20 (m, 9 H), 6.52-6.35 (m, 2 H), 3.60 (d, 2 H), 2.60 (s, 3 H).  
 
5.1.14 Preparation of D20 + D16 
MeO
Ph
 
Rf=0.6 (10:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.34-7.15 (m, 5 H),   
6.98 (s, 1 H), 6.84 (s, 1 H), 6.38-6.05 (m, 2 H), 3.66 (s, 3 H),  
3.47 (d, J = 6.3 Hz, 1 H), 3.39 (d, J = 6.4 Hz, 1 H), 2.22 (s, 6 H).  
 
5.1.15 Preparation of D20 + D17 
Ph
 
Rf=0.6 (9:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.10-
7.19 (m, 12 H), 6.60-6.30 (m, 2 H), 4.02, 3.70 (d, J = 4.7, 7.6 Hz, 2 H) . 
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5.1.16 Preparation of D20 + D18 
O
Ph
 
Rf=0.6 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.10-7.25 (m, 12 H),  
6.54 (m, 2 H), 3.93, 3.70 (d, J = 5.1, 5.7 Hz, 2 H)  
 
5.1.17 Preparation of  (E)-ethyl 3-phenylbut-2-enoate, D21 
Ph
CO2Et
D21  
Rf=0.7 (10:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.48 (m, 2 H), 7.38  
(m, 3 H), 6.14(d, J = 1.2 Hz, 1 H), 4.22 (q, J =7.1 Hz, 2 H), 2.58 (d, J = 1.2 Hz, 3 H),  
1.32 (t, J = 7.1 Hz); 13C NMR (62.5 MHz, CDCl3) δ 166.8, 155.5, 142.2, 128.9, 128.4,  
126.3, 117.1, 59.8, 17.9, 14.3. 
 
5.1.18 Preparation of (E)-methyl stilbene, D22 
Ph
Ph
D22  
Rf=0.8 (10:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.56 (m, 2 H), 7.43-
7.27 (m, 8 H), 6.87 (s, 1 H), 2.31 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 143.9, 138.3,  
137.4, 129.1, 128.3, 128.1, 127.6, 127.1, 126.4, 126.0, 17.5. 
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5.1.19 Preparation of  D23 
PhAc
D23  
Rf=0.7 (2:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.12 (s, 1 H), 7.88  
(d, J =7.7 Hz, 1 H), 7.73(d, J =7.7 Hz, 1 H ), 7.50-7.26 (m, 6 H), 6.89 (s, 1 H),  
2.65 (s, 3 H), 2.31(s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 198.3, 144.4, 137.9, 137.2,  
136.5, 130.6, 129.1, 128.7, 128.6, 128.2, 127.1, 126.7, 125.7, 26.8, 17.5. 
 
5.1.20 reparation of  cyclohex-2-enylbenzene, cyclohex-3-enylbenzene D25 
Ph
D25  
Rf=0.9 (Hex); 1H NMR (250 MHz, CDCl3) δ 7.34-7.15 (m, 5 H), 5.92-
5.69 (m, 2 H), 3.40 and 2.81 (m, 1 H), 2.20-1.52 (m, 6 H). 
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5.2 Oxidative dimerization: Pd(II) catalysis in the presence of oxygen using aqueous 
media 
 
5.2.1 Representative Experimental Procedure : Preparation of Biphenyl, D33 
D33  
Phenylboronic acid (122 mg, 1.0 mmol, 1 equiv.) was mixed with water in the  
reaction flask (10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the solution  
was added NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 
equiv.). A balloon of O2 was placed over the neck of the flask and the solution was stirred
at room temperature for 3 h. The mixture was then diluted with 1:1 Hex/EtOAc (10 mL), 
extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine (10 mL). The organic 
layer was concentrated in vacuo, and subjected to flash chromatography (30 g SiO2,  
eluted with 10:1 Hex/EtOAc) to afford biphenyl (73 mg, 95%). Rf=0.9 (Hex); 1H NMR 
(250 MHz, CDCl3) δ 1.57(s, 9 H), 6.37(d, 1 H, J =16.0 Hz), 7.38(m, 3 H),7.50(m, 2 H),  
7.59(d, 1 H, J =16.0 Hz); 13C NMR (250 MHz, CDCl3) δ 28.2, 80.5, 120.1, 127.9,  
128.8, 129.9, 134.6, 143.5, 166.3. 
 
 
157
5.2.2 Preparation of  4,4'-dimethoxybiphenyl,  D34 
MeO OMe
D34  
Rf=0.4 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.49 (d, 4 H, J =8.4 Hz), 
6.97(d, 4 H, J =8.4 Hz), 3.85 (s, 6 H); 13C NMR (62.5 MHz, CDCl3) δ 158.6, 133.4,  
127.7, 114.1, 55.3. 
 
5.2.3 Preparation of  N4,N4,N4',N4'-tetramethylbiphenyl-4,4'-diamine, D37 
N N
D37  
Rf=0.4 (5:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.56 (d, J = 8.8 Hz, 4 H),
 7.88 (d, J = 8.8 Hz, 4 H), 3.05 (s, 12 H). 
 
5.2.4 Preparation of 1,1'-binaphthyl, D44 
D44  
Rf=0.8 (1:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.96 (m, 4 H), 7.61  
(m, 2 H), 7.52-7.39 (m, 6 H), 7.30 (m, 2 H). 
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5.2.5 Preparation of 5,5'-bibenzo[d][1,3]dioxole, D36 
O
O
O
O
D36  
3,4-(Methylenedioxy)Phenylboronic acid (126 mg, 1.0 mmol, 1 equiv.) was  
mixed with a 0.1 M stock aqueous solution of cetyltrimethylammonium hydrogensulfate  
in the reaction flask (10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the  
solution was added NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg,  
0.05 mmol, 0.05 equiv.). A balloon of O2 was placed over the neck of the flask and the  
solution was stirredat room temperature for 3 h. The mixture was then diluted with 1:1  
Hex/EtOAc (10 mL), extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine 
(10 mL). The organic layer was concentrated in vacuo, and subjected to flash  
chromatography (30 g SiO2, eluted with 10:1 Hex/EtOAc) to afford biphenyl  
(100 mg, 84%). Rf=0.7 (1:1 Hex/EtOAc); 1H NMR (250MHz, CDCl3)  
δ 6.99-6.95 (m, 4 H), 6.87-6.83 (m, 2 H), 5.99 (s, 4 H). 
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5.2.6 Preparation of  2,2'-binaphthyl, D43 
D43  
Rf=0.7 (1:1 hexanes/EtOAc); 1H NMR (250 MHz, CDCl3) δ 8.18 (s, 2 H),  
7.99-7.87 (m, 8 H), 7.57-7.48 (m, 4 H). 
 
5.2.7 Preparation of 2,2'-dimethylbiphenyl, D41 
D41  
o-Toluylboronic acid (136 mg, 1.0 mmol, 1 equiv.) was mixed with 
a 0.1 M stock aqueous solution of tetradecyltrimethylammonium bromide in the reaction  
flask (10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the solution was added
 NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 equiv.).  
A balloon of O2 wasplaced over the neck of the flask and the solution was stirred at room  
temperature for 3 h. The mixture was then diluted with 1:1 Hex/EtOAc (10 mL),  
extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine (10 mL). The organic 
layer was concentrated in vacuo, and subjected to flash chromatography (30 g SiO2,  
eluted with 10:1 Hex/EtOAc) to afford biphenyl (60 mg, 61%). Rf=0.8 (5:1 Hex/EtOAc);
1H NMR (250 MHz, CDCl3) δ 7.31-7.13 (m, 8 H), 2.10 (s, 6 H). 
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5.2.8 Preparation of biphenyl-3,3'-dicarbonitrile, D38 
NC CND38  
Rf=0.6 (1:1 Hex/EtOAc); 1H NMR(250MHz, CDCl3) δ 7.90-7.75 (m, 4 H),  
7.70 (m, 2 H), 7.62 (m, 2 H).  
 
5.2.9 Preparation of (1E,3E)-1,4-diphenylbuta-1,3-diene, D48 
D48  
trans-2-Phenylvinylboronic acid (148 mg, 1.0 mmol, 1 equiv.) was mixed with 
 a 0.1 M stock aqueous solution of cetyltrimethylammonium hydrogensulfate in the  
reaction flask (10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the solution 
was added NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 
equiv.). A balloon of O2 wasplaced over the neck of the flask and the solution was stirred 
at room temperature for 3 h. The mixture was then diluted with 1:1 Hex/EtOAc (10 mL), 
extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine (10 mL). The organic 
layer was concentrated in vacuo, and subjected to flash chromatography (30 g SiO2, 
eluted with 10:1 Hex/EtOAc) to afford biphenyl (80 mg, 75%). Rf=0.7 (5:1 Hex/EtOAc);
1H NMR (250 MHz, CDCl3) δ 7.55-7.20 (m, 10 H), 7.05-6.85 (m, 2 H), 6.75-
6.60 (m, 2 H). 
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5.2.10 Preparation of  (1E,3E)-1,4-bis(4-fluorophenyl)buta-1,3-diene, D49 
F
F
D49  
trans-2-(4-fluorophenyl)vinylboronic acid (166 mg, 1.0 mmol, 1 equiv.) was  
mixed with a 0.1 M stock aqueous solution of tetradecyltrimethylammonium bromide in  
the reaction flask (10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the  
solution was added NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05  
mmol, 0.05 equiv.). A balloon of O2 wasplaced over the neck of the flask and the solution
was stirred at room temperature for 3 h. The mixture was then diluted with 1:1  
Hex/EtOAc (10 mL), extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine 
(10 mL). The organic layer was concentrated in vacuo, and subjected to  
flash chromatography (30 g SiO2, eluted with 10:1 Hex/EtOAc) to afford biphenyl  
(60 mg, 61%). Rf=0.8 (1:1 Hex/EtOAc); 1H NMR (250 MHz, CDCl3) δ 7.40 (m, 4 H), 
7.02 (m, 4 H), 6.88-6.81 (m, 2 H), 6.65-6.58 (m, 2 H). 
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5.2.11 Preparation of  (1E,3E)-1,4-bis(4-fluorophenyl)buta-1,3-diene, D51 
D51  
trans-1-hexene-1-ylboronic acid (128 mg, 1.0 mmol, 1 equiv.) was mixed with 
a 0.1 M stock aqueous solution of tetrabutylammonium hydroxide in the reaction flask  
(10.0 mL, 0.1 M solution) and rapid stirring was begun. Into the solution was added  
NaOAc (272 mg, 2.0 mmol, 2 equiv.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 equiv.).  
A balloon of O2 wasplaced over the neck of the flask and the solution was stirred at room 
temperature for 3 h. The mixture was then diluted with 1:1 Hex/EtOAc (10 mL),  
extracted with 1:1 Hex/EtOAc (3×20 mL), then washed with brine (10 mL). The organic 
layer was concentrated in vacuo, and subjected to flash chromatography  
(30 g SiO2, eluted with 10:1 Hex/EtOAc) to afford biphenyl (65 mg, 79%). Rf=0.9  
(5:1 Hex/EtOAc);1H NMR (250 MHz, CDCl3) δ 6.02-5.97 (m, 2 H), 5.61-5.53  
(m, 2 H), 2.06-1.97 (m, 4 H), 1.50-1.25 (m, 8 H), 1.00-0.88 (m, 6 H). 
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Appendix A: Selected 1H NMR and 13C NMR Spectra 
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